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A B S T R A C T
Background
Non-invasive brain stimulation techniques aim to induce an electrical stimulation of the brain in an attempt to reduce chronic pain
by directly altering brain activity. They include repetitive transcranial magnetic stimulation (rTMS), cranial electrotherapy stimulation
(CES) and transcranial direct current stimulation (tDCS).
Objectives
To evaluate the efficacy of non-invasive brain stimulation techniques in chronic pain.
Search methods
We searched CENTRAL, MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS, the Cochrane PaPaS Group Trials Register and
clinical trials registers.
Selection criteria
Randomised and quasi-randomised studies of rTMS, CES or tDCS if they employed a sham stimulation control group, recruited
patients over the age of 18 with pain of three months duration or more and measured pain as a primary outcome.
Data collection and analysis
Two authors independently extracted and verified data. Where possible we entered data into meta-analyses. We excluded studies judged
as being at high risk of bias from the analysis.
Main results
We included 33 trials in the review (involving 937 people)(19 rTMS, eight CES and six tDCS). Only one study was judged as being
at low risk of bias.
Studies of rTMS (involving 368 participants ) demonstrated significant heterogeneity. Pre-specified subgroup analyses suggest that low-
frequency stimulation is ineffective. A short-term effect on pain of active high-frequency stimulation of the motor cortex in single-dose
studies was suggested (standardised mean difference (SMD) -0.40, 95% confidence interval (CI) -0.26 to -0.54, P < 0.00001). This
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equates to a 15% (95% CI 10% to 20%) reduction in pain which does not clearly exceed the pre-established criteria for a minimally
clinically important difference (> 15%).
For CES (four studies, 133 participants) no statistically significant difference was found between active stimulation and sham. Analysis
of tDCS studies (five studies, 83 people) demonstrated significant heterogeneity and did not find a significant difference between active
and sham stimulation. Pre-specified subgroup analysis of tDCS applied to the motor cortex suggested superiority of active stimulation
over sham (SMD -0.59, 95% CI -1.10 to -0.08).
Non-invasive brain stimulation appears to be associated with minor and transient side effects.
Authors’ conclusions
Single doses of high-frequency rTMS of the motor cortex may have small short-term effects on chronic pain. The effects do not clearly
exceed the predetermined threshold of minimal clinical significance. Low-frequency rTMS is not effective in the treatment of chronic
pain. There is insufficient evidence from which to draw firm conclusions regarding the efficacy of CES or tDCS. The available evidence
suggests that tDCS applied to the motor cortex may have short-term effects on chronic pain and that CES may be ineffective. There
is a need for further, rigorously designed studies of all types of stimulation.
P L A I N L A N G U A G E S U M M A R Y
Stimulating the brain without surgery in the management of chronic pain
Various devices are available that can electrically stimulate the brain without the need for surgery or any invasive treatment. There are
three main treatment types: repetitive transcranial magnetic stimulation (rTMS) in which the brain is stimulated by a coil applied to
the scalp, cranial electrotherapy stimulation (CES) in which electrodes are clipped to the ears or applied to the scalp and transcranial
direct current stimulation (tDCS), in which electrodes are applied to the scalp. These have been used to try to reduce pain by aiming
to alter the activity of the brain but the efficacy of these treatments is uncertain.
This review included 33 studies, 19 of rTMS, eight of CES and six of tDCS. Only one study was judged as having a low risk of bias.
Analysis suggests that low-frequency rTMS is not effective but that a single-dose of high-frequency stimulation of the motor cortex
area of the brain provides short-term pain relief. This effect appears to be small. There is limited and conflicting evidence from studies
involving multiple doses of rTMS. Most studies of rTMS are small and there is substantial variation between studies in terms of the
treatment methods used.
There was insufficient evidence from which to draw strong conclusions regarding CES or tDCS but the available evidence does not
suggest that CES is an effective treatment. There is limited evidence that tDCS to the motor cortex may have short-term effects on
chronic pain but it is not possible to estimate the size of this effect accurately.
The reporting of side effects varied across the studies. Of the studies that clearly reported side effects only short-lived and minor side
effects such as headache, nausea and skin irritation were reported.
More studies of rigorous design and adequate size are required to evaluate all forms of non-invasive brain stimulation for the treatment
of chronic pain accurately.
B A C K G R O U N D
Description of the condition
Chronic pain is a common problem. When defined as pain of
greater than three months duration, prevalence studies indicate
that up to half the adult population suffer from chronic pain, and
10% to 20% experience clinically significant chronic pain (Smith
2008). In Europe 19% of adults experience chronic pain of mod-
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erate to severe intensity with serious negative implications for their
social and working lives and many of these receive inadequate pain
management (Breivik 2006). Chronic pain is a heterogenous phe-
nomenon that results from a wide variety of pathologies including
chronic tissue injury such as arthritis, peripheral nerve injury, cen-
tral nervous system injury as well as a range of chronic pain syn-
dromes such as fibromyalgia. It is likely that different mechanisms
of pain production underpin these different causes of chronic pain
(Ossipov 2006).
Description of the intervention
Brain stimulation techniques have been used to address a variety of
pathological pain conditions including fibromyalgia, chronic post-
stroke pain and complex regional pain syndrome (Cruccu 2007;
Fregni 2007;Gilula 2007) and clinical studies of both invasive and
non-invasive techniques have produced preliminary data show-
ing reductions in pain (Cruccu 2007; Fregni 2007; Lefaucheur
2008b). Various types of brain stimulation, both invasive and non-
invasive are currently in clinical use for the treatment of chronic
pain (Cruccu 2007). Non-invasive stimulation techniques require
no surgical procedure and are therefore easier and safer to apply
than invasive procedures.
Repetitive transcranial magnetic stimulation (rTMS) involves
stimulation of the cerebral cortex (the outer layer of the brain) by a
stimulating coil applied to the scalp. Electric currents are induced
in the neurons (brain cells) directly using rapidly changing mag-
netic fields (Fregni 2007). Trains of these stimuli are applied to
the target region of the cortex to induce alterations in brain activ-
ity both locally and in remote brain regions (Leo 2007). A recent
meta-analysis suggested that rTMS may be more effective in the
treatment of neuropathic pain conditions (pain arising as a result
of damage to the nervous system, as in diabetes, traumatic nerve
injury, stroke, multiple sclerosis, epilepsy, spinal cord injury and
cancer) with a central compared to a peripheral nervous system
origin (Leung 2009).
Transcranial direct current stimulation (tDCS) and cranial elec-
trotherapy stimulation (CES) involve the safe and painless appli-
cation of low intensity (commonly ≤ 2 mA) electrical current to
the cerebral cortex of the brain (Fregni 2007; Gilula 2007). tDCS
has been developed as a clinical tool for the modulation of brain
activity in recent years and uses relatively large electrodes that are
applied to the scalp over the targeted brain area to deliver a weak
constant current (Lefaucheur 2008a). Recent clinical studies have
concluded that tDCS was more effective than sham stimulation at
reducing pain in both fibromyalgia and spinal cord injury related
pain (Fregni 2006a; Fregni 2006b). CES was initially developed in
the USSR as a treatment for anxiety and depression in the 1950s
and its use later spread to Europe and the USA where it began to
be considered and used as a treatment for pain (Kirsch 2000). The
electrical current inCES is commonly pulsed and is applied via clip
electrodes that are attached to the patients earlobes. A Cochrane
Review of non-invasive treatments for headaches (Bronfort 2004)
identified limited evidence that CES is superior to placebo in re-
ducing pain intensity after six to 10 weeks of treatment.
How the intervention might work
Brain stimulation techniques primarily seek to modulate activity
in brain regions by directly altering the level of brain activity. The
aim of brain stimulation in the management of pain is to reduce
pain by altering activity in the areas of the brain that are involved
in pain processing.
Both tDCS and rTMS have been shown tomodulate brain activity
specific to the site of application and the stimulation parameters.
As a general rule low-frequency rTMS (≤ 1Hz) results in lowered
cortical excitability at the site of stimulation, whereas high-fre-
quency stimulation (≥ 5 Hz) results in raised cortical excitability
(Lefaucheur 2008a; Pascual-Leone 1999). Similarly anodal tDCS,
wherein the anode electrode is placed over the cortical target re-
sults in a raised level of excitability at the target, whereas cathodal
stimulation decreases local cortical excitability (Nitsche 2008). It
is suggested that the observed alterations in cortical excitability
(readiness for activity) following rTMS and tDCS that last beyond
the time of stimulation are the result of long-term synaptic changes
(Lefaucheur 2008a). Modulation of activity in brain networks is
also proposed as the mechanism of action of CES therapy and it is
suggested that therapeutic effects are primarily achieved by direct
action upon the hypothalamus, limbic system and/or the reticular
activating system (Gilula 2007).
Imaging studies in humans suggest that motor cortex stimulation
may reduce pain by modulating activity in networks of brain areas
involved in pain processing, such as the thalamus and by facilitat-
ing descending pain inhibitory mechanisms (Garcia-Larrea 1997;
Garcia-Larrea 1999; Peyron 2007).
Sham credibility issues for rTMS studies
An issue regarding the credibility of sham conditions specifically
for rTMS studies is whether the sham condition that is employed
controls for the auditory (clicking sounds of various frequen-
cies) and sensory stimulation that occurs during active stimula-
tion (Lisanby 2001; Loo 2000). Various types of sham have been
proposed including angling the coil away from the scalp (thus pre-
serving the auditory cues but not the sensation of stimulation),
using coils that mimic the auditory cues combined with gentle
scalp electrical stimulation to mask the sensation and simple inert
coils that reproduce neither the sound nor the sensation of active
stimulation. Failure to control for such cues may impact nega-
tively on patient blinding, particularly in cross-over design studies.
Lisanby 2001 and Loo 2000 suggest that an ideal sham condition
for rTMS should:
1. not stimulate the cortex;
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2. be the same as active stimulation in visual terms and in
terms of its position on the scalp; and
3. not differ from active stimulation in terms of the acoustic
and afferent sensory sensations that it elicits.
Devices have been developed that meet these criteria (Borckardt
2008; Rossi 2007; Sommer 2006). There is evidence that simply
angling the coil away from the scalp at an angle of less than 90°
may still result in brain stimulation and not be truly inert (Lisanby
2001). This strategy is also easily detected by the recipient of
stimulation. In these ways this type of sham might obscure or
exaggerate a real clinical effect of active stimulation.
Why it is important to do this review
This approach to pain treatment is relatively novel. It is important
to assess the existing literature robustly to ascertain the current level
of supporting evidence and to inform future research and potential
clinical use. Recent reviews have addressed this area and concluded
that non-invasive brain stimulation can exert a significant effect on
chronic pain but have restricted their findings to specific cortical
regions, types of painful condition or types of stimulation and did
not carry out a thorough assessment of study quality or risk of bias
(Lefaucheur 2008b; Leung 2009; Lima 2008).
O B J E C T I V E S
To review all randomised and quasi-randomised studies of non-
invasive cortical stimulation techniques in the treatment of chronic
pain. The key aims of the review were:
1. to critically evaluate the efficacy of non-invasive cortical
stimulation techniques compared to sham controls for chronic
pain; and
2. to critically evaluate the influence of altered treatment
parameters (i.e. stimulation method, parameters, dosage, site) on
the efficacy of non-invasive cortical stimulation for chronic pain.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-randomised trials
(e.g. by order of entry or date of birth) that utilise a sham control
group were included. We included parallel and cross-over study
designs. We included studies regardless of language or blinding.
Types of participants
We included studies including male or female participants over the
age of 18 years with any chronic pain syndrome (with a duration
of > 3 months). It was not anticipated that any studies are likely to
exist in a younger population.Migraine andother headache studies
were not included due to the episodic nature of these conditions.
Types of interventions
We included studies investigating the therapeutic use of non-inva-
sive forms of brain stimulation (tDCS, rTMS or CES).We did not
include studies of electroconvulsive therapy (ECT) as its mech-
anism of action (the artificial induction of an epileptic seizure
(Stevens 1996)) differs substantially from the other forms of brain
stimulation. Invasive forms of brain stimulation involving the use
of electrodes implanted within the brain and indirect forms of
stimulation such as caloric vestibular stimulation and occipital
nerve stimulation were also not included.
Types of outcome measures
Primary outcomes
The primary outcome measure was change in self-reported pain
using validated measures of pain intensity such as visual analogue
scales (VAS), verbal rating scales (VRS) or numerical rating scales
(NRS).
Secondary outcomes
Secondary outcomes that were extracted when available include
self-reported disability data, quality of life measures and the inci-
dence/nature of adverse events.
Search methods for identification of studies
Electronic searches
For the OVIDMEDLINE search, the subject search was run with
the Cochrane Highly Sensitive Search Strategy (CHSSS) for iden-
tifying randomised trials in MEDLINE: sensitivity maximising
version (2008 revision) as referenced in Chapter 6 and detailed in
box 6.4c of the Cochrane Handbook for Systematic Reviews of Inter-
ventions Version 5.0.1 (Higgins 2008). The authors have slightly
adapted this filter to include the term “sham” in the title or ab-
stract. The search strategy and filter proposed for MEDLINE is
presented inAppendix 1 and included a combination of controlled
vocabulary (MeSH) and free-text terms. All database searches were
based on this strategy but were appropriately revised to suit each
database.
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Electronic databases
To identify studies for inclusion in this review we searched the
following electronic databases to identify published articles:
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2009, issue 4);
• the Cochrane Pain, Palliative and Supportive Care Group
Trials Register (current issue);
• OVID MEDLINE (1950 to November Week 3 2009);
• OVID EMBASE ( (1980 to Week 47 2009);
• PsycINFO (1806 to November Week 4 2009);
• CINAHL (1982 to 11 January 2010); and
• LILACS (1982 to 15 December 2009).
Searching other resources
Reference lists
We searched reference lists of all eligible trials, key textbooks and
previous systematic reviews to identify additional relevant articles.
Unpublished data
We searched the National Research Register (NRR) Archive,
Health Services Research Projects in Progress (HSRProj), Current
Controlled Trials register (incorporating the meta-register of con-
trolled trials and the International Standard Randomised Con-
trolled Trial Number (ISRCTN)) to identify research in progress
and unpublished research.
Language
The search attempted to identify all relevant studies irrespective
of language. We assessed non-English papers and, if necessary,
translated with the assistance of a native speaker.
We sent a final list of included articles to two experts in the field
of therapeutic brain stimulation with a request that they review
the list for possible omissions.
Data collection and analysis
Selection of studies
Two review authors (NOC and BW) independently checked
search results and included eligible studies. Initially the titles and/
or abstracts of identified studies were read by two review authors
(NOC& BW). Where it was clear from the study title or abstract
that the study was not relevant or did not meet the selection cri-
teria it was excluded. If it was unclear then we assessed the full
paper, as well as all studies that appeared to meet the selection cri-
teria. Disagreement between review authors was resolved through
discussion between the two review authors. Where resolution was
not achieved a third review author (LDS) considered the paper(s)
in question.
Data extraction and management
Two review authors (NOC and BW) extracted data independently
using a standardised form that was piloted by both authors inde-
pendently on three randomised controlled trials of transcutaneous
electrical nerve stimulation prior to the searches. Discrepancies
were resolved by consensus. The form included the following.
• Risk of bias assessment results.
• Country of origin.
• Study design.
• Study population - condition; pain type; duration of
symptoms; age range; gender split; prior management.
• Sample size - active and control groups.
• Intervention - stimulation site, parameters and dosage
(including number and duration of trains of stimuli and number
of pulses for rTMS studies).
• Type of sham.
• Credibility of sham (for rTMS studies - see below).
• Outcomes - mean post-intervention pain scores for the
active and sham treatment groups at all follow-up points.
• Results - short-term, intermediate and long-term follow up.
• Adverse effects.
Assessment of risk of bias in included studies
We assessed risk of bias using the Cochrane ’Risk of bias’ assess-
ment tool outlined in Chapter 8 of the Cochrane Handbook for
Systematic Reviews of Interventions Version 5.0.1 (Higgins 2008).
The criteria assessed for parallel study designs (using yes/no/un-
clear judgements) were: adequate sequence generation; adequate
allocation concealment; adequate blinding of assessors; adequate
blinding of participants; adequate assessment of incomplete out-
come data; whether free of suggestion of selective outcome report-
ing; and whether free of other bias.
The criteria assessed for cross-over study designs (using yes/no/
unclear judgements) were: adequate sequence generation; whether
data were clearly free from carry-over effects; adequate blinding
of assessors; adequate blinding of participants; whether free of the
suggestion of selective outcome reporting; and whether free of
other bias.
Two review authors (NOCandBW) independently checked risk of
bias. Disagreement between review authors was resolved through
discussion between the two review authors. Where resolution was
not achieved the paper(s) in question were considered by a third
review author (LDS).
Assessment of sham credibility
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We rated the type of sham used in studies of rTMS for credi-
bility as optimal (the sham controls for the auditory and sensory
characteristics of stimulation and is visually indistinguishable from
real stimulation (Lisanby 2001; Loo 2000)) and sub-optimal (fails
to account for either the auditory and sensory characteristics of
stimulation, or is visually distinguishable from the active stimu-
lation, or fails on more than one of these criteria). We made a
judgement of unclear where studies did not adequately describe
the sham condition. Two independent review authors (NOC and
BW) performed rating of sham credibility. Disagreement between
review authors was resolved through consensus. Where resolution
was not achieved the paper(s) in question were considered by a
third review author (LDS). Where sham credibility was assessed
as unclear or sub-optimal we made a judgement of ’unclear’ for
the criteria ’adequate blinding of participants’ in the risk of bias
assessment.
Measures of treatment effect
We used standardised mean difference (SMD) to express the size
of treatment effect on pain intensity measured with VAS or NRS.
In order to aid interpretation of the pooled effect size we back-
transformed the SMD to a 0 to 100 mm VAS format on the basis
of the mean standard deviation from trials using 0 to 100 mm
VAS. We considered the likely clinical importance of the pooled
effect size using the criteria proposed in the IMMPACT consensus
statement (Dworkin 2008). Specifically we judged a decrease in
pain of < 15% as no important change, ≥ 15% as a minimally
important change, 30% as a moderately important change and ≥
50% as a substantially important change.
Unit of analysis issues
We entered cross-over trials into a meta-analysis where it was clear
that the data were free of carry-over effects. We entered cross-
over trials into a meta-analysis where it was clear that the data
were free of carry-over effects. We combined the results of cross-
over studies with parallel studies by imputing the post-treatment
between-condition correlation coefficient from an included study
that presented individual patient data and using this to calculate
the standard error of the standardisedmeandifference (SE(SMD)).
This data was entered into the meta-analysis using the generic
inverse-variance method as suggested in the Cochrane Handbook
for Systematic Reviews of Interventions, section 16.4.6.2 (Higgins
2008).
Dealing with missing data
Where insufficient data were presented in the study report to en-
ter a study into the meta-analysis, we contacted study authors to
request access to the missing data.
Data synthesis
We performed pooling of results where adequate data supported
this using RevMan 5 software (version 5.0.23) (RevMan 2008) us-
ing a random effects model. We considered separate meta-analyses
for different forms of stimulation intervention (i.e. rTMS, tDCS
and CES) and for short-term (0 to < 1 week post-intervention),
mid-term (≥ 1 to 6 weeks post-intervention) and long-term (≥
6 weeks post-intervention) outcomes where adequate data were
identified.
Where more than one data point was available for short-term out-
comes, we used the first post-stimulation measure, where multiple
treatments were given we took the first outcome at the end of the
treatment period. For medium-term outcomes where more than
one data point was available, we used the measure that fell closest
to the mid-point of this time period.
Subgroup analysis and investigation of heterogeneity
We assessed heterogeneity using the Chi2 test to investigate it’s
statistical significance and the I2 statistic to estimate the amount.
Where significant heterogeneity (P < 0.1) was present we explored
subgroup analysis. Pre-planned comparisons included site of stim-
ulation, frequency of TMS stimulation (low ≤ 1 Hz, high ≥
5 Hz), multiple versus single-dose studies, the type of painful
condition (central neuropathic versus peripheral neuropathic ver-
sus non-neuropathic pain versus facial pain (for each stimulation
type). Central neuropathic pain included pain due to identifiable
pathology of the central nervous system (e.g. stroke, spinal cord
injury), peripheral neuropathic pain included injury to the nerve
root or peripheral nerves, facial pain included trigeminal neuralgia
and other idiopathic chronic facial pains, non-neuropathic pain
included all chronic pain conditions without a clear neuropathic
cause (e.g. chronic low back pain, fibromyalgia, complex regional
pain syndrome type I).
Sensitivity analysis
When sufficient datawere available, we conducted sensitivity anal-
yses on the following study factors: risk of bias, sham credibility
(for rTMS studies), and cross-over versus parallel group designs.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
See:Characteristics of included studies; Characteristics of excluded
studies.
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Results of the search
Published data
The search strategy identified 1148 citations, including 305 dupli-
cates. See Appendix 3 for full details of the search results. Screen-
ing of the 843 unique citations by title and abstract identified 39
as potentially eligible for the review. Three studies were identified
from handsearching of the reference lists of included studies of
which two were not retrievable in abstract or full manuscript form.
The level of agreement between review authors, calculated using
the kappa statistic for study eligibility based on title and abstract
alone, was 0.77. Three more papers were identified by the review
authors that were not picked up from the search strategy. These
were also deemed to be potentially eligible for the review. One
of the experts contacted to review the search results for possible
omissions identified one additional study. The full-text screening
of the 44 citations identified 33 eligible studies. The kappa level of
agreement between authors for eligibility from full-text screening
was 0.87.
Unpublished data
The search strategy identified 5920 registered studies. Screening of
the studies by the register records identified 23 studies that might
potentially produce relevant data. Of these seven were duplicated
across trials registers, leaving 16 unique registered studies. The
level of agreement between review authors for eligibility from the
trial register records, calculated using the kappa statistic was 0.89.
The contact author for each of these studies was contacted by post
or email with a request for any relevant data that might inform
the review. No data were available from any of these studies for
inclusion in this review.
Included studies
Country of origin and language of publication
Of the 44 studies considered 33 met the eligibility criteria (André-
Obadia 2006; André-Obadia 2008; Boggio 2009; Borckardt
2009; Capel 2003; Carretero 2009; Cork 2004; Defrin 2007;
Fenton 2009; Fregni 2005; Fregni 2006a; Fregni 2006b; Gabis
2003; Gabis 2009; Hirayama 2006; Irlbacher 2006; Kang 2009;
Katsnelson 2004; Khedr 2005; Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Lichtbroun 2001; Mori 2010; Passard 2007; Pleger 2004; Rollnik
2002; Saitoh 2007; Tan 2000; Tan 2006; Valle 2009). All but one
of the studies (Irlbacher 2006, written in German) was written in
English. Studies were undertaken inBrazil, Egypt, Europe (France,
Germany, Italy, Spain and the UK), Israel, Japan, Russia, South
Korea and the USA. Most studies were based in a laboratory or
outpatient pain clinic setting.
Type of stimulation, application and use
Nineteen studies investigated rTMS (André-Obadia 2006; André-
Obadia 2008; Borckardt 2009; Carretero 2009; Defrin 2007;
Fregni 2005; Hirayama 2006; Irlbacher 2006; Kang 2009; Khedr
2005; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Passard 2007; Pleger 2004;
Rollnik 2002; Saitoh 2007). Eight studies investigatedCES (Capel
2003; Cork 2004; Gabis 2003; Gabis 2009; Katsnelson 2004;
Lichtbroun 2001; Tan 2000; Tan 2006) and six studies investi-
gated tDCS (Boggio 2009; Fenton 2009; Fregni 2006a; Fregni
2006b; Mori 2010; Valle 2009).
Study designs
There was a mixture of parallel and cross-over study designs.
For rTMS there were four parallel studies (Carretero 2009;
Defrin 2007; Khedr 2005; Passard 2007) and 15 cross-over
studies (André-Obadia 2006; André-Obadia 2008; Borckardt
2009; Fregni 2005; Hirayama 2006; Irlbacher 2006; Kang
2009; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur 2004;
Lefaucheur 2006; Lefaucheur 2008; Pleger 2004; Rollnik 2002;
Saitoh 2007). ForCES there were five parallel studies (Gabis 2003;
Gabis 2009; Katsnelson 2004; Lichtbroun 2001; Tan 2006) and
three cross-over studies (Capel 2003; Cork 2004; Tan 2000) of
which two were considered as parallel studies, with only the open-
ing phase of the study considered in this review because sub-
sequent phases were unblinded (Capel 2003; Cork 2004). For
tDCS therewere four parallel studies (Fregni 2006a; Fregni 2006b;
Mori 2010; Valle 2009) and two cross-over studies (Boggio 2009;
Fenton 2009).
Study participants
The included studies were published between 2000 and 2010. In
rTMS studies sample sizes at the study outset ranged from four
to 60 participants with a total of 422 participants randomised.
Of these studies nine had 20 or more participants (André-Obadia
2008; Carretero 2009; Hirayama 2006; Irlbacher 2006; Khedr
2005; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Passard 2007). In CES studies sample size ranged from 20 to 75
with a total of 391 randomised participants and in tDCS studies
sample size ranged from seven to 32 participants with a total of
83 randomised participants. Only one study of tDCS had over 20
participants (Fregni 2006b).
Studies included a variety of chronic pain conditions. Eight rTMS
studies included participants with neuropathic pain of mixed ori-
gin; of these five included a mix of central, peripheral and facial
neuropathic pain patients (André-Obadia 2006; André-Obadia
2008; Hirayama 2006; Lefaucheur 2004; Lefaucheur 2008), two
included a mix of central and peripheral neuropathic pain pa-
tients (Lefaucheur 2006; Saitoh 2007) of which one study (Saitoh
2007) included a patient with phantom limb pain. One study
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included a mix of central neuropathic pain and phantom limb
pain patients (Irlbacher 2006). One study included a mix of cen-
tral and facial neuropathic pain patients Lefaucheur 2001a, two
rTMS studies included only central neuropathic pain patients
(Defrin 2007; Kang 2009), one included only peripheral neuro-
pathic pain patients (Borckardt 2009) and four studies included
non-neuropathic chronic pain including fibromyalgia (Carretero
2009; Passard 2007), chronic pancreatitis pain (Fregni 2005) and
complex regional pain syndrome type I (CRPSI) (Pleger 2004).
Finally one study included a mix of peripheral neuropathic and
non-neuropathic chronic pain (Rollnik 2002) including one par-
ticipant with phantom limb pain and one with osteomyelitis. The
majority (13) of rTMS studies specified chronic pain that was
refractory to current medical management (André-Obadia 2006;
André-Obadia 2008, Defrin 2007, Hirayama 2006; Kang 2009;
Khedr 2005; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur
2004; Lefaucheur 2006; Lefaucheur 2008; Rollnik 2002; Saitoh
2007). This inclusion criteria was varyingly described as in-
tractable, resistant to medical intervention or drug management.
Of studies of CES, one study included participants with pain
related to osteoarthritis of the hip and knee (Katsnelson 2004),
two studied chronic back and neck pain (Gabis 2003; Gabis
2009). Of these the later study also included participants with
chronic headache but these data were not considered in this re-
view. Two studies included participants with fibromyalgia (Cork
2004; Lichtbroun 2001) and two studies included participants
with chronic pain following spinal cord injury (Capel 2003; Tan
2006), although it is unclear from these study reports whether the
pain was classified as neuropathic or non-neuropathic. One study
included participants with a mixture of “neuromuscular pain” ex-
cluding fibromyalgia of which back pain was reportedly the most
prevalent complaint (Tan 2000) although further detail was not
reported on.
Of studies of tDCS one study included participants with a mix-
ture of central, peripheral and facial neuropathic pain (Boggio
2009), one study included participants with neuropathic pain sec-
ondary to multiple sclerosis (Mori 2010), one included partici-
pants with central neuropathic pain following spinal cord injury
(Fregni 2006a) and two studies included non neuropathic pain,
specifically chronic pelvic pain (Fenton 2009) and fibromyalgia
(Fregni 2006b). Three studies of tDCS specified recruiting par-
ticipants with pain that was refractory to medical management
(Boggio 2009; Fenton 2009; Fregni 2006a).
Most studies included both male and female participants ex-
cept the studies of Fenton 2009 (chronic pelvic pain) and Fregni
2006b (fibromyalgia). Two studies did not present data specifying
the gender distribution of participants (Capel 2003; Katsnelson
2004).
Outcomes
Primary outcomes
All included studies assessed pain using self-reported pain visual
analogue or numerical rating scales. There was variation in the
precise measure of pain (for example, current pain intensity, aver-
age pain intensity over 24 hours) and in the anchors used particu-
larly for the upper limit of the scale (e.g. “worst pain imaginable”,
“unbearable pain”, “most intense pain sensation”). Several studies
did not specify the anchors used.
All studies assessed pain at the short-term (< 1 week post-treat-
ment) follow-up stage. Twelve studies reported collecting out-
come data for medium-term (≥ 1 to 6 weeks post-treatment)
(André-Obadia 2008; Borckardt 2009; Carretero 2009; Defrin
2007; Fenton 2009; Fregni 2006a; Fregni 2006b; Gabis 2009;
Kang 2009; Khedr 2005; Lefaucheur 2001a; Mori 2010; Passard
2007; Valle 2009). Of these data could be extracted from four
study reports (Carretero 2009; Gabis 2009; Kang 2009) and the
authors of three studies provided the data upon request (Khedr
2005; Mori 2010; Passard 2007). Four studies reported collecting
outcome data for long-term (> 6 weeks) follow up (Gabis 2009;
Kang 2009; Passard 2007; Valle 2009). Of these data could be
extracted from Gabis 2009 and Kang 2009 and the authors of
Passard 2007 provided the data upon request.
Secondary outcomes
Only secondary outcomes that distinctly measured self-reported
disability or quality of life were considered for extraction and in-
cluded in the Characteristics of included studies table. Five studies
used measures of disability or pain interference (Cork 2004; Kang
2009; Passard 2007; Tan 2000; Tan 2006) and five studies col-
lected measures of quality of life (Fregni 2006b; Lichtbroun 2001;
Mori 2010; Passard 2007; Valle 2009).
Studies of rTMS
See Table 1 for a summary of stimulation characteristics utilised
in rTMS studies.
Stimulation location
The parameters for rTMS application varied significantly be-
tween studies including by site of stimulation, stimulation pa-
rameters and the number of stimulation sessions. The majority of
rTMS studies targeted the primary motor cortex (M1) (André-
Obadia 2006; André-Obadia 2008; Defrin 2007; Hirayama
2006; Irlbacher 2006; Kang 2009; Khedr 2005; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Lefaucheur 2008; Passard 2007; Pleger 2004;Rollnik 2002; Saitoh
2007). Of these one study specified stimulation of the right hemi-
sphere (Kang 2009), two studies specified stimulation over the
midline (Defrin 2007; Pleger 2004) and the remainder stimulated
over the contralateral cortex to the side of dominant pain. One
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of these studies (Hirayama 2006) also investigated stimulation
of the supplementary motor area (SMA), pre-motor area (PMA)
and primary somatosensory cortex (S1). Two studies stimulated
the pre-frontal cortex (PFC) with one study stimulating the left
PFC (Borckardt 2009) and one study the right dorsolateral PFC
(DLPFC) (Carretero 2009). One study investigated stimulation
of the left and right secondary somatosensory cortex as separate
treatment conditions (Fregni 2005).
Stimulation parameters
Frequency
Eight studies investigated low-frequency (< 5 Hz) rTMS (André-
Obadia 2006; Carretero 2009; Fregni 2005; Irlbacher 2006;
Lefaucheur 2001b; Lefaucheur 2006; Lefaucheur 2008; Saitoh
2007). Of these one study used a frequency of 0.5 Hz in
one treatment condition (Lefaucheur 2001b) and the rest used
a frequency of 1 Hz. Eighteen studies investigated high-fre-
quency (≥ 5 Hz) rTMS (André-Obadia 2006; André-Obadia
2008; Borckardt 2009; Defrin 2007; Fregni 2005; Hirayama
2006; Irlbacher 2006; Kang 2009; Khedr 2005; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Lefaucheur 2008; Passard 2007; Pleger 2004;Rollnik 2002; Saitoh
2007). Of these three studies used 5Hz stimulation (Defrin 2007;
Hirayama 2006; Irlbacher 2006), 10 studies used 10 Hz stimula-
tion (Borckardt 2009; Kang 2009; Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008;
Passard 2007; Pleger 2004; Saitoh 2007) and four studies used 20
Hz stimulation (André-Obadia 2006; André-Obadia 2008; Fregni
2005; Khedr 2005; Rollnik 2002).
Other parameters
Wide variation was observed between studies for various stimu-
lation parameters. The overall number of rTMS pulses delivered
varied from 120 to 4000. The study by Defrin 2007 reported
a total number of pulses of 500 although the reported stimula-
tion parameters of 500 trains, delivered at a frequency of 5 Hz
for 10 seconds would imply 25000 pulses. Six studies specified a
posteroanterior orientation of the stimulating coil (André-Obadia
2006; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Lefaucheur 2008; Passard 2007) one study specified a coil orien-
tation 45º posterolateral to the midline (Kang 2009), one study
compared a posteroanterior coil orientation with a medial-lateral
coil orientation (André-Obadia 2008) and the remaining studies
did not specify the orientation of the coil. Within studies that
reported the information the duration and number of trains and
the inter-train intervals varied. One study did not report this in-
formation (Fregni 2005).
Type of sham
rTMS studies employed a variety of sham controls. In nine studies
the stimulating coil was angled away from the scalp to prevent sig-
nificant cortical stimulation. Of these four studies (André-Obadia
2006; André-Obadia 2008; Kang 2009; Khedr 2005) specified
that the coil was also elevated from the scalp and five studies spec-
ified that the coil was angled 45º away from the scalp Carretero
2009; Hirayama 2006; Pleger 2004; Rollnik 2002; Saitoh 2007)
of which two studies (Hirayama 2006; Saitoh 2007) also simulta-
neously electrical stimulated the skin of the scalp in both the active
and sham stimulation conditions in order to mask the sensations
elicited by active rTMS and thus preserve participants’ blinding.
The remaining 10 studies utilised sham coils. Of these four studies
specified that the sham coil made similar or identical sounds to
those elicited during active stimulation (Borckardt 2009; Defrin
2007; Irlbacher 2006; Passard 2007). Six studies did not specify
whether the sham coil controlled for the auditory characteristics
of active stimulation (Fregni 2005; Lefaucheur 2001a; Lefaucheur
2001b; Lefaucheur 2004; Lefaucheur 2006; Lefaucheur 2008).
Adverse event reporting
Thirteen studies did not report any information regarding adverse
events (Borckardt 2009; Cork 2004; Defrin 2007; Gabis 2009;
Kang 2009; Katsnelson 2004; Khedr 2005; Lefaucheur 2006;
Lefaucheur 2008; Lichtbroun 2001; Pleger 2004; Tan 2000; Tan
2006).
Studies of CES
See Table 2 for a summary of stimulation characteristics utilised
in CES studies.
Stimulation device, parameters and electrode location
Four studies of CES used the “Alpha-stim” CES device (Elec-
tromedical Products International, Inc, Mineral Wells, Texas,
USA). This device uses two ear clip electrodes that attach to each
of the participant’s ears (Cork 2004; Lichtbroun 2001; Tan 2000;
Tan 2006) these studies utilised stimulation intensities of 100 µA
with a frequency of 0.5 Hz. One study (Capel 2003) used a device
manufactured by Carex (Hemel Hempstead, UK) that also used
earpiece electrodes and delivered a stimulus intensity of 12 µA.
Two studies used the “Pulsatilla 1000” device (PulseMazor Instru-
ments, Rehavol, Israel) (Gabis 2003; Gabis 2009). The electrode
array for this device involved an electrode attached to each of the
participant’s mastoid processes and one attached to the forehead;
current is passed to the mastoid electrodes. One study (Katsnelson
2004) used the “Nexalin” device (Kalaco Scientific Inc, Scottsdale,
AZ, USA). With this device current is applied to a forehead elec-
trode and returned via electrodes placed behind the patient’s ears.
These three studies utilised significant higher current intensities
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than those using ear clip electrodes with intensities of 4mA (Gabis
2003; Gabis 2009) and 11 to 15 mA (Katsnelson 2004).
All CES studies gavemultiple treatment sessions for each treatment
group with variation between the number of treatments delivered.
Capel 2003 delivered treatments twice daily for four days. Cork
2004 delivered treatment once daily for a three-week period.Gabis
2003 andGabis 2009 delivered treatment once daily for eight days,
Katsnelson 2004 for five days, Lichtbroun 2001 for 30 days and
Tan 2006 for 21 days. Tan 2000 delivered 12 treatments although
the frequency of these is unclear from the study report.
Type of sham
Five studies utilised inert sham units (Capel 2003; Cork 2004;
Lichtbroun 2001; Tan 2000; Tan 2006). These units were visually
indistinguishable from the active devices. Stimulation at the inten-
sities used is subsensation and as such it should not have been pos-
sible for participants to distinguish between the active and sham
conditions.
Two studies (Gabis 2003; Gabis 2009) utilised an “active placebo”
treatment unit. This sham device was visually indistinguishable
and delivered a current of much lower intensity (≤0.75 mA) than
the active stimulator to evoke a similar sensation to ensure patient
blinding. Similarly Katsnelson 2004 utilised a visually indistin-
guishable sham device that delivered brief pulses of current of < 1
mA. The placebo conditions used in these three studies delivered
current at much greater intensities than those used in the active
stimulation conditions of the other CES studies.
Studies of tDCS
See Table 3 for a summary of stimulation characteristics utilised
in tDCS studies.
Stimulation parameters and electrode location
Two studies of tDCS stimulated the dorsolateral prefrontal cortex
in one treatment group (Fregni 2006b; Valle 2009). Six studies
stimulated the motor cortex (Boggio 2009;Fenton 2009; Fregni
2006a; Fregni 2006b;Mori 2010; Valle 2009). Of these four stim-
ulated the cortex contralateral to the side of worst pain (Boggio
2009; Fregni 2006a; Fregni 2006b; Mori 2010) of which two
studies stimulated the opposite hemisphere to the dominant hand
where pain did not have a unilateral dominance (Fregni 2006a;
Fregni 2006b). One study stimulated the left hemisphere for all
conditions (Valle 2009). One study of chronic pelvic pain stim-
ulated the opposite hemisphere to the dominant hand in all sub-
jects (Fenton 2009). One study specifically investigated the use of
tDCS in conjunction with transcutaneous electrical nerve stim-
ulation (TENS) therapy (Boggio 2009). Data comparing active
tDCS and sham TENS with sham tDCS and sham TENS were
extracted for the purposes of this review.
Three studies (Fregni 2006a; Fregni 2006b; Mori 2010) delivered
a current intensity of 2 mA for 20 minutes once a day for five
days. One study (Fenton 2009) applied a current intensity of 1
mA once a day for two days and one study (Boggio 2009) applied
one treatment per stimulation condition at an intensity of 2 mA
for 30 minutes.
All studies of tDCS utilised a sham condition whereby active
stimulation was ceased after 30 seconds without the participants’
knowledge.
Excluded studies
See Characteristics of excluded studies. We excluded 11 studies
after consideration of the full study report. Of these one was not
a study of brain stimulation (Frentzel 1989), two did not assess
self-reported pain as an outcome (Belci 2004; Johnson 2006), four
were not restricted to participants with chronic pain (Evtiukhin
1998; Katz 1991; Longobardi 1989; Pujol 1998), one study was
unclear on the duration of participants’ symptoms (Avery 2007),
two were single case studies (Silva 2007; Zaghi 2009), one study
presented duplicate data from a study already accepted for inclu-
sion (Roizenblatt 2007, duplicate data from Fregni 2006b) and
one did not employ a sham control (Evtiukhin 1998).
Risk of bias in included studies
Risk of bias varied across studies for all of the assessment criteria.
For a summary of risk of bias assessment across studies see Figure
1. The (kappa statistic) level of agreement between the two review
authors across all risk of bias criteria was 0.73.
Sequence generation
For the criteria ’adequate sequence generation’ cross-over trials
were awarded a judgement of ’Yes’ where the study report men-
tioned that the order of treatment conditions was randomised.
Since this criteria has a greater potential to introduce bias in parallel
designs a judgement of ’Yes’ was only awarded where the method
of randomisation was specified and adequate.
All cross-over trials were judged as having a low risk of bias for
this criteria. Of the parallel trials five trials were judged as having
an unclear risk of bias (Carretero 2009; Cork 2004; Defrin 2007;
Katsnelson 2004; Tan 2006) as they did not specify the method of
randomisation used. One study was judged as having a high risk
of bias for this criteria (Khedr 2005) as the report suggests that
patients were allocated depending on the day of the week on which
they were recruited, which was not judged as being genuinely
random.
Allocation concealment
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The criteria ’Adequate concealment of allocation’ was only con-
sidered for studies with parallel designs. Six studies did not report
concealment of allocation and were judged as ’Unclear’ (Carretero
2009; Cork 2004; Defrin 2007; Katsnelson 2004; Passard 2007;
Tan 2006) and one study (Khedr 2005) was judged as having a
high risk of bias for this criteria since themethod of randomisation
employed would not have supported concealment of allocation.
Blinding
Blinding of assessors
Eleven studies did not specify whether they blinded outcome asses-
sors (Borckardt 2009;Hirayama 2006; Irlbacher 2006; Lefaucheur
2001a; Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006;
Pleger 2004; Rollnik 2002; Saitoh 2007; Tan 2000).While studies
used self-reported pain outcomes we considered that the complex
nature of the intervention and the level of interaction this entails
between participants and assessors suggests that a lack of blinding
of researchers engaged in the collection of outcomes might poten-
tially introduce bias. As such, where blinding of assessors was not
clearly stated a judgement of ’Unclear’ was made for this criteria.
Blinding of participants
rTMS studies
All studies attempted to blind participants. However, due to the
difficulties involved in producing a robust sham control in rTMS
studies (see Assessment of risk of bias in included studies) an as-
sessment was made of sham credibility. Where sham coils were
utilised they did not control for the sensory aspects of stimulation.
Where the coil was angulated or angulated and elevated away from
the scalp, this is potentially distinguishable both visually and by
the sensory effects of stimulation. Two studies (Hirayama 2006;
Saitoh 2007) simultaneously electrically stimulated the scalp dur-
ing rTMS stimulation to mask the differences in sensation be-
tween conditions. However, by angulating the coil away from the
scalp participants may have been able to visually distinguish be-
tween the conditions. All rTMS studies were assessed as having
sub-optimal sham control conditions and were therefore assessed
as having an ’Unclear’ risk of bias.
All studies of tDCS and CES were assessed as having a low risk of
bias for this criteria.
Incomplete outcome data
Seven studies were assessed as having an unclear risk of bias
for this criteria (André-Obadia 2006; Boggio 2009; Cork 2004;
Katsnelson 2004; Lefaucheur 2006; Lichtbroun 2001). In the
study of André-Obadia 2006 two participants (17% of the study
cohort) did not complete the study and this was not clearly ac-
counted for in the data analysis. This was also the case for Boggio
2009where two subjects (25%of the cohort) failed to complete the
study. Four studies did not clearly report levels of drop-out (Cork
2004; Katsnelson 2004; Lefaucheur 2006; Lichtbroun 2001). Two
studies were assessed as having a high risk of bias for this criteria
(Irlbacher 2006; Tan 2000). In the study by Irlbacher 2006 only
13 of the initial 27 participants completed all of the treatment
conditions. In the study by Tan 2000 17 participants did not com-
plete the study (61% of the cohort) and this was not clearly ac-
counted for in the analysis. We considered this level of withdrawal
unsustainable.
Selective reporting
Studies were assessed as having a high risk of bias for this criteria
where the study report did not produce adequate data to assess
the effect size for all groups/conditions, and these data were not
made available upon request. Six studies (Capel 2003; Cork 2004;
Fregni 2005; Katsnelson 2004; Lichtbroun 2001; Valle 2009) were
assessed as having a high risk of bias for this criteria. Two studies
were judged as being at unclear risk of bias (Fregni 2006a; Fregni
2006b). In the reports of these studies data were not presented in a
format that could be easily interpreted.On request data were avail-
able from these two studies for the primary outcome at baseline
and short-term follow up but not for other follow-up points.The
remaining studies were assessed as having a low risk of bias for this
criteria.
Other potential sources of bias
Carry-over effects in cross-over trials
One study (Fenton 2009) was judged as unclear on this criteria
as no pre-stimulation data were provided and no investigation of
carry-over effects was discussed in the study report. In one cross-
over study (Saitoh 2007) baseline differences between the sham
and the 10 Hz stimulation condition were notable. A paired t-test
did not show a significant difference (P > 0.1) and this study was
judged as having a low risk of bias for carry-over effects.
Other sources of bias
One study of CES (Katsnelson 2004) did not clearly present rel-
evant baseline group characteristics of the included participants
and was judged as being at high risk of bias for this criteria. One
study of CES (Tan 2000) also applied electrical stimulation to the
painful body area as part of the treatment which may have affected
the final outcomes. Two studies of CES (Gabis 2003; Gabis 2009)
used an “active placebo condition” that delivered a level of cortical
stimulation that was greater than that used in the active arm of
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other CES studies. It is possible that delivering cortical stimula-
tion in the sham group might mask differences between the sham
and active condition. Also such a large difference in current in-
tensity compared with other studies of CES might be a source of
heterogeneity. These three studies were judged as ’Unclear’ on this
criteria.
Effects of interventions
Primary outcome: pain
rTMS for short-term relief of chronic pain
The primarymeta-analysis pooled data from all rTMS studies with
low or unclear risk of bias where data were available (n = 368, after
correction for multiple comparisons n = 267) including cross-over
and parallel designs (André-Obadia 2006; André-Obadia 2008;
Borckardt 2009; Carretero 2009; Defrin 2007; Hirayama 2006;
Kang 2009; Lefaucheur 2001a; Lefaucheur 2001b; Lefaucheur
2004; Lefaucheur 2006; Lefaucheur 2008; Passard 2007; Pleger
2004; Pleger 2004; Rollnik 2002; Saitoh 2007). The studies by
Khedr 2005, and Irlbacher 2006 were excluded as they were clas-
sified as having a high risk of bias on at least one criteria. The
correlation coefficient used to calculate the SE(SMD) for cross-
over studies was imputed from data extracted from André-Obadia
2008 (as outlined in Unit of analysis issues). The number of par-
ticipants in each cross-over study was divided by the number of
comparisons made by that study. For parallel studies the SEMwas
calculated from the 95% confidence intervals of the standardised
mean difference (SMD) and both the SMD and the SEMwere en-
tered into the meta-analysis. This was then entered into the meta-
analysis with the SMD using the generic inverse variance method.
Figure 2 shows the forest plot for this analysis.
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Figure 2. Forest plot of comparison: 1 rTMS, outcome: 1.1 Pain short-term follow up
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Substantial heterogeneity (I2 = 71%) was observed and was inves-
tigated using pre-planned subgroup analysis. Categorising studies
by high (≥ 5Hz) or low (< 5Hz) frequency rTMS reduced hetero-
geneity in the low-frequency group (I2 = 0%). In this group there
was evidence of no effect of low-frequency rTMS for short-term
relief of chronic pain. However, substantial heterogeneity was ob-
served in the high-frequency group (I2 = 68%). Separating studies
that deliver a single treatment per condition with those that de-
livered multiple treatment sessions did not reduce heterogeneity
substantially in multiple-dose studies (I2 = 87%) or single-dose
studies (I2 = 61%). Restricting the analysis to single-dose stud-
ies of high-frequency stimulation of the motor cortex (corrected
n = 184) reduced heterogeneity (I2 = 36%). Figure 3 shows the
forest plot for this subgroup analysis. In this group the pooled
SMD was -0.40 (95% confidence interval (CI) -0.26 to -0.54),
P < 0.00001. The SMD was back transformed to a mean dif-
ference using the pooled standard deviation from the largest trial
in the analysis that carried the most weight in the meta-analysis
(Lefaucheur 2004). This was then used to estimate the real per-
centage change on a 0 to 100 mm VAS of active stimulation com-
pared with the sham condition in that study. This equated to a
reduction of 9.3 mm (95% CI 6.2 mm to 12.5 mm), or a percent-
age change of 15% (95% CI 10% to 20%) of the control group
outcome. This estimate just reaches the pre-established criteria for
a minimally clinically important difference (> 15%) although the
confidence intervals do not clearly fall above this threshold. Of
the included studies in this subgroup eight did not clearly report
blinding of assessors and were awarded a judgement of ’Unclear’
risk of bias for this criteria (Hirayama 2006; Lefaucheur 2001a;
Lefaucheur 2001b; Lefaucheur 2004; Lefaucheur 2006; Pleger
2004; Rollnik 2002; Saitoh 2007). Sensitivity analysis removing
these studies reduced heterogeneity to I2 = 0% although only three
studies (André-Obadia 2006; André-Obadia 2008; Lefaucheur
2008) were preserved in the analysis. There remained a statisti-
cally significant difference between sham and active stimulation
although the SMDreduced to -0.31 (95%CI -0.13 to -0.49). This
equates to a pain reduction of 7 mm (95% CI 3 mm to 11 mm)
on a 0 to 100 mm VAS pain scale or a percentage change of 12%
(95% CI 9% to 18%) in comparison with sham stimulation. For
multiple-dose studies of high-frequency motor cortex stimulation
heterogeneity was high (I2 = 86%).
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Figure 3. Forest plot of comparison: 1 rTMS, outcome: 1.5 Pain short-term, subgroup analysis: motor
cortex studies only (low-frequency studies excluded).
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There were insufficient data to support the planned subgroup
analysis by the type of painful condition as planned. However,
when the analysis was restricted to studies including only well-
defined neuropathic pain populations (excluding Carretero 2009;
Passard 2007; Pleger 2004; Rollnik 2002) there was little impact
on heterogeneity (I2 = 71%). When the analysis was restricted to
studies of single-dose high-frequency motor cortex stimulation in
well-defined neuropathic pain populations (excluding data from
Pleger 2004; Rollnik 2002) there was little effect on the pooled
estimate (SMD -0.45, 95%CI -0.60 to -0.29) or heterogeneity (I2
= 37%). However, when the same process was applied tomultiple-
dose studies of high-frequency motor cortex stimulation (exclud-
ing data from Passard 2007) heterogeneity was reduced to a neg-
ligible level (I2 = 2%) and the results suggest a significant benefit
of sham over active therapy (SMD 0.5, 95% CI 0.09 to 0.93, P =
0.02).
Sensitivity analysis
To assess whether the imputation of standard errors for cross-over
studies was robust the analysis was repeated with the correlation
coefficient reduced to 0.65 and increased to 0.85. This had no
marked effect on the overall analysis. The same process was applied
to the subgroup analysis of single-dose studies of high-frequency
motor cortex stimulation. This had a negligible impact on the
effect size or the statistical significance of this subgroup but a
large impact on heterogeneity (increased correlation coefficient I2
= 59%, correlation decreased I2 = 5%).
To assess the impact of excluding the studies of Irlbacher 2006
and Khedr 2005, the analysis was performed with data from these
studies included. While this produced a modest increase in the
SMD it increased heterogeneity from 71% to 73%. Inclusion of
the Khedr 2005 study to the multiple-dose studies of high-fre-
quency motor cortex stimulation subgroup increased heterogene-
ity (I2 = 92%). Inclusion of the Irlbacher 2006 study to the single-
dose studies of high-frequencymotor cortex stimulation subgroup
also increased heterogeneity (I2 = 46%).
Small study effects/publication bias
Small study effects were investigated using Egger’s test. The results
are not suggestive of a significant influence of small study effects
(P = 0.570).
rTMS for medium-term relief of chronic pain (< 6 weeks
post-treatment)
Three studies provided data on medium-term pain outcomes (
Carretero 2009; Lefaucheur 2001a; Kang 2009; Khedr 2005;
Passard 2007). Of these the study by Khedr 2005 was excluded as
it was classified as having a high risk of bias (see Figure 4). The
analysis included 42 participants. Overall heterogeneity was high
(I2 = 75%). We performed sensitivity analysis to assess the impact
of excluding the study by Khedr 2005. Including this study did
not reduce heterogeneity (I2 = 81%). There was insufficient data
from which to draw any firm conclusions and the existing data are
conflicting.
Figure 4. Forest plot of comparison: 1 rTMS, outcome: 1.6 Pain: medium-term follow up.
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rTMS for long-term relief of chronic pain (≥ 6 weeks post-
treatment)
Only two studies provided data for long-term pain relief (Kang
2009; Passard 2007) (see Figure 5). The analysis included 37 par-
ticipants. There was no heterogeneity (I2 = 0%). There was in-
sufficient evidence from which to draw firm conclusions for this
comparison but the available data are not suggestive of a long-
term effect of rTMS on chronic pain (P = 0.57).
Figure 5. Forest plot of comparison: 1 rTMS, outcome: 1.7 Pain: long-term follow up.
Adverse events
Of the rTMS studies that reported adverse events eight studies
reported none (André-Obadia 2006; André-Obadia 2008; Fregni
2005; Hirayama 2006; Lefaucheur 2001a; Lefaucheur 2001b;
Lefaucheur 2004; Saitoh 2007). Carretero 2009 reported neck
pain or headache symptoms in six out of 14 participants in the
active stimulation group compared with two out of 12 in the sham
group. One participant in the active stimulation group reported
worsening depression and four participants in the sham group
reported symptoms of nausea and tiredness. Passard 2007 reported
incidence of headaches (four out of 15 participants in the active
group versus five out of 15 in the sham group), feelings of nausea
(one participant in the active group), tinnitus (two participants
in the sham group) and dizziness (one participant in the sham
group). Rollnik 2002 reported that one participant experienced
headache but it is unclear in the report whether this was following
active or sham stimulation.
CES for short-term pain relief
Three studies (Gabis 2003; Gabis 2009; Tan 2006) provided data
for this analysis. All studies utilised a parallel group design and
so we used a standard inverse variance meta-analysis using SMD.
Four studies did not provide the necessary data to enter into the
analysis (Capel 2003; Cork 2004; Katsnelson 2004; Lichtbroun
2001) and two studies were classified as being at high risk of bias on
criteria other than ’free of selective outcome reporting’ (Katsnelson
2004; Tan 2000). See Figure 6 for the forest plot of this analysis.
The studies by Gabis 2003 and Gabis 2009 differ substantially to
that of Tan 2006 on the location of electrodes and the intensity of
the current provided. Despite this there was no heterogeneity (I2 =
0%). No individual study in this analysis demonstrates superiority
of active stimulation over sham and the results of themeta-analysis
do not demonstrate statistical significance (P = 0.08).
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Figure 6. Forest plot of comparison: 2 CES, outcome: 2.1 Pain: short-term follow up.
There were insufficient data to perform a meta-analysis for
medium or long-term pain outcomes for CES.
Adverse events
Only two studies of CES reported the incidence of adverse events
(Capel 2003; Gabis 2003). In these studies no adverse events were
reported.
tDCS for short-term pain relief
Adequate data were available from five studies (Boggio 2009;
Fenton 2009; Fregni 2006a; Fregni 2006b; Mori 2010) for this
analysis (n = 83). The correlation coefficient used to calculate the
SE(SMD) for cross-over studies was imputed from data extracted
from Boggio 2009. One study (Fregni 2006b) compared two dis-
tinct active stimulation conditions to one sham condition. Com-
bining the treatment conditions was considered inappropriate as
each involved stimulation of different locations and combination
would hinder subgroup analysis. Instead both comparisons were
included separately with the number of participants in the sham
control group divided by the number of comparisons (corrected n
= 73). The overall meta-analysis (Figure 7) did not demonstrate a
significant effect of active stimulation (P = 0.37) but heterogeneity
was substantial (I2 = 71%). Subgroup analysis restricted to com-
parisons of active motor cortex stimulation (Figure 8) (excluding
one group from Fregni 2006b) reduced heterogeneity to a level
of non-statistical significance (I2 = 45%) and suggests superiority
of active over sham stimulation (SMD -0.59, 95% CI -1.10 to -
0.08, P = 0.02). Given the wide confidence interval it was con-
sidered inappropriate to back transform the SMD to a VAS as the
resulting estimate would be difficult to interpret.
Figure 7. Forest plot of comparison: 3 tDCS, outcome: 3.2 Pain short-term follow up.
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Figure 8. Forest plot of comparison: 3 tDCS, outcome: 3.5 Pain short-term follow up, subgroup analysis:
motor cortex studies only.
Sensitivity analysis
To assess whether the imputation of standard errors for cross-over
studies was robust the analysis was repeated with the imputed
correlation coefficient reduced and increased by a value of 0.1.
This had little impact on the overall meta-analysis but when the
correlation was increased in the subgroup analysis of motor cortex
studies the level of heterogeneity reached statistical significance (I
2 = 51%).
Small study effects/publication bias
Small study effects were investigated using Egger’s test. The results
are not suggestive of a significant influence of small study effects for
the overall analysis (P = 0.528) or for the motor cortex subgroup
analysis (P = 0.075).
Adverse events
All studies of tDCS reported the incidence of adverse events.
Of these two studies reported none (Fregni 2006a; Mori 2010).
Boggio 2009 reported that one participant experienced headache
with active stimulation. The study by Fenton 2009 reported three
cases of headache, two of neck ache, one of scalp pain and five of
a burning sensation over the scalp in the active stimulation group
versus one case of headache in the sham stimulation group. Fregni
2006b reported one case of sleepiness and one of headache in re-
sponse to active stimulation of the DLPFC, three cases of sleepi-
ness and three of headache with active stimulation of M1 and one
case of sleepiness and two of headache in response to sham stim-
ulation. Valle 2009 reported “minor and uncommon” side effects
such as skin redness and tingling which where equally distributed
between active and sham stimulation. Four studies monitored for
possible effects on cognitive function using the Mini Mental State
Examination questionnaire (Boggio 2009; Fregni 2006a; Fregni
2006b; Valle 2009) and three of these also used a battery of cog-
nitive tests including the digit-span memory test and the Stroop
word-colour test (Boggio 2009; Fregni 2006a; Fregni 2006b) and
simple reaction time tasks (Fregni 2006a). No studies demon-
strated any negative influence of stimulation on these outcomes.
No studies of TDCS reported severe or lasting side effects.
Secondary outcomes: disability and quality of life
There were insufficient data from which to draw reliable conclu-
sions for any secondary outcomemeasure for any stimulation type.
D I S C U S S I O N
Summary of main results
Repetitive transcranial magnetic stimulation (rTMS)
for chronic pain
Meta-analysis of all rTMS studies in chronic pain demonstrated
significant heterogeneity. Predetermined subgroup analysis sug-
gests a beneficial short-term effect of single-dose high-frequency
rTMS applied to themotor cortex. This effect is small and does not
conclusively exceed the threshold of minimal clinical significance.
The limited evidence frommultiple-dose studies of rTMS demon-
strates conflicting results with substantial heterogeneity both over-
all and when the analysis is confined to high-frequency motor cor-
tex studies. Low-frequency rTMS does not appear to be effective.
There is insufficient and conflicting evidence at medium-term fol-
low-up points to allow firm conclusions to be drawn and at long-
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term follow-up points there is limited evidence suggesting no ben-
efit of active stimulation over sham.
Cranial electrotherapy stimulation (CES) for chronic
pain
There is insufficient evidence fromwhich to drawfirm conclusions
regarding the efficacy of CES. However, the evidence from trials
where it is possible to extract data is not suggestive of a significant
beneficial effect. While there are substantial differences within
the trials in terms of the populations studied and the stimulation
parameters used, there is no measurable heterogeneity and no trial
shows a clear benefit of active CES over sham stimulation.
Transcranial direct current stimulation (tDCS) for
chronic pain
There is insufficient evidence fromwhich to drawfirm conclusions
regarding the efficacy of tDCS. The existing evidence demon-
strates substantial heterogeneity. Subgroup analysis suggests supe-
riority of active over sham stimulation of the motor cortex for
short-term pain relief but the confidence intervals are too wide for
the purposes of estimating the effect size.
Adverse effects
Across all stimulation modalities there is no evidence of serious or
lasting adverse effects of non-invasive brain stimulation. rTMS,
tDCS and sham stimulation are associated with transient adverse
effects such as headache, scalp irritation anddizziness but reporting
of adverse effects was inconsistent and did not allow for a detailed
analysis.
Secondary outcome measures
There were insufficient data from which to draw any reliable con-
clusions regarding the effect of any stimulation type on disability
or quality of life.
Overall completeness and applicability of
evidence
The evidence for rTMS in this review is relatively complete. We
were unable to extract data from one study (Fregni 2005) but this
included five subjects and sowe consider it unlikely that this would
have affected the results of the analysis significantly. We are aware
of no missing data that might have affected the subgroup analysis
of high-frequency motor cortex stimulation.
We were unable to extract data from four out of seven studies of
CES and these data were not available upon request. This may
have impacted upon the results of our meta-analysis although one
of those studies (Katsnelson 2004)would have been excluded from
the meta-analysis as it was judged as being at a risk of bias on
criteria other than selective outcome reporting.
We were unable to extract data from one study of tDCS (Valle
2009) and these data were not available upon request. These data
would have significantly contributed to the power of the meta-
analysis by the introduction of a further 41 participants. Therefore
our meta-analyses of tDCS and CES should be considered an
incomplete summary of the evidence.
Quality of the evidence
No study of rTMS could be judged as having a low risk of bias
across all criteria. The predominant reason for this was the use of
sub-optimal sham controls that were unable to control for all pos-
sible sensory cues associated with active stimulation. A number of
studies did not clearly report blinding of assessors and sensitivity
analysis excluding those studies that did not report assessor blind-
ing reduced both heterogeneity and the pooled effect size. A recent
meta-epidemiological study has provided empirical evidence that
incomplete blinding in controlled trials that measure subjective
outcomes may exaggerate the observed effect size by 25% (Wood
2008). It is therefore reasonable to expect that incomplete blind-
ing may have exaggerated the effect size seen in the current anal-
ysis of rTMS. It could be reasonably argued that the presence of
a subgroup of single-dose studies of high-frequency stimulation
specific to themotor cortex that does demonstrate superiority over
sham with acceptable levels of heterogeneity is evidence for a spe-
cific clinical effect of rTMS. It should be considered, however, that
high-frequency rTMS is associated with more intense sensory and
auditory cues that might plausibly elicit a larger placebo response,
and the included studies were unable to control conclusively for
these factors. Additionally there are insufficient data relating to
stimulation of cortical regions other than the motor cortex from
which to draw reliable comparisons. The effect size for the high-
frequency studies of motor cortex rTMS approaches our predeter-
mined threshold for clinical significance but the lower 95% confi-
dence intervals do not meet this threshold. This estimate is based
solely on single-dose studies and the evidence for multiple-dose
studies is currently both limited and conflicting.
No study of CES could be judged as having a low risk of bias across
all criteria. Despite this, no study from which data were available
demonstrated a clear advantage of active over sham stimulation.
There was substantial variation in the stimulation parameters used
between studies. Notably three studies (Gabis 2003; Gabis 2009;
Katsnelson 2004) utilised an “active placebo” control in which
stimulating current was delivered but at much lower intensities.
These intensities well exceed those employed in the active stim-
ulation condition of other studies of CES devices and as such it
could be hypothesised that they might induce a therapeutic ef-
fect themselves. This could possibly disadvantage the active stim-
ulation group in these studies. However, the data available in the
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meta-analysis does not suggest such a trend and statistical hetero-
geneity between studies entered into the analysis was low.
One study of tDCS was judged as having a low risk of bias on all
criteria (Mori 2010). However, the one study (Valle 2009) that we
could not enter into the meta-analysis would have been judged at
low risk of bias had this data been available. There is evidence that
the sham control used in tDCS does achieve effective blinding of
participants (Gandiga 2006) and studies were judged as being at
low risk of bias if they reported formally blinding the participants.
However, while this form of blinding is validated for stimulation
intensities of 1 mA all of the studies identified in this review used
stimulation intensities of 2 mA which may be more likely to elicit
sensation. One study report (Mori 2010) alludes in the discussion
to experiencing difficulties with blinding at 2 mA. This suggests a
possible source of biaswithin the existing evidence base in favour of
active stimulation but we are unaware of any systematic evaluation
of the integrity of tDCS sham controls at this stimulation intensity.
All of the 33 studies may be considered to be small in terms of
sample size. Given the trend seen in tDCS studies of the motor
cortex towards a beneficial effect on short-term pain outcomes it
is possible that the existing analysis lacks adequate power and that
further large studies may demonstrate therapeutic benefit.
Potential biases in the review process
There is substantial variation between the included studies of
rTMS and tDCS. Studies varied in terms of the clinical popula-
tions included, the stimulation parameters and location, the num-
ber of treatment sessions delivered and in the length of follow up
employed. This heterogeneity is reflected in the I2 statistic for the
overall rTMS and tDCS meta-analyses. However, subgroup inves-
tigation significantly reduced this heterogeneity. While the sub-
group analyses used in this review were prespecified in the review
protocol they should be considered as observational rather than
randomised data and thus the evidence from them is less robust.
Themajority of rTMS and tDCS studies specifically recruited par-
ticipants whose symptoms were resistant to current clinical man-
agement andmost rTMS studies specifically recruited participants
with neuropathic pain. As such it is important to recognise that
this analysis in large part reflects the efficacy of rTMS and tDCS
for refractory chronic pain conditions and may not be as accurate
a reflection of their efficacy across all chronic pain conditions.
One study included in the in the analysis of rTMS studies (Defrin
2007) demonstrated a difference in pain levels between the two
groups at baseline that exceeded the size of the difference observed
at follow up. Specifically the group that received sham stimulation
reported less pain at baseline than those in the active stimulation
group. The use in the current analysis of a between-groups rather
than a change from baseline comparison is likely to have affected
the results although the study contributes only 1.5% weight to the
overall meta-analysis and the study itself reported no difference in
the degree of pain reduction between the active and sham stimu-
lation groups.
The analysis of tDCS for short-term pain included a combination
of studies that delivered a varied number of treatments but there
were insufficient data to support a subgroup analysis specific to
this variable. This analysis is also affected by one study that does
not demonstrate a trend toward superiority of active over sham
stimulation (Fenton 2009). This study delivered fewer treatment
sessions compared with some others in the analysis. Additionally
the authors of this study concluded in favour of active stimulation
by comparing the average pain outcome over a one-week period,
whereas in the current analysis post-stimulation data from the day
of the final treatment session was used. However, this study fulfils
the criteria for inclusion into the analysis and post-hoc sensitivity
analysis excluding this study was considered inappropriate.
The method used to back transform the pooled SMD to a visual
analogue scale and subsequent calculation of the effect as a per-
centage improvement does rest upon the assumption that the stan-
dard deviation and the pain levels in the study used (Lefaucheur
2004) are representative of the wider body of evidence. The study
was chosen as it was the largest study and contributed the most
weight to the analysis. Review of both the standard deviation and
the control group pain scores in Lefaucheur 2004 suggests that
they fall around the middle of distributed values. However, the
results of this back transformation should be considered an esti-
mate.
Agreements and disagreements with other
studies or reviews
The European Federation of Neurological Societies (EFNS) pub-
lished guidelines on the use of neurostimulation therapy for
chronic neuropathic pain in 2007 (Cruccu 2007) following a re-
view of the existing literature. Using a narrative synthesis of the ev-
idence they similarly concluded that there was moderate evidence
(two randomised controlled trials) that high-frequency rTMS (≥
5 Hz) of the motor cortex induces significant pain relief in central
post-stroke pain and several other neuropathic conditions but that
the effect is modest and short-lived. They did not recommend its
use as a sole clinical treatment but suggest that it might be con-
sidered in the treatment of short-lasting pain.
A recent review (Leung 2009) performed a meta-analysis of indi-
vidual patient data from studies of motor cortex rTMS for neuro-
pathic pain conditions. Whilst the analysis was restricted to stud-
ies that clearly reported the neuroanatomical origin of participants
pain (and therefore excluded some of the studies included in the
current analysis) the overall analysis suggests a similar effect size of
13.7% improvement in pain (excluding the study of Khedr 2005).
The authors also performed an analysis of the influence of the
neuro-anatomical origins of pain on the effect size. They noted a
trend suggestive of a larger treatment effect in central compared
with peripheral neuropathic pain states although this did not reach
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statistical significance. While the data in the current review were
not considered sufficient to support a detailed subgroup analysis
by neuro-anatomical origin of pain, the exclusion of studies that
did not specifically investigate neuropathic pain did not signifi-
cantly affect the overall analysis and the two multiple-dose stud-
ies of motor cortex rTMS for central neuropathic pain that were
included (Defrin 2007; Kang 2009) failed to demonstrate superi-
ority of active over sham stimulation.
All but one of the included studies in the review by Leung 2009
delivered high-frequency (≥ 5Hz) rTMS and no clear influence of
frequency variations was observed within this group. The authors
suggest that the number of doses delivered may be more crucial
to the therapeutic response than the frequency (within the high-
frequency group) based on the larger therapeutic response seen in
the study of Khedr 2005 that was excluded from the current anal-
ysis. This review preceded the studies by Defrin 2007 and Kang
2009 that did not demonstrate superiority of active over sham
stimulation. While there are limited data to test this proposition
robustly the results of the subgroup analysis of multiple-dose stud-
ies of high-frequency motor cortex rTMS in neuropathic pain do
not suggest a benefit of active stimulation over sham.
Lima and Fregni (Lima 2008) undertook a systematic review and
meta-analysis of motor cortex stimulation for chronic pain. They
pooled data from rTMS and tDCS studies. While the report states
that data were collected on mean between-group pain scores they
are not presented. The authors present the pooled data for the
number of responders to treatment across studies. They conclude
that the number of responders is significantly higher following
active stimulation compared with sham (risk ratio 2.64, 95% CI
1.63 to 4.30). In their analysis the threshold for treatment response
is defined as a global response according to each study’s own defi-
nition and as such it is difficult to interpret and may not be well-
standardised. They note a greater response to multiple doses of
stimulation, an observation that is not reliably reflected in the cur-
rent review. Additionally they included the study of Khedr 2005
(excluded from this review due to high risk of bias) and Canavero
2002 (excluded on title and abstract as it is not a randomised
or quasi-randomised study). The current review also includes a
number of motor cortex rTMS studies published since that review
(André-Obadia 2008; Defrin 2007; Kang 2009; Lefaucheur 2006;
Lefaucheur 2008; Passard 2007; Saitoh 2007). Neither the review
of Leung 2009 or Lima 2008 applied a formal quality or risk of
bias assessment.
While the current review also suggests a small significant short-
term benefit of high-frequency motor cortex rTMS in the treat-
ment of chronic pain the effect is small, appears short-term and
although the pooled estimate approaches the threshold of mini-
mal clinical significance it is possible that it might be inflated by
methodological biases in the included studies.
Kirsch 2000 reviewed studies of CES in the management of
chronic pain and concluded in favour of the use of CES. The re-
view did not report any formalised search strategy, inclusion crite-
ria or quality assessment and discussed a number of unpublished
studies that remain unpublished at the time of the current review.
Using a more systematic methodology and including papers pub-
lished since that review we found that the data that were available
for meta-analysis do not suggest a statistically or clinically impor-
tant benefit of active CES over sham.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is evidence that low-frequency rTMS is not clinically effec-
tive in the treatment of chronic pain. Subgroup analysis suggests
that single doses of high-frequency rTMS of the motor cortex
have small short-term effects on chronic pain although the limited
evidence from multiple-dose studies of high-frequency rTMS to
the motor cortex is conflicting. As such it is not currently clear
whether rTMS represents a useful clinical tool and more evidence
is needed. There is insufficient evidence from which to draw firm
conclusions regarding the efficacy of tDCS or CES for the treat-
ment of chronic pain.
Implications for research
The existing evidence across all forms of non-invasive brain stim-
ulation is dominated by small studies with unclear risk of bias and
there is a need for larger rigorously controlled trials. Studies should
endeavour to report primary outcomes clearly in a format that
facilitates data extraction so that an inclusive meta-analysis might
be possible, particularly in studies of CES and tDCS. All stud-
ies of non-invasive brain stimulation techniques should measure,
record and clearly report adverse events to both active and sham
stimulation. Further studies of tDCS should give consideration to
the integrity of participant blinding, particularly when utilising
stimulation intensities that exceed 1 mA.
In rTMS the evidence base is dominated by studies of intractable
neuropathic pain and there is little evidence from which to draw
conclusions regarding other types of chronic pain. All of the in-
cluded rTMS studies are affected by the use of sub-optimal sham
conditions thatmay adversely impact uponblinding. Future rTMS
research should consider employing recently developed sham coils
that control for all of the sensory aspects of stimulation. Such coil
systems should be robustly validated as reliable and valid sham
controls. The current results suggest that any future trial of rTMS
in chronic pain should utilise high-frequency stimulation param-
eters. The influence of other stimulation parameters on efficacy
is currently unclear. The results suggest that the motor cortex is
the most promising site for stimulation, however this may be a
function of the small number of studies that stimulated other cor-
tical regions. There is a particular need for more multiple-dose
studies of rTMS that measure both short and long-term clinical
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outcomes to determine whether the effect seen in this review can
be considered clinically useful.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [author-defined order]
André-Obadia 2006
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management, candidates for invasive MCS
n = 14
Age: 31 to 66 mean 53 SD 11
Duration of symptoms: mean 6.9 years SD 4
Gender distribution: 10 M, 4 F
Interventions Stimulation type: rTMS figure of 8 coil
Stimulation parameters:
Condition 1: frequency 20Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 4 sec; ITI 84 sec; total no. pulses 1600
Condition 2: frequency 1 Hz; coil orientation lateromedial; no. of trains 1; duration of
trains 26 mins, total no. pulses 1600
Condition 3: sham - same as for condition 2 with coil angled away perpendicular to
scalp
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 1 for each condition
Outcomes Primary: VAS 0 to 10 cm, anchors “no pain” to “unbearable pain”
When taken: immediately post-stimulation then daily for 1 week
Secondary: none
Notes Adverse events: none
Data requested from authors and received
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Comment: method of randomisation not
specified but less likely to introduce bias in
a cross-over design
Quote: “Three different sessions of stimu-
lation were administered in random order
to each patient.”
Incomplete outcome data addressed?
All outcomes
Unclear risk 2 participants lost to follow up and not ac-
counted for in the data analysis. Given the
small sample size it may influence the re-
sults
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André-Obadia 2006 (Continued)
Free of selective reporting? Low risk Pain outcomes reported for all participants.
Change from baseline figures given, point
measures requested from study authors and
received
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “To ensure the double blind evalu-
ation effects, the physician applying mag-
netic stimulation was different from the
one collecting the clinical data, who in turn
was not aware of themodality of rTMS that
had been used in each session.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment
“sub optimal”. Coil angled away from scalp
and not in contact in sham condition.Does
not control for sensory characteristics of ac-
tive stimulation and is visually distinguish-
able
Free from carry-over effects? Low risk Comment: a 2-week wash-out period
was observed between stimulation condi-
tions and possible carry-over effects were
checked and ruled out in the analysis
André-Obadia 2008
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: France
Setting: laboratory based
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management, candidates for invasive MCS
n = 30
Age: 31 to 72, mean 55 (SD 10.5)
Duration of symptoms: mean 5 years (SD 3.9)
Gender distribution: 23 M, 7 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 20Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 4 sec; ITI 84 sec; total no. pulses 1600
Condition 2: frequency 20 Hz, coil orientation lateromedial; no. of trains 20; duration
of trains 4 sec; ITI 84 sec; total no. pulses 1600
Condition 3: sham - same as for active conditions with coil angled away perpendicular
to scalp
Stimulation location: motor cortex contralateral to painful side
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André-Obadia 2008 (Continued)
Number of treatments: 1 for each condition
Outcomes Primary: 0 to 10 NRS (anchors “no pain” to “unbearable pain”)
When taken: daily for 2 weeks post-stimulation
Secondary: none
When taken: daily for 2 weeks post stimulation.
Notes Adverse events: none
Data requested from authors
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “the order of sessions was ran-
domised (by computerized random-num-
ber generation)”
Incomplete outcome data addressed?
All outcomes
Low risk Comment: 2 participants apparently lost to
follow up and not obviously accounted for
in the analysis. However, this is less than
10% and is unlikely to have strongly influ-
enced the results
Free of selective reporting? Low risk Comment: medial-lateral coil orientation
condition data not presented but provided
by authors on request
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “The physician who applied the
procedure received from a research assistant
one sealed envelope containing the order of
the rTMS sessions for a given patient. The
order remained unknown to the physician
collecting clinical data.”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment -
sub-optimal. Coil angled away from scalp
and not in contact in sham condition.Does
not control for sensory characteristics of ac-
tive stimulation and is visually distinguish-
able
Free from carry-over effects? Low risk Comment: a 2-week wash-out period
was observed between stimulation condi-
tions and possible carry-over effects were
checked and ruled out in the analysis
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Boggio 2009
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management.
n = 8
Age: 40 to 82 mean 63.3 SD 5.6
Duration of symptoms: 1 to 20 years mean 8.3 SD 5.6
Gender distribution: 2 M, 6 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 30 minutes
Condition 1: active tDCS/active TENS
Condition 2: active tDCS/sham TENS
Condition 3: sham tDCS/sham TENS
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 1 for each condition
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: VAS 0 to 10 anchors “no pain” to “worst possible pain”
When taken: pre and post each stimulation
Secondary: none
Notes Adverse events: 1 headache reported during active stimulation
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “All the patients received the 3
treatments.... in a randomised order (we
used a computer generated randomisation
list with the order of entrance).”
Incomplete outcome data addressed?
All outcomes
Unclear risk Comment: 2 participants lost to follow up.
It is unclear how these data were accounted
for as there are no missing data apparent in
the results tables. However, this may have
an impact given the small sample size
Free of selective reporting? Low risk Comment: primary outcome data pre-
sented clearly and in full
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “All evaluations were carried out by
a blinded rater”
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Boggio 2009 (Continued)
Adequate blinding of participants? Low risk Comment: there is evidence in supporting
type of sham control as credible
Free from carry-over effects? Low risk Comment: a 48-hour wash-out period
was observed between stimulation condi-
tions and possible carry-over effects were
checked and ruled out in the analysis
Quote: “To analyze whether there was a
carryover effect, we initially performed and
showed that the baselines for the 3 condi-
tions were not significantly different (P =
0.51). We also included the variable order
in our model and this model also showed
that order is not a significant term (P = 0.
7).”
Borckardt 2009
Methods Cross-over randomised controlled trial; 2 conditions
Participants Country of study: USA
Setting: laboratory
Condition: peripheral neuropathic pain
Prior management details: not specified
n = 4
Age: 33 to 58 mean 46 SD 11
Duration of symptoms: 5 to 12 years, mean 10.25 SD 3.5
Gender distribution: 1 M, 3 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 10 Hz; coil orientation not specified; 100% RMT;
no. of trains 40; duration of trains 10 sec; ITI 20 sec; total no. pulses 4000
Stimulation location: L pre-frontal cortex
Number of treatments: 3 over a 5-day period
Control type: Neuronetics sham coil (looks and sounds identical)
Outcomes Primary: average daily pain 0 to 10 Likert scale, anchors “no pain at all” to “worst pain
imaginable”
When taken: post-stimulation for each condition (unclear how many days post) and
daily for 3 weeks post-stimulation
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
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Borckardt 2009 (Continued)
Adequate sequence generation? Low risk Quote: “The order (real first or sham first)
was randomised”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out
Free of selective reporting? Low risk Comment: all results reported clearly and
in full
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: not specified
Adequate blinding of participants? Unclear risk Quote: “Twoof the four participants (50%)
correctly guessed which treatment periods
were real and sham, which is equal to
chance. All four of the participants ini-
tially said that they did not know which
was which, and it was not until they were
pushed to “make a guess” that they were
able to offer an opinion about which ses-
sions were real and which were sham.”
Comments: sham credibility assessment -
sub-optimal. Sham coil controls for au-
ditory cues and is visually indistinguish-
able from active stimulation but does not
control for sensory characteristics of active
stimulation
Free from carry-over effects? Low risk Comment: a 3-week wash-out period was
observed. Presented average pain values are
very similar pre- each condition
Capel 2003
Methods Partial cross-over randomised controlled trial. NB: Only first phase results will be con-
sidered therefore the trial will be considered as having a parallel design
Participants Country of study: UK
Setting: residential educational centre
Condition: post SCI pain (unclear whether this is neuropathic or otherwise)
Prior management details: unclear
n = 30
Age: unclear
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Capel 2003 (Continued)
Duration of symptoms: unclear
Gender distribution: unclear
Interventions Stimulation type: CES
Stimulation parameters: frequency 10Hz; pulse width 2msec; intensity 1 2µA; duration
53 mins
Stimulation location: ear clip electrodes
Number of treatments: x 2 daily for 4 days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: 0 to 10 VAS “level of pain”, anchors not specified
When taken: daily during the treatment period
Secondary: none
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Comment: method equivalent to picking
out of a hat
Quote: “Subjects would be randomly as-
signed into two groups according to their
choice of treatment device....The devices
were numbered for identification, but nei-
ther the administrators nor the recipients
of the treatment could distinguish between
the devices.”
Allocation concealment? Low risk Comment: this is achieved through the
method of randomisation
Incomplete outcome data addressed?
All outcomes
Low risk Comment: 3 subjects withdrew (not vol-
untarily) and while the data are not clearly
accounted for in the data analysis this con-
stitutes 10% of the overall cohort and is
unlikely to have strongly influenced the re-
sults
Quote: “Three of the 30 subjects included
were withdrawn from the study after com-
mencement, one of whom developed an
upper respiratory infection, and two oth-
ers were withdrawn from the study be-
cause their medication (either H2 antago-
nist anti-ulcer or steroidal inhalant) were
interacting with the TCET treatment.”
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Capel 2003 (Continued)
Free of selective reporting? High risk Comment: pain score values are not pro-
vided for any time point
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “neither the administrators nor the
recipients of the treatment could distin-
guish between the devices.”
Adequate blinding of participants? Low risk Quote: “neither the administrators nor the
recipients of the treatment could distin-
guish between the devices.”
Carretero 2009
Methods Parallel randomised clinical trial
Participants Country of study: Spain
Setting: outpatient clinic
Condition: fibromyalgia (with major depression)
Prior management details: unclear
n = 26
Age: active group: 47.5 SD 5.7, sham group 54.9 SD 4.9
Duration of symptoms: unclear “chronic”
Gender distribution: 2 M, 24 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 1 Hz; coil orientation not specified; 110% RMT; no.
of trains 20; duration of trains 60 sec; ITI 45 sec; no. of pulses 1200
Stimulation location: R dorsolateral prefrontal cortex
Number of treatments: up to 20 on consecutive working days
Control type: coil angled 45º from the scalp
Outcomes Primary: Likert pain scale 0 to 10, anchors “no pain” to “extreme pain”
When taken: 2 weeks, 4 weeks and 8 weeks from commencement of study
Secondary: none
Notes Adverse events
Active group: neck pain/headache 6/14 participants, worsening depression 1/14 partic-
ipants
Sham group: 2/12 neck pain/headache, 4/12 nausea/tiredness
Risk of bias
Bias Authors’ judgement Support for judgement
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Carretero 2009 (Continued)
Adequate sequence generation? Unclear risk Comment: method of randomisation not specified
Allocation concealment? Unclear risk Comment: allocation concealment not specified
Incomplete outcome data addressed?
All outcomes
Low risk Comment: only one participant in each group did
not complete the study. Unlikely to have strongly
influenced the findings
Free of selective reporting? Low risk Comment: outcomes presented clearly and in full
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: patients and raters (but not the treating physi-
cian) were blind to the procedure
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-opti-
mal. Coil angled 45º away from scalp. Does not con-
trol for sensory characteristics of active stimulation
and is visually distinguishable
Cork 2004
Methods Cross-over randomised controlled trial (to be considered as parallel - first treatment phase
only)
Participants Country of study: USA
Setting: pain clinic
Condition: fibromyalgia
Prior management details: unclear
n = 74
Age: 22 to 75 mean 53
Duration of symptoms:1 to 21 years mean 7.3
Gender distribution: 4 M, 70 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width unclear; intensity 100 µA; wave-
form shape modified square wave biphasic 50% duty cycle; duration 60 mins
Stimulation location: ear clip electrodes
Number of treatments: ? daily for 3 weeks
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: 0 to 5 numerical pain intensity scale, anchors “no pain” to “worst pain imag-
inable”
When taken: immediately following the 3-week treatment period
Secondary: Oswestry Disability Index
When taken: immediately following the 3-week treatment period
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Cork 2004 (Continued)
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Comment: method of randomisation not
specified
Allocation concealment? Unclear risk Comment: allocation concealment not
specified
Incomplete outcome data addressed?
All outcomes
Unclear risk Comment: drop-out rate not reported
Free of selective reporting? High risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any time point
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “All staff, the physicians, and the
patient were blind to the treatment condi-
tions.”
Adequate blinding of participants? Low risk Quote: “All staff, the physicians, and the
patient were blind to the treatment condi-
tions.”
Defrin 2007
Methods Parallel randomised controlled trial
Participants Country of study: Israel
Setting: outpatient department
Condition: post SCI central neuropathic pain
Prior management details: refractory to drug, physical therapy and complementary ther-
apy management
n = 12
Age: 44 to 60 mean 54 SD 6
Duration of symptoms: > 12 months
Gender distribution: 7 M, 4 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 5 Hz; coil orientation not specified; 115% RMT; no.
of trains 500; duration of trains 10 sec; ITI 30 sec; total no. pulses 500 reported, likely
to have been 25,000 judging by these parameters
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Defrin 2007 (Continued)
Stimulation location: motor cortex - midline
Number of treatments: x 10, x 1 daily on consecutive days
Control type: sham coil - visually the same and make similar background noise
Outcomes Primary: 15 cm 0 to 10 VAS pain intensity, anchors “no pain sensation” to “most intense
pain sensation”
When taken: pre and post each stimulation session
Secondary: McGill pain questionnaire
When taken: 2 and 6-week follow-up period
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Comment: method of randomisation not speci-
fied
Quote: “Patients were randomised into 2 groups
that received either real or sham rTMS”
Allocation concealment? Unclear risk Comment: allocation concealment not specified
Incomplete outcome data addressed?
All outcomes
Low risk Comment: only one participant withdrew for “lo-
gistic reasons”. Unlikely to have strongly influ-
enced the findings
Free of selective reporting? Low risk Comment: while group means/SD are not pre-
sented in the study report, the study authors have
provided the requested data
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “The patients as well as the person con-
ducting the outcome measurements were blind to
the type of treatment received.”
Adequate blinding of participants? Unclear risk Quote: “Two coils were used; real and sham, both
of which were identical in shape and produced a
similar background noise.”
Comment: sham credibility assessment - sub-op-
timal. Sham coil controls for auditory cues and is
visually indistinguishable from active stimulation
but does not control for sensory characteristics of
active stimulation over the scalp. Given that stim-
ulation was delivered at 110% RMT active stim-
ulation, but not sham, is likely to have elicited
muscle twitches in peripheral muscles
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Fenton 2009
Methods Cross-over randomised controlled trial
Participants Country of study: USA
Setting: unclear
Condition: chronic pelvic pain
Prior management details: refractory to treatment
n = 7
Age: mean 38
Duration of symptoms: mean 80 months
Gender distribution: all F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 1 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: M1 dominant hemisphere
Number of treatments: 2
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: VAS overall pain, pelvic pain, back pain, migraine pain, bladder pain, bowel
pain, abdomen pain, and pain with intercourse. Anchors not specified
When taken: daily during stimulation and then for 2 weeks post each condition
Secondary: none
Notes Adverse events:
Active group: 3 headache, 2 neck ache, 1 scalp pain, 5 scalp burning sensation
Sham group: 1 headache, 0 neck ache, 0 scalp pain, 0 scalp burning sensation
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out reported
Free of selective reporting? Low risk Comment: variance measures not presented
for group means post-stimulation but data
provided by author on request
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “All other personnel in the study, in-
cluding the investigators, study coordinators,
participants, and their families, and all primary
medical caregivers, were blinded.”
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Fenton 2009 (Continued)
Adequate blinding of participants? Low risk Quote: “All other personnel in the study, in-
cluding the investigators, study coordinators,
participants, and their families, and all primary
medical caregivers, were blinded.”
Free from carry-over effects? Unclear risk Comments: pre-stimulation data are not pre-
sented and no formal investigation for carry-
over effects is discussed
Fregni 2005
Methods Cross-over randomised controlled trial
Participants Country of study: USA
Setting: laboratory
Condition: chronic pancreatitis pain
Prior management details: not specified
n = 5
Age: 44 SD 11
Duration of symptoms: not specified “chronic”
Gender distribution: not specified
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 1 Hz; coil orientation not specified; 90% RMT; no.
of trains not specified; duration of trains not specified; ITI not specified; total no. pulses
1600
Stimulation location: left and right secondary somatosensory area (SII)
Number of treatments: 1 for each condition
Control type: sham “specially designed sham coil”. No further details
Outcomes Primary: pain VAS, anchors not specified
When taken: after each stimulation session
Secondary: none
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “The order of stimulation was ran-
domised and counterbalanced across patients
using a Latin square design.”
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out reported
40Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fregni 2005 (Continued)
Free of selective reporting? High risk Comment: pain score numerical values are not
provided clearly with measures of variance for
any time point for the sham condition
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “Patients were blinded to treatment
condition, and a blinded rater evaluated anal-
gesic use, patient’s responses in a Visual Ana-
logue Scale (VAS) of pain.... immediately after
each session of rTMS.”
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment “un-
clear”. Type of sham coil not specified
Free from carry-over effects? Low risk Quote: “Importantly, baseline pain scoreswere
not significantly different across the six condi-
tions of stimulation....speaking against carry-
over effect.”
Fregni 2006a
Methods Parallel randomised controlled trial
Participants Country of study: Brazil
Setting: laboratory
Condition: post SCI central neuropathic pain
Prior management details: refractory to drug management
n = 17
Age: mean 35.7 SD 13.3
Duration of symptoms: chronic > 3/12
Gender distribution: 14 M, 3 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: motor cortex (contralateral tomost painful side or dominant hand)
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: Pain VAS 0 to 10cm, anchors “no pain” to “worst pain possible”
When taken: before and after each stimulation and at 16-day follow up
Secondary: none
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
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Fregni 2006a (Continued)
Adequate sequence generation? Low risk Quote: “Randomization was performed using the
order of entrance in the study and a previous
randomisation list generated by a computer us-
ing random blocks of six (for each six patients,
two were randomised to sham and four to active
tDCS) in order to minimize the risk of unbal-
anced group sizes.”
Allocation concealment? Low risk Comment: the use of a pre-generated randomisa-
tion list should ensure this
Incomplete outcome data addressed?
All outcomes
Low risk Quote: “we analyzed the primary and secondary
endpoints using the intention-to-treat method in-
cluding patients who received at least one dose
of the randomised treatment and had at least one
post-baseline efficacy evaluation. We used the last
evaluation carried out to the session before the
missed session, assuming no further improvement
after the dropout, for this calculation.”
Free of selective reporting? Unclear risk Comment: pain score numerical values are not
provided clearly in the study report with measures
of variance for any time point. On request data
were available for the primary outcome at one
follow-uppoint but not for other follow-up points
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “All evaluations were performed by a
blinded rater”
Adequate blinding of participants? Low risk Quote: “3-week double-blinded treatment”
Fregni 2006b
Methods Parallel randomised controlled trial; 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: unclear
n = 32
Age: 53.4 SD 8.9
Duration of symptoms: condition 1: 8.4 SD 9.3 years, condition 2: 10.0 SD 7.8 years,
condition 3: 8.1 SD 7.5 years
Gender distribution: 0 M, 32 F
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Fregni 2006b (Continued)
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: condition 1: dorsolateral prefrontal cortex, condition 2: Motor
cortex, condition 3: shammotor cortex. All conditions contralateral to most painful side
or dominant hand
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS 0 to 10 cm, anchors not specified
When taken: at the end of the stimulation period and at 21-day follow up
Secondary: quality of life: Fibromyalgia Impact Questionnaire
Notes Adverse events:
Condition 1 (DLPFC): sleepiness (1/11 participants), headache (1/11)
Condition 2 (motor cortex): sleepiness (3/11), headache (3/11)
Sham group: sleepiness (1/10), headache (2/10)
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Randomizationwas performedus-
ing the order of entry into the study and
a previous computer-generated randomisa-
tion list, using random blocks of 6 patients
(for each 6 patients, 2 were randomised to
each group) in order to minimize the risk
of unbalanced group sizes.”
Allocation concealment? Low risk Comment: the use of a pre-generated ran-
domisation list should have adequately en-
sured this
Incomplete outcome data addressed?
All outcomes
Low risk Quote: “One patient (in the M1 group)
withdrew, and the few missing data were
considered to be missing at random. We
analyzed data using the intent-to-treat
method and the conservative last observa-
tion carried forward approach.”
Free of selective reporting? Unclear risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for most time points in the study re-
port. On request data were available for the
primary outcome at one follow-up point
but not for other follow-up points
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Fregni 2006b (Continued)
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “All of the assessments were con-
ducted by raters who were blinded to the
treatment arm.”
Adequate blinding of participants? Low risk Quote: “a period of double-blinded treat-
ment, during which patients received daily
treatment”
Gabis 2003
Methods Parallel randomised controlled trial
Participants Country of study: USA
Setting: pain clinic
Condition: chronic back and neck pain
Prior management details: unclear
n = 20
Age: 20 to 77
Duration of symptoms: 0.5 to 40 years
Gender distribution: 9 M, 11 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 77 Hz; pulse width 3.3 msec; intensity ≤ 4 mA;
waveform shape biphasic asymmetric; duration 30 mins
Stimulation location: 3 electrodes, one attached to either mastoid process and one to the
forehead
Number of treatments: 8, x 1 daily on consecutive days
Control type: ”active placebo“ units visually indistinguishable. Delivered 50 Hz fre-
quency, intensity ≤ 0.75 mA. Note: may not be inert
Outcomes Primary: pain VAS, anchors not specified
When taken: pre and post each stimulation
Secondary: none
Notes Adverse events: mild skin redness under electrodes in some patients. 5% experienced
mild short duration headaches or dizziness during or up to 10 mins following treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: ”The paramedic administered treatments
based on a computer-elicited randomisation list.“
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Gabis 2003 (Continued)
Allocation concealment? Low risk Quote: ”The paramedic administered treatments
based on a computer-elicited randomisation list.
At enrolment in the study, the investigator as-
signed the next random number in that patient’s
category. The investigator did not have access to
the randomisation list until after the
study was completed.
Incomplete outcome data addressed?
All outcomes
Low risk Comment: all participants completed the study
Free of selective reporting? Low risk Comment: while pain score numerical values are
not provided clearly with measures of variance for
most time points in the study report the study
authors have provided the requested data
Free of other bias? Unclear risk Comment: an active placebo that delivers current
may not be inert and may bias against between
group differences (0.75 mA exceeds the intensity
of the active arms of other CES trials)
Adequate blinding of assessors? Low risk Quote: “The active placebo device was indistin-
guishable to the patient and medical team.”
Adequate blinding of participants? Low risk Quote: “The active placebo device was indistin-
guishable to the patient and medical team from
the real TCES device - it was designed to give the
patient the feeling of being treated, inducing an
individual sensation of skin numbness or muscle
contraction”
Gabis 2009
Methods Parallel randomised controlled trial
Participants Country of study: Israel
Setting: pain clinic
Condition: chronic back and neck pain
Prior management details: unclear
n = 75 (excluding headache participants)
Age: mean 53.9 range 22 to 82
Duration of symptoms: 0.5 to 40 years
Gender distribution: 35 M, 40 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 77 Hz; pulse width 3.3 msec; intensity ≤ 4 mA;
waveform shape biphasic asymmetric; duration 30 mins
Stimulation location: 3 electrodes, one attached to either mastoid process and one to the
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Gabis 2009 (Continued)
forehead
Number of treatments: 8, x 1 daily on consecutive days
Control type: “active placebo” units visually indistinguishable. Delivered 50 Hz fre-
quency, intensity ≤ 0.75 mA. Note: may not be inert
Outcomes Primary: pain VAS, anchors not specified
When taken: pre and post each stimulation. 3 weeks and 3 months following treatment
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “The paramedic administered treatments
based on a computer-elicited randomisation list”
Allocation concealment? Low risk Quote: “The paramedic administered treatments
based on a computer-elicited randomisation list.
At enrolment, the investigator assigned the next
random number in that patient’s category. The
investigator did not have access to the randomi-
sation list until study completion.”
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out is indicated comparing
the results with the number enrolled
Free of selective reporting? Low risk Comment: results for primary outcomes are re-
ported clearly and in full
Free of other bias? Unclear risk Comment: an active placebo that delivers current
may not be inert and may bias against between
group differences (0.75 mA exceeds the intensity
of the active arms of other CES trials)
Adequate blinding of assessors? Low risk Quote: “The investigator did not have access to
the randomisation list until study completion”
Adequate blinding of participants? Low risk Quote: “The placebo device was indistinguishable
from the active device”
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Hirayama 2006
Methods Cross-over randomised controlled trial; 5 conditions
Participants Country of study: Japan
Setting: laboratory
Condition: intractable deafferentation pain (mixed central, peripheral and facial)
Prior management details: intractable
n = 20
Age: 28 to 72 years
Duration of symptoms: 1.5 to 24.3 years, mean 6.4 SD 6
Gender distribution: 13 M,7 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 5 Hz; coil orientation not specified; 90% RMT; no.
of trains 10; duration of trains 10 sec; ITI 50 sec; total no. pulses 500
Stimulation location: condition 1: motor cortex, condition 2: primary sensory cortex,
condition 3: pre-motor area, condition 4: supplementary motor area, condition 5: sham
Number of treatments: 1 for each condition
Control type: coil angled 45º from scalp with synchronised electrical scalp stimulations
to mask sensation
Outcomes Primary: pain intensity VAS, anchors not specified
When taken: 0, 30, 60, 90, 180 minutes post-stimulation
Secondary: none
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “All targets were stimulated in ran-
dom order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data addressed?
All outcomes
Low risk Quote: “All 20 patients underwent all
planned sessions of navigation- guided
rTMS”
Free of selective reporting? Low risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any time point but data provided
upon request
Free of other bias? Low risk Comment: no significant other bias de-
tected
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Hirayama 2006 (Continued)
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not re-
ported
Adequate blinding of participants? Unclear risk Quote: “The patientswere unable to distin-
guish sham stimulation from actual rTMS,
because the synchronized electrical stim-
ulation applied to the forehead made the
forehead spasm, as was the case with actual
TMS”
Comment: sham credibility assessment -
sub-optimal. Sensory and auditory aspects
are controlled for but angulation of coil
away from the scalp may be visually distin-
guishable
Free from carry-over effects? Low risk Comment: authors provided requested
data. Appears free of carry-over effects
Irlbacher 2006
Methods Cross-over randomised controlled trial; 3 conditions
Participants Country of study: Germany
Setting: laboratory
Condition: phantom limb pain (PLP) and central neuropathic pain (CNP)
Prior management details: unclear
n = 27
Age: (median) PLP 46.6, CNP 51.1
Duration of symptoms: mean PLP 15.2 SD14.8, CNP 3.9 SD 4.1
Gender distribution: 16 M, 11 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 1 Hz; coil orientation not specified; 95% RMT; no. of trains
not specified; duration of trains not specified; ITI not specified; total no. pulses 500
Condition 2: frequency 5 Hz; coil orientation not specified; 95% RMT; no. of trains
not specified; duration of trains not specified; ITI not specified; total no. pulses 500
Condition 3: sham frequency 2 Hz; coil orientation not specified; no. of trains not
specified; duration of trains not specified; ITI not specified; total no. pulses 500
Stimulation location: motor cortex, contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil. Mimics sight and sound of active treatment
Outcomes Primary: 0 to 100 mm VAS pain intensity, anchors “no pain” and “most intense pain
imaginable”
When taken: pre and post stimulation.
Secondary: none
48Non-invasive brain stimulation techniques for chronic pain (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Irlbacher 2006 (Continued)
Notes Adverse events: one participant reported increased pain following 5Hz active stimulation
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data addressed?
All outcomes
High risk Comment: 13 of 27 participants did not
complete all treatment conditions and this
drop-out is not clearly accounted for in the
analysis
Free of selective reporting? Low risk Comment: primary outcome data pre-
sented clearly and in full
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Sham credibility assessment - sub-optimal.
Sham coil controls for auditory cues and is
visually indistinguishable from active stim-
ulation but does not control for sensory
characteristics of active stimulation
Free from carry-over effects? Low risk Quote: “The VAS values before the stimu-
lation showed no significant differences in
the various types of treatment”
Kang 2009
Methods Cross-over randomised controlled trial
Participants Country of study: S Korea
Setting: university hospital outpatient setting
Condition: post SCI central neuropathic pain
Prior management details: resistant to drug, physical or complementary therapies
n = 11
Age: 33 to 75, mean 54.8
Duration of symptoms: chronic
Gender distribution: 6 M, 5 F
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Kang 2009 (Continued)
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation angled 45º posterolaterally;
80% RMT; no. of trains 20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Stimulation location: R motor cortex, hand area
Number of treatments: 5, x 1 daily
Control type: coil elevated and angled away from the scalp
Outcomes Primary: NRS average pain over last 24 hours, anchors “no pain sensation” to “most
intense pain sensation imaginable”
When taken: immediately after the 3rd and 5th treatments and 1, 3, 5 and 7 weeks after
the end of the stimulation period
Secondary: BPI - pain interference (surrogate measure of disability)
When taken: as for the NRS
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “The real and sham rTMS stimula-
tions were separated by 12 weeks and per-
formed in a random order according to the
prepared allocation code.”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no participants withdrew after re-
ceiving the first treatment condition
Free of selective reporting? Low risk Comment: results for primary outcomes are
reported clearly and in full
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “a different researcher collected the
clinical data; the latter researcher was not
aware of the type of rTMS (real or sham)”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. Coil angled away from scalp and not
in contact in shamcondition.Does not control
for sensory characteristics of active stimulation
and is visually distinguishable
Free from carry-over effects? Low risk Comment: a 12-week wash-out period was
observed. The pre-stimulation baseline scores
closely match
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Katsnelson 2004
Methods Parallel randomised controlled trial; 3 conditions
Participants Country of study: Russia
Setting: unclear
Condition: hip and knee osteoarthritis
Prior management details: unclear
n = 64
Age: unclear
Duration of symptoms: unclear
Gender distribution: unclear
Interventions Stimulation type: CES
Stimulation parameters:frequency not specified; pulse width not specified; intensity 11
to 15 mA; waveform shape: condition 1 symmetric, condition 2 asymmetric; duration
40 mins
Stimulation location: appears to be one electrode attached to either mastoid process and
one to the forehead
Number of treatments: 5, x 1 daily for 5 consecutive
Control type: sham unit - visually indistinguishable from active units
Outcomes Primary: 0 to 10 NRS, anchors “no pain” to “very painful”
When taken: unclear. Likely to be pre and post each stimulation session and then daily
for 1 week after
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Quote: “If subjects passed all criteria they
were randomly assigned to one of the two
active treatments or the sham treatment.”
Comment: method of randomisation not
specified
Allocation concealment? Unclear risk Comment: not specified
Incomplete outcome data addressed?
All outcomes
Unclear risk Comment: drop-out level not specified
Free of selective reporting? High risk Comment: it is unclear in the report which
time points are reported for primary out-
comes
Free of other bias? High risk Comment: the reporting of baseline group
characteristics is insufficient
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Katsnelson 2004 (Continued)
Adequate blinding of assessors? Low risk Quote: “The physicians, like all other par-
ticipants in the study, were unaware of
which treatment each subject received.”
Adequate blinding of participants? Low risk Quote: “The physicians, like all other par-
ticipants in the study, were unaware of
which treatment each subject received.”
Khedr 2005
Methods Parallel randomised controlled trial
Participants Country of study: Egypt
Setting: university hospital neurology department
Condition: neuropathic pain, mixed central (post-stroke) and facial (trigeminal neural-
gia) pain
Prior management details: refractory to drug management
n = 48
Age: post-stroke 52.3 SD 10.3, trigeminal neuralgia 51.5 SD 10.7
Duration of symptoms: post-stroke 39 months SD 31, trigeminal neuralgia 18 months
SD 17
Gender distribution: 8 M, 16 F
Interventions Stimulation type: rTMS
Stimulation parameters:frequency 20 Hz; coil orientation not specified; 80% RMT; no.
of trains 10; duration of trains 10 sec; ITI 50 sec; total no. pulses 2000
Stimulation location: motor cortex contralateral to the side of worst pain
Number of treatments: 5, x 1 on consecutive days
Control type: coil elevated and angled away from scalp
Outcomes Primary: pain VAS, anchors not specified
When taken: post 1st, 4th and 5th stimulation session and 15 days after the last session
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? High risk Quote: “Patients were randomly assigned to one
of the two groups, depending on the day of the
week on which they were recruited”
Comment: not truly random
Allocation concealment? High risk Comment: the method of sequence generation
makes concealment of allocation unlikely
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Khedr 2005 (Continued)
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out is apparent from the pre-
sented data
Free of selective reporting? Low risk Comment: while pain score numerical values are
not provided clearly with measures of variance for
all time points in the study report, the study au-
thors have provided the requested data
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “The second author evaluated these mea-
sures blindly-that is, without knowing the type of
rTMS”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-op-
timal. Coil angled away from scalp and not in
contact in sham condition. Does not control for
sensory characteristics of active stimulation and is
visually distinguishable
Lefaucheur 2001a
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: intractable neuropathic pain (mixed central and facial)
Prior management details: refractory to drug management
n = 14
Age: 34 to 80, mean 57.2
Duration of symptoms: not specified “chronic”
Gender distribution: 6 M, 8 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:frequency 10 Hz; coil orientation not specified; 80% RMT; no.
of trains 20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Stimulation location: motor cortex, contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil used (?inert)
Outcomes Primary: 0 to 10 VAS, anchors not specified
When taken: daily for 12 days post-stimulation
Secondary: none
Notes Adverse events: none
Risk of bias
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Lefaucheur 2001a (Continued)
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Two different sessions of rTMS sep-
arated by 3 weeks at least were randomly per-
formed in each patient”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out is apparent from the
presented data
Free of selective reporting? Low risk Comment: pain score numerical values are not
provided clearly with measures of variance for
any time point in the report but were provided
by authors on request
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. This study uses the same sham coil as
that used in Lefaucheur 2004, which in that
paper is stated as not meeting the criteria of an
ideal sham
Free from carry-over effects? Low risk Comment: 3/52wash-out periodmakes carry-
over effects unlikely
Lefaucheur 2001b
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central and peripheral)
Prior management details: refractory to drug management
n = 18
Age: 28 to 75, mean 54.7
Duration of symptoms: not specified “chronic”
Gender distribution: 11 M, 7 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10Hz; coil orientation posteroanterior; 80% RMT; no. of trains
20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Condition 2: frequency 0.5Hz; coil orientation posteroanterior; no. of trains 1; duration
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of trains 20 minutes; total no. pulses 600
Condition 3: sham - same as for condition 1 with sham coil
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0 to 10 VAS pain, anchors not specified
When taken: 5 to 10 minutes post-stimulation.
Secondary: none
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “To study the influence of the fre-
quency of stimulation, three different sessions
of rTMS separated by three weeks at least were
randomly performed in each patient”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out is apparent from the
presented data
Free of selective reporting? Low risk Comment: results for primary outcomes are
reported clearly and in full
Free of other bias? Unclear risk Comment: the results of some of the planned
data analysis (ANOVAof group differences af-
ter each condition) are not reported. However
adequate data are available for inclusion in the
meta analysis
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. This study uses the same sham coil as
that used in Lefaucheur 2004, which in that
paper is stated as not meeting the criteria of an
ideal sham
Free from carry-over effects? Low risk Comment: 3-week wash-out observed and no
clear imbalance in pre-stimulation pain scores
between conditions
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Lefaucheur 2004
Methods Cross-over randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management
n = 60
Age: 27 to 79, mean 54.6
Duration of symptoms: not specified “chronic”
Gender distribution: 28 M, 32 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:frequency 10 Hz; coil orientation posteroanterior; 80% RMT;
no. of trains 20; duration of trains 5 sec; ITI 55 sec; total no. pulses 1000
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Control type: sham coil
Outcomes Primary: 0 to 10 VAS pain, anchors not specified
When taken: 5 minutes post-stimulation
Secondary: none
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “one of the following two protocols
was applied in a random order”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out is apparent from the
presented data
Free of selective reporting? Low risk Comment: results for primary outcomes are
reported clearly and in full
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Quote: “ideal sham...which should be per-
formed by means of a coil similar to the real
one in shape, weight, and location on the
scalp, producing a similar sound and similar
scalp skin sensation, but generating no electri-
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Lefaucheur 2004 (Continued)
cal field within the cortex. Such a sham coil
has not yet been designed, and at present, the
sham coil used in this study is to our knowl-
edge the more valid for clinical trials.”
Comments: sham credibility assessment - sub-
optimal
Free from carry-over effects? Low risk Comment: 3-week wash-out observed and no
clear imbalance in pre-stimulation pain scores
between conditions
Lefaucheur 2006
Methods Cross-over randomised controlled trial, 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: unilateral chronic neuropathic pain (mixed central and peripheral)
Prior management details:refractory to drug management
n = 22
Age: 28 to 75, mean 56.5 SD 2.9
Duration of symptoms: 2 to 18 years, mean 5.4 SD 4.1
Gender distribution: 12 M, 10 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 6 sec; ITI 54 sec; total no. pulses 1200
Condition 2: frequency 1 Hz; coil orientation posteroanterior; 90% RMT; no. of trains
1; duration of trains 20 minutes; total no. pulses 1200
Condition 3: sham coil
Stimulation location: motor cortex contralateral to painful side
Number of treatments: x 1 for each condition
Outcomes Primary: 0 to 10 VAS pain, anchors not specified
When taken: pre and post-stimulation
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Three sessions of motor cortex
rTMS, separated by at least 3 weeks, were
performed in random order”
Comment: method of randomisation not
specified but less critical in cross-over de-
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Lefaucheur 2006 (Continued)
sign
Incomplete outcome data addressed?
All outcomes
Unclear risk Comment: level of drop-out not reported
and unclear from the presented data
Free of selective reporting? Low risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any time point in the study report
but were provided by the authors on re-
quest
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is only re-
ported for measures of cortical excitability
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment
- sub-optimal. This study uses the same
Lefaucheur 2004, which in that paper is
stated as not meeting the criteria of an ideal
sham
Free from carry-over effects? Low risk Quote: “Post hoc tests did not reveal any
differences between the three pre-rTMS as-
sessments regarding excitability values or
pain levels”
Lefaucheur 2008
Methods Cross-over randomised controlled trial, 3 conditions
Participants Country of study: France
Setting: laboratory
Condition: neuropathic pain (mixed central, peripheral and facial)
Prior management details: refractory to drug management for at least 1 year
n = 46
Age: 27 to 79, mean 54.2
Duration of symptoms: chronic > 1 year
Gender distribution: 23 M, 23 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10Hz; coil orientation posteroanterior; 90% RMT; no. of trains
20; duration of trains 6 sec; ITI 54 sec; total no. pulses 1200
Condition 2: frequency 1 Hz; coil orientation posteroanterior; 90% RMT; no. of trains
1; duration of trains 20 minutes; total no. pulses 1200
Condition 3: sham coil
Stimulation location: motor cortex contralateral to painful side
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Lefaucheur 2008 (Continued)
Number of treatments: x 1 for each condition
Outcomes Primary: 0 to 10 VAS, anchors not specified
When taken: pre and post-stimulation
Secondary: none
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Three different sessions of rTMS.
.... were performed in a random order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data addressed?
All outcomes
Low risk Comment: 2 participants dropped out but
this is < 5% of the cohort. Unlikely to have
strongly influenced the findings
Free of selective reporting? Low risk Comment: results for all outcomes are re-
ported clearly and in full
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “In all cases, the examiner was
blinded to the type of rTMS administered.
”
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment -
sub-optimal. This study uses the same sham
coil as that used in Lefaucheur 2004, which
in that paper is stated as not meeting the
criteria of an ideal sham
Free from carry-over effects? Low risk Comment: 3-week wash-out observed and
no clear imbalance in pre-stimulation pain
scores between conditions
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Lichtbroun 2001
Methods Parallel randomised controlled study
Participants Country of study: USA
Setting: outpatient fibromyalgia clinic
Condition: fibromyalgia
Prior management details: unclear
n = 60
Age: 23 to 82, mean 50
Duration of symptoms: 1 to 40 years, mean 11
Gender distribution: 2 M, 58 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; 50% duty cycle; intensity 100 µA; waveform
shape biphasic square wave; duration 60 mins
Stimulation location: ear clip electrodes
Number of treatments: 30, x 1 daily for consecutive days
Control type: sham unit - indistinguishable from active unit
Outcomes Primary: 10-point self-rating pain scale, anchors not specified
When taken: post-stimulation (not precisely defined)
Secondary: quality of life - 0 to 10 VAS scale (data not reported)
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “the subjects were randomly assigned
into three separate groups by an office secretary
who drew their names, which were on separate
sealed slips of paper in a container”
Allocation concealment? Low risk Comment: probably given the quote above
Incomplete outcome data addressed?
All outcomes
Unclear risk Drop-out levels are not specified in the report.
Intention-to-treat analysis not discussed in the
report
Free of selective reporting? High risk Comment: pain score numerical values are not
provided clearly with measures of variance for
any time points in the study report
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “All subjects, staff, the examining physi-
cian and the psychometrician remained blind to
the treatment conditions”
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Adequate blinding of participants? Low risk Comment: see previous quote
Mori 2010
Methods Parallel randomised controlled trial
Participants Country of study: Italy
Setting: laboratory
Condition: neuropathic pain secondary to multiple sclerosis
Prior management details:refractory to drug management and medication discontinued
over previous month
n = 19
Age: 23 to 69, mean 44.8 SD 27.5
Duration of symptoms: 1 to 10 years, mean 2.79 SD 2.64
Gender distribution: 8 M, 11 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: motor cortex, contralateral to painful side
Number of treatments: 5, x 1 daily on consecutive days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: 0 to 100 mm VAS pain, anchors “no pain” to “worst possible pain”
When taken: end of treatment period and x 1 weekly over 3-week follow up
Secondary: quality of life, multiple sclerosis quality of life-54 scale (MSQoL-54)
When taken: as for primary outcome
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Randomization was performed using the
order of entrance in the study and a previous ran-
domization list generated by a computer.”
Allocation concealment? Low risk Comment: likely given that the randomisation list
was generated pre-study
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out observed
Quote: “none of the patients enrolled discontin-
ued the study.”
Free of selective reporting? Low risk Comment: between-group means are not pre-
sented clearly to allowmeta-analysis but data pro-
vided on request
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Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “Patients and assessing physician were
blinded to group allocation while the treating
physician, who had to set the tDCS or sham-stim-
ulation protocol on the stimulator, was aware of
the stimulation condition. To minimize commu-
nicationbetweenblinded andnon-blindedpartic-
ipants, the treating physicianwas instructednot to
talk to patients and the assessing physician about
the study protocol”
Adequate blinding of participants? Low risk Comment: see quote above
Passard 2007
Methods Parallel randomised controlled trial
Participants Country of study: France
Setting: laboratory
Condition: fibromyalgia
Prior management details: unclear
n = 30
Age: active group: 52.6 SD 7.8, sham group 55.3 SD 8.9
Duration of symptoms: active group: 8.1 SD 7.9, sham group: 10.8 SD 8.6
Gender distribution: 1 M, 29 F
Interventions Stimulation type: rTMS, figure of 8 coil
Stimulation parameters: frequency 10 Hz; coil orientation posteroanterior; 80% RMT;
no. of trains 25; duration of trains 8 secs; ITI 52 secs; total no. pulses 2000
Stimulation location: motor cortex contralateral to painful side
Number of treatments: 10, x 1 daily for 10 working days
Control type: sham rTMS coil. Mimics sight and sound of active treatment
Outcomes Primary: 0 to 10 NRS of average pain intensity over last 24 hours, anchors “no pain” to
“maximal pain imaginable”
When taken: daily during treatment period and at 15, 30 and 60 days post-treatment
follow up
Secondary: Fibromyalgia Impact Questionnaire
When taken: as for primary outcome
Notes Adverse events: headaches 4 active, 5 sham, nausea 1 active, tinnitus 2 sham, dizziness 1
sham
Risk of bias
Bias Authors’ judgement Support for judgement
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Passard 2007 (Continued)
Adequate sequence generation? Low risk Quote: “patients who met all inclusion criteria
were randomly assigned, according to a computer-
generated list, to two groups”
Allocation concealment? Unclear risk Comment: allocation concealment not specified
Incomplete outcome data addressed?
All outcomes
Low risk Comment: equal drop-out in each group and ap-
propriately managed in the data analysis
Quote: “All randomized patients with a baseline
and at least one post-baseline visit with efficacy
data were included in the efficacy analyses (intent
to treat analysis).”
“All the patients received the full course of treat-
ment and were assessed on D15 and D30. Four
patients (two in each treatment group) withdrew
from the trial between days 30 and 60”
Free of selective reporting? Low risk Comment: while pain score numerical values are
not provided clearly with measures of variance for
all time points in the study report, the study au-
thors have provided the requested data
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “investigators were blind to treatment
group.”
Adequate blinding of participants? Unclear risk Quote: “Sham stimulation was carried out with
the ‘Magstim placebo coil system’, which physi-
cally resembles the active coil and makes similar
sounds.”
Comment: sham credibility assessment - sub-op-
timal. Sham coil controls for auditory cues and is
visually indistinguishable from active stimulation
but does not control for sensory characteristics of
active stimulation over the scalp
Pleger 2004
Methods Cross-over randomised controlled trial
Participants Country of study: Germany
Setting: laboratory
Condition: complex regional pain syndrome type I
Prior management details: drug management ceased for 48 hours prior to study
n = 10
Age: 29 to 72, mean 51
Duration of symptoms: 24 to 72 months, mean 35
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Gender distribution: 3 M, 7 F
Interventions Stimulation type: rTMS
Stimulation parameters: frequency 10 Hz; coil orientation unspecified; 110% RMT; no.
of trains 10; duration of trains 1.2 secs; ITI 10 secs; total no. pulses 120
Stimulation location: motor cortex hand area
Number of treatments: 1 for each condition
Control type: coil angled 45º away from scalp
Outcomes Primary: 0 to 10 VAS current pain intensity, anchors “ no pain” to “most extreme pain”
When taken: 30 secs, 15, 45 and 90 mins post-stimulation
Secondary: none
When taken: 30 seconds, 15, 45 and 90 minutes post stimulation
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Using a computerized random gen-
erator, five patients were first assigned to the
placebo group (sham rTMS), while the others
were treated using verum rTMS”
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out is apparent from the
presented data
Free of selective reporting? Low risk Comment: while sham group results not pre-
sented in the study report, the study authors
have provided the requested data
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. Coil angled 45º away from scalp.
Does not control for sensory characteristics of
active stimulation and is visually distinguish-
able
Free from carry-over effects? Low risk Quote: “The initial pain intensities (VAS)
were similar prior to verum and sham rTMS
(Student’s paired t-test, P = 0.47). The level of
intensity was also independent of whether the
patients were first subjected to sham or verum
rTMS (P > 0.05).”
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Rollnik 2002
Methods Cross-over randomised controlled trial
Participants Country of study: Germany
Setting: pain clinic
Condition: chronic pain (mixed musculoskeletal and neuropathic)
Prior management details: “intractable”
n = 12
Age: 33 to 67, mean 51.3 SD 12.6
Duration of symptoms: mean 2.7 SD 2.4
Gender distribution: 6 M, 6 F
Interventions Stimulation type: rTMS, circular coil for arm symptoms, double cone coil for leg symp-
toms)
Stimulation parameters:frequency 20 Hz; coil orientation not specified; 80% RMT; no.
of trains 20; duration of trains 2 sec; ITI not specified; total no. pulses 800; treatment
duration 20 minutes
Stimulation location: motor cortex (midline)
Number of treatments: x 1 for each condition
Control type: coil angled 45º away from the scalp
Outcomes Primary: 0 to 100 mm VAS pain intensity, anchors “no pain” to “unbearable pain”
When taken: 0, 5, 10 and 20 minutes post-stimulation
Secondary: none
Notes Adverse events: headaches - 1 participant (unclear whether during active or sham stim-
ulation)
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote “sham and active stimulation were
given in a random order”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
Low risk Comment: only one participant withdrew due
to “headaches”. Unlikely to have strongly in-
fluenced the findings
Free of selective reporting? Low risk Comment: while pain score numerical values
are not provided clearly with measures of vari-
ance for all time points in the study report,
the study authors have provided the requested
data
Free of other bias? Low risk Comment: no significant other bias detected
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Rollnik 2002 (Continued)
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors is not re-
ported
Adequate blinding of participants? Unclear risk Comments: sham credibility assessment - sub-
optimal. Coil angled 45º away from scalp.
Does not control for sensory characteristics
of active stimulation over the scalp and is vi-
sually distinguishable. Given that stimulation
was delivered at 110% RMT active stimula-
tion, but not sham, is likely to have elicited
muscle twitches in peripheral muscles
Free from carry-over effects? Low risk Comment: not clearly demonstrated in the
study report but clear from unpublished data
provided by the study authors (baseline mean
group pain scores: active stimulation 65.1 SD
16, sham stimulation 66.9 SD 17.4)
Saitoh 2007
Methods Cross-over randomised controlled trial, 4 conditions
Participants Country of study: Japan
Setting: laboratory
Condition: neuropathic pain (mixed central and peripheral)
Prior management details: intractable
n= 13
Age: 29 to 76 mean 59.4
Duration of symptoms: 2 to 35 years, mean 10.2 SD 9.7
Gender distribution: 7 M, 6 F
Interventions Stimulation type: rTMS figure of 8 coil
Stimulation parameters:
Condition 1: frequency 10 Hz; coil orientation not specified; 90% RMT; no. of trains
5; duration of trains 10 sec; ITI 50 sec; total no. pulses 500
Condition 2: frequency 5 Hz; coil orientation not specified; 90% RMT; no. of trains
10; duration of trains 10 sec; ITI 50 sec; total no. pulses 500
Condition 3: frequency 1 Hz; coil orientation not specified; 90% RMT; no. of trains 1;
duration of trains 500 sec; total no. pulses 500
Condition 4: sham, coil angled 45º from scalp with synchronised electrical scalp stimu-
lations to mask sensation
Stimulation location: motor cortex over the representation of the painful area
Number of treatments: 1 for each condition
Outcomes Primary: VAS pain, anchors not specified
When taken: 0, 15, 30, 60, 90 and 180 minutes post-stimulation
Secondary: none
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Saitoh 2007 (Continued)
Notes Adverse events: none
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “rTMS was applied to all the pa-
tients at frequencies of 1, 5, and 10 Hz and
as a sham procedure in random order”
Comment: method of randomisation not
specified but less critical in cross-over de-
sign
Incomplete outcome data addressed?
All outcomes
Low risk Quote: “All 13 patients participated in
all planned sessions of navigation-guided
rTMS”
Comment: no drop-out observed
Free of selective reporting? Low risk Comment: while pain score numerical val-
ues are not provided clearly with measures
of variance for all time points in the study
report, the study authors have provided the
requested data
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not re-
ported
Adequate blinding of participants? Unclear risk Comment: sham credibility assessment -
sub-optimal. Sensory and auditory aspects
are controlled for but angulation of coil
away from the scalp may be visually distin-
guishable
Free from carry-over effects? Low risk Comment: not clearly demonstrated in the
study report but paired t-tests on unpub-
lished baseline data provided by the study
authors suggest that carry-over was not a
significant issue
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Tan 2000
Methods Cross-over randomised controlled trial
Participants Country of study: USA
Setting: tertiary care teaching hospital
Condition: neuromuscular pain (excluding fibromyalgia)
Prior management details: unclear
n = 28
Age: 45 to 65, mean 55.6
Duration of symptoms: 4 to 45 years, mean 15
Gender distribution: 25 M, 3 F
Interventions Stimulation type: CES
Stimulation parameters: frequency 0.5 Hz; pulse width not specified; intensity 10 to 600
µA; waveform shape not specified
Stimulation location: ear clip electrodes
Number of treatments: 12, frequency of treatment not specified
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: VAS 0 to 5 pain intensity
When taken: pre and post each treatment
Secondary: life interference scale, sickness impact profile - Roland Scale
When taken: not specified
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “each subjectwas randomly assigned to
receive either the active or the sham treatment
first”
Comment: method of randomisation not
specified but less critical in cross-over design
Incomplete outcome data addressed?
All outcomes
High risk Comment: only 17 participants completed the
study and this drop-out (over 50%) is not
clearly accounted for in the analysis
Free of selective reporting? Low risk Comment: primary outcome data presented
clearly
Free of other bias? Unclear risk Comment: participants also received local
stimulation to the painful area that may have
elicited a therapeutic effect
Adequate blinding of assessors? Unclear risk Comment: blinding of assessors not reported
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Tan 2000 (Continued)
Adequate blinding of participants? Low risk Quote: “sham treatment was made possible by
having the treatment delivered via a black box”
Comment: sham and active stimulators visu-
ally indistinguishable
Free from carry-over effects? Low risk Quote: “Note that there were no significant
differences in pain ratings pre-post changes be-
tween the active and sham groups”
Tan 2006
Methods Parallel randomised controlled trial
Participants Country of study: USA
Setting: medical centre
Condition: post SCI pain (not clearly neuropathic)
Prior management details: unclear
n = 40
Age: 38 to 82
Duration of symptoms: chronic > 6 months
Gender distribution: all male
Interventions Stimulation type: CES
Stimulation parameters: frequency not specified; pulse width not specified; intensity 100
to 500 µA; waveform shape not specified; duration 1 hour per session
Stimulation location: ear clip electrodes
Number of treatments: 21, x 1 daily for consecutive days
Control type: sham CES unit indistinguishable from active unit
Outcomes Primary: Brief Pain Inventory (0 to 10 NRS), anchors “no pain” to “pain as bad as you
can imagine”
When taken: post-treatment period
Secondary: pain interference sub-scale of BPI
When taken: as for primary outcome
Notes Adverse events: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Quote: “The participants were then randomly as-
signed to either the active or sham CES treatment
groups”
Comment: method of randomisation not speci-
fied
Allocation concealment? Unclear risk Comment: allocation concealment not specified
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Tan 2006 (Continued)
Incomplete outcome data addressed?
All outcomes
Low risk Comment: only 2 (5%) patients withdrew from
the study.Unlikely to have strongly influenced the
findings
Free of selective reporting? Low risk Comment: primary outcomes presented clearly
and in full
Free of other bias? Low risk Comment: no significant other bias detected
Adequate blinding of assessors? Low risk Quote: “The investigators,research assistant (RA)
, and participants were blinded to treatment type
until the end of the initial phase.”
Adequate blinding of participants? Low risk Comment: see quote above
Valle 2009
Methods Parallel randomised controlled trial, 3 conditions
Participants Country of study: Brazil
Setting: laboratory
Condition: fibromyalgia
Prior management details: refractory to medical intervention
n = 41
Age: mean 54.8 SD 9.6 years
Duration of symptoms: condition 1: 7.54 SD 3.93 years, condition 2: 8.39 SD 2.06
years, condition 3: 8.69 SD 3.61 years
Gender distribution: 0 M; 41 F
Interventions Stimulation type: tDCS
Stimulation parameters: intensity 2 mA, 35 cm2 electrodes, duration 20 minutes
Stimulation location: condition 1: left dorsolateral prefrontal cortex, condition 2: left
motor cortex, condition 3: sham left motor cortex
Number of treatments: 10, x 1 daily on consecutive working days
Control type: sham tDCS (switched off after 30 seconds stimulation)
Outcomes Primary: pain VAS 0 to 10 cm, anchors not specified
When taken: immediately post-treatment, averaged over 3 days post-treatment, 30 and
60 days post-treatment
Secondary: quality of life; Fibromyalgia Impact Questionnaire
Notes Adverse events:
Quote: “minor and uncommon - such as skin redness and tingling - and distributed
equally across groups of stimulation”
Risk of bias
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Valle 2009 (Continued)
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Quote: “Randomizationwas performedus-
ing the order of entrance in the study and
a previous randomisation list generated by
a computer”
Allocation concealment? Low risk Comment: the use of a pre-generated ran-
domisation list should have adequately en-
sured this
Incomplete outcome data addressed?
All outcomes
Low risk Comment: no drop-out occurred
Free of selective reporting? High risk Comment: pain score numerical values are
not provided clearly with measures of vari-
ance for any post-treatment time point in
the study report
Free of other bias? Low risk Comment: no significant other bias de-
tected
Adequate blinding of assessors? Low risk Quote: “Subjects remained blinded to
treatment group throughout the study”
Adequate blinding of participants? Low risk Quote: “blinded raters carried out all as-
sessments”
CES: cranial electrotherapy stimulation
CNP: central neuropathic pain
BPI: brief pain inventory
F: female
ITI: inter-train interval
L: left
M: male
MCS: motor cortex stimulation (MCS)
NRS: numerical rating scale
PLP: phantom limb pain
R: right
RMT: resting motor threshold
rTMS: repetitive transcranial magnetic stimulation
SCI: spinal cord injury
SD: standard deviation
tDCS: transcranial direct current stimulation
VAS: visual analogue scale
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Avery 2007 The duration of painful symptoms is unclear. May not be exclusively chronic pain
Belci 2004 Pain is not measured as an outcome
Evtiukhin 1998 A study of postoperative pain. No sham control employed
Frentzel 1989 Not a study of brain stimulation
Johnson 2006 Self-reported pain is not measured
Katz 1991 Study not confined to chronic pain
Longobardi 1989 Not clearly studying chronic pain
Pujol 1998 Subjects are a mixture of acute and chronic pain patients
Roizenblatt 2007 Duplicated data from Fregni 2006a study
Silva 2007 A single case report
Zaghi 2009 A single case report with no sham control utilised
Characteristics of studies awaiting assessment [ordered by study ID]
Shklar 1997
Methods Unable to retrieve study report
Participants -
Interventions -
Outcomes -
Notes -
Vatashsky 1997
Methods Unable to retrieve study report
Participants -
Interventions -
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Vatashsky 1997 (Continued)
Outcomes -
Notes -
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D A T A A N D A N A L Y S E S
Comparison 1. rTMS
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain short-term follow up 16 Std. Mean Difference (Random, 95% CI) -0.20 [-0.37, -0.03]
1.1 Low-frequency ≤ 1 Hz 6 Std. Mean Difference (Random, 95% CI) 0.17 [-0.01, 0.35]
1.2 High-frequency ≥ 5 Hz 15 Std. Mean Difference (Random, 95% CI) -0.32 [-0.51, -0.13]
2 Sensitivity analysis - imputed
correlation coefficient increased
17 Std. Mean Difference (Random, 95% CI) -0.21 [-0.38, -0.05]
2.1 Low-frequency ≤ 1 Hz 6 Std. Mean Difference (Random, 95% CI) 0.16 [0.02, 0.30]
2.2 High-frequency ≥ 5 Hz 16 Std. Mean Difference (Random, 95% CI) -0.33 [-0.52, -0.15]
3 Sensitivity analysis - imputed
correlation coefficient
decreased
16 Std. Mean Difference (Random, 95% CI) -0.19 [-0.37, -0.01]
3.1 Low-frequency ≤ 1 Hz 6 Std. Mean Difference (Random, 95% CI) 0.18 [-0.03, 0.38]
3.2 High-frequency ≥ 5 Hz 15 Std. Mean Difference (Random, 95% CI) -0.31 [-0.51, -0.11]
4 Pain short-term follow
up, subgroup analysis:
multiple-dose vs single-dose
studies
17 Std. Mean Difference (Random, 95% CI) -0.20 [-0.37, -0.03]
4.1 Single-dose studies 12 Std. Mean Difference (Random, 95% CI) -0.22 [-0.37, -0.06]
4.2 Multiple-dose studies 5 Std. Mean Difference (Random, 95% CI) -0.24 [-1.25, 0.76]
5 Pain short-term follow up,
subgroup analysis: motor cortex
studies only, low frequency
studies excluded
14 Std. Mean Difference (Random, 95% CI) -0.36 [-0.54, -0.18]
5.1 Single-dose studies 11 Std. Mean Difference (Random, 95% CI) -0.40 [-0.54, -0.26]
5.2 Multiple-dose studies 3 Std. Mean Difference (Random, 95% CI) 0.10 [-1.06, 1.26]
6 Sensitivity analysis - imputed
correlation increased. Pain
short-term follow up, subgroup
analysis: motor cortex studies
only, low frequency studies
excluded
14 Std. Mean Difference (Random, 95% CI) -0.37 [-0.55, -0.19]
6.1 Single-dose studies 11 Std. Mean Difference (Random, 95% CI) -0.42 [-0.57, -0.28]
6.2 Multiple-dose studies 3 Std. Mean Difference (Random, 95% CI) 0.10 [-1.04, 1.24]
7 Sensitivity analysis - imputed
correlation decreased. Pain
short-term follow up, subgroup
analysis: motor cortex studies
only, low frequency studies
excluded
14 Std. Mean Difference (Random, 95% CI) -0.35 [-0.55, -0.16]
7.1 Single-dose studies 11 Std. Mean Difference (Random, 95% CI) -0.39 [-0.52, -0.25]
7.2 Multiple-dose studies 3 Std. Mean Difference (Random, 95% CI) 0.10 [-1.08, 1.29]
8 Pain medium-term follow up 4 Std. Mean Difference (Random, 95% CI) Totals not selected
8.1 Low-frequency ≤ 1 Hz 1 Std. Mean Difference (Random, 95% CI) 0.0 [0.0, 0.0]
8.2 High-frequency ≥ 5 Hz 3 Std. Mean Difference (Random, 95% CI) 0.0 [0.0, 0.0]
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9 Pain long-term follow up 2 Std. Mean Difference (Random, 95% CI) -0.10 [-0.46, 0.26]
10 Disability/pain interference
short term follow up
2 Std. Mean Difference (Random, 95% CI) Totals not selected
11 Disability/pain interference
medium term follow up
2 Std. Mean Difference (Random, 95% CI) Totals not selected
12 Disability/pain interference
long-term follow up
2 Std. Mean Difference (Random, 95% CI) Totals not selected
13 Quality of life short-term
follow up
1 Std. Mean Difference (Random, 95% CI) Totals not selected
14 Quality of life medium-term
follow up
1 Std. Mean Difference (Random, 95% CI) Totals not selected
15 Quality of life long-term follow
up
1 Std. Mean Difference (Random, 95% CI) Totals not selected
Comparison 2. CES
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain short-term follow up 3 133 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.65, 0.04]
Comparison 3. tDCS
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain post single treatment 5 Std. Mean Difference (Random, 95% CI) Totals not selected
2 Pain short-term follow up 5 Std. Mean Difference (Random, 95% CI) -0.37 [-1.01, 0.28]
3 Pain short-term sensitivity
analysis: correlation increased
5 Std. Mean Difference (Random, 95% CI) -0.36 [-0.97, 0.26]
4 Pain short-term sensitivity
analysis: correlation decreased
5 Std. Mean Difference (Random, 95% CI) -0.37 [-1.05, 0.30]
5 Pain short-term follow up,
subgroup analysis: motor
cortex studies only
5 Std. Mean Difference (Random, 95% CI) -0.59 [-1.10, -0.08]
6 Pain short-term follow up, motor
cortex subgroup, sensitivity
analysis: correlation increased
5 Std. Mean Difference (Random, 95% CI) -0.57 [-1.07, -0.07]
7 Pain short-term follow up, motor
cortex subgroup, sensitivity
analysis: correlation decreased
5 Std. Mean Difference (Random, 95% CI) -0.61 [-1.12, -0.10]
8 Pain medium-term follow up 2 Std. Mean Difference (Random, 95% CI) Totals not selected
9 Quality of life short-term follow
up
1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
10 Quality of life medium-term
follow up
1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
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Analysis 1.1. Comparison 1 rTMS, Outcome 1 Pain short-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 1 Pain short-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency ≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.259137) 4.0 % -0.02 [ -0.52, 0.49 ]
Carretero 2009 0.6 (0.403061) 2.7 % 0.60 [ -0.19, 1.39 ]
Lefaucheur 2001b 0.156 (0.2299) 4.3 % 0.16 [ -0.29, 0.61 ]
Lefaucheur 2006 (1) 0.37847 (0.21398) 4.5 % 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 0.14778 (0.140702) 5.4 % 0.15 [ -0.13, 0.42 ]
Saitoh 2007 -0.169857 (0.33183) 3.3 % -0.17 [ -0.82, 0.48 ]
Subtotal (95% CI) 24.2 % 0.17 [ -0.01, 0.35 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.68, df = 5 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.062)
2 High-frequency ≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.259406) 4.0 % -0.07 [ -0.57, 0.44 ]
Andr -Obadia 2008 (2) -0.41092 (0.190803) 4.8 % -0.41 [ -0.78, -0.04 ]
Andr -Obadia 2008 (3) -0.287518 (0.186973) 4.8 % -0.29 [ -0.65, 0.08 ]
Borckardt 2009 -2.717609 (0.742558) 1.1 % -2.72 [ -4.17, -1.26 ]
Defrin 2007 1.12 (0.642857) 1.4 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (4) 0.23554 (0.310818) 3.5 % 0.24 [ -0.37, 0.84 ]
Hirayama 2006 (5) -0.38726 (0.317881) 3.4 % -0.39 [ -1.01, 0.24 ]
Hirayama 2006 (6) 0.19336 (0.309447) 3.5 % 0.19 [ -0.41, 0.80 ]
Hirayama 2006 (7) 0.18872 (0.309312) 3.5 % 0.19 [ -0.42, 0.79 ]
Kang 2009 0.43402 (0.216221) 4.5 % 0.43 [ 0.01, 0.86 ]
Lefaucheur 2001a -0.9332 (0.219521) 4.5 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b -0.274478 (0.232786) 4.3 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091099) 5.9 % -0.34 [ -0.52, -0.17 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Lefaucheur 2006 -0.64827 (0.227388) 4.4 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 -0.334132 (0.143793) 5.3 % -0.33 [ -0.62, -0.05 ]
Passard 2007 -1.08 (0.392857) 2.7 % -1.08 [ -1.85, -0.31 ]
Pleger 2004 -0.138771 (0.217836) 4.5 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199019) 4.7 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (8) -1.158204 (0.42585) 2.5 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (9) -1.110603 (0.418912) 2.5 % -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) 75.8 % -0.32 [ -0.51, -0.13 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 60.05, df = 19 (P<0.00001); I2 =68%
Test for overall effect: Z = 3.31 (P = 0.00094)
Total (95% CI) 100.0 % -0.20 [ -0.37, -0.03 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 85.27, df = 25 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.33 (P = 0.020)
-4 -2 0 2 4
Favours active Favours sham
(1) 1Hz
(2) antero-posterior coil orientation
(3) medial-lateral coil orientation
(4) S1
(5) M1
(6) PMA
(7) SMA
(8) 5Hz
(9) 10 Hz
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Analysis 1.2. Comparison 1 rTMS, Outcome 2 Sensitivity analysis - imputed correlation coefficient
increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 2 Sensitivity analysis - imputed correlation coefficient increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency ≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.207033) -0.02 [ -0.42, 0.39 ]
Carretero 2009 0.6 (0.403061) 0.60 [ -0.19, 1.39 ]
Lefaucheur 2001b 0.15649 (0.183689) 0.16 [ -0.20, 0.52 ]
Lefaucheur 2006 (1) 0.37847 (0.170956) 0.38 [ 0.04, 0.71 ]
Lefaucheur 2008 0.14778 (0.100545) 0.15 [ -0.05, 0.34 ]
Saitoh 2007 -0.169857 (0.26511) -0.17 [ -0.69, 0.35 ]
Subtotal (95% CI) 0.16 [ 0.02, 0.30 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 5.11, df = 5 (P = 0.40); I2 =2%
Test for overall effect: Z = 2.25 (P = 0.024)
2 High-frequency ≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.207248) -0.07 [ -0.47, 0.34 ]
Andr -Obadia 2008 (2) -0.41092 (0.152439) -0.41 [ -0.71, -0.11 ]
Andr -Obadia 2008 (3) -0.287518 (0.385697) -0.29 [ -1.04, 0.47 ]
Borckardt 2009 -2.717609 (0.593256) -2.72 [ -3.88, -1.55 ]
Defrin 2007 1.12 (0.642857) 1.12 [ -0.14, 2.38 ]
Fregni 2005 0 (0) 0.0 [ 0.0, 0.0 ]
Hirayama 2006 (4) 0.23554 (0.248323) 0.24 [ -0.25, 0.72 ]
Hirayama 2006 (5) 0.19336 (0.247228) 0.19 [ -0.29, 0.68 ]
Hirayama 2006 (6) -0.38726 (0.253967) -0.39 [ -0.89, 0.11 ]
Hirayama 2006 (7) 0.18872 (0.24712) 0.19 [ -0.30, 0.67 ]
Kang 2009 0.43402 (0.172747) 0.43 [ 0.10, 0.77 ]
Lefaucheur 2001a -0.9332 (0.175383) -0.93 [ -1.28, -0.59 ]
Lefaucheur 2001b -0.274478 (0.185981) -0.27 [ -0.64, 0.09 ]
Lefaucheur 2004 -0.344828 (0.072782) -0.34 [ -0.49, -0.20 ]
-4 -2 0 2 4
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Lefaucheur 2006 -0.64827 (0.181669) -0.65 [ -1.00, -0.29 ]
Lefaucheur 2008 -0.334132 (0.102753) -0.33 [ -0.54, -0.13 ]
Passard 2007 -1.08 (0.392857) -1.08 [ -1.85, -0.31 ]
Pleger 2004 -0.138771 (0.174037) -0.14 [ -0.48, 0.20 ]
Rollnik 2002 -0.150199 (0.159003) -0.15 [ -0.46, 0.16 ]
Saitoh 2007 (8) -1.110603 (0.334683) -1.11 [ -1.77, -0.45 ]
Saitoh 2007 (9) -1.158204 (0.340227) -1.16 [ -1.83, -0.49 ]
Subtotal (95% CI) -0.33 [ -0.52, -0.15 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 89.10, df = 19 (P<0.00001); I2 =79%
Test for overall effect: Z = 3.48 (P = 0.00051)
Total (95% CI) -0.21 [ -0.38, -0.05 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 128.56, df = 25 (P<0.00001); I2 =81%
Test for overall effect: Z = 2.50 (P = 0.013)
-4 -2 0 2 4
Favours active Favours sham
(1) 1Hz
(2) antero-posterior coil orientation
(3) medial-lateral coil orientation
(4) S1
(5) PMA
(6) M1
(7) SMA
(8) 5Hz
(9) 10 Hz
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Analysis 1.3. Comparison 1 rTMS, Outcome 3 Sensitivity analysis - imputed correlation coefficient
decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 3 Sensitivity analysis - imputed correlation coefficient decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency ≤ 1 Hz
Andr -Obadia 2006 -0.016296 (0.316249) 3.9 % -0.02 [ -0.64, 0.60 ]
Carretero 2009 0.6 (0.403061) 3.0 % 0.60 [ -0.19, 1.39 ]
Lefaucheur 2001b 0.15649 (0.280589) 4.4 % 0.16 [ -0.39, 0.71 ]
Lefaucheur 2006 0.37847 (0.26114) 4.6 % 0.38 [ -0.13, 0.89 ]
Lefaucheur 2008 0.14778 (0.153584) 6.2 % 0.15 [ -0.15, 0.45 ]
Saitoh 2007 -0.169857 (0.404963) 3.0 % -0.17 [ -0.96, 0.62 ]
Subtotal (95% CI) 25.1 % 0.18 [ -0.03, 0.38 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.85, df = 5 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 1.70 (P = 0.089)
2 High-frequency ≥ 5 Hz
Andr -Obadia 2006 -0.066506 (0.316577) 3.9 % -0.07 [ -0.69, 0.55 ]
Andr -Obadia 2008 (1) -0.41092 (0.232855) 5.0 % -0.41 [ -0.87, 0.05 ]
Andr -Obadia 2008 (2) -0.287518 (0.385697) 3.2 % -0.29 [ -1.04, 0.47 ]
Borckardt 2009 -2.717609 (0.906213) 0.9 % -2.72 [ -4.49, -0.94 ]
Defrin 2007 1.12 (0.642857) 1.6 % 1.12 [ -0.14, 2.38 ]
Hirayama 2006 (3) 0.23554 (0.37932) 3.2 % 0.24 [ -0.51, 0.98 ]
Hirayama 2006 (4) 0.18872 (0.377483) 3.2 % 0.19 [ -0.55, 0.93 ]
Hirayama 2006 (5) -0.38726 (0.387941) 3.1 % -0.39 [ -1.15, 0.37 ]
Hirayama 2006 (6) 0.19336 (0.377647) 3.2 % 0.19 [ -0.55, 0.93 ]
Kang 2009 0.43402 (0.263875) 4.6 % 0.43 [ -0.08, 0.95 ]
Lefaucheur 2001a -0.9332 (0.267902) 4.5 % -0.93 [ -1.46, -0.41 ]
Lefaucheur 2001b -0.274478 (0.284091) 4.3 % -0.27 [ -0.83, 0.28 ]
Lefaucheur 2004 -0.344828 (0.111177) 6.7 % -0.34 [ -0.56, -0.13 ]
Lefaucheur 2006 -0.64827 (0.277503) 4.4 % -0.65 [ -1.19, -0.10 ]
-2 -1 0 1 2
Favours active Favours sham
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Lefaucheur 2008 -0.334132 (0.156958) 6.1 % -0.33 [ -0.64, -0.03 ]
Passard 2007 -1.08 (0.392857) 3.1 % -1.08 [ -1.85, -0.31 ]
Pleger 2004 -0.138771 (0.265846) 4.5 % -0.14 [ -0.66, 0.38 ]
Rollnik 2002 -0.150199 (0.242881) 4.9 % -0.15 [ -0.63, 0.33 ]
Saitoh 2007 (7) -1.158204 (0.519705) 2.2 % -1.16 [ -2.18, -0.14 ]
Saitoh 2007 (8) -1.110603 (0.511237) 2.2 % -1.11 [ -2.11, -0.11 ]
Subtotal (95% CI) 74.9 % -0.31 [ -0.51, -0.11 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 43.21, df = 19 (P = 0.001); I2 =56%
Test for overall effect: Z = 3.08 (P = 0.0021)
Total (95% CI) 100.0 % -0.19 [ -0.37, -0.01 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 62.64, df = 25 (P = 0.00004); I2 =60%
Test for overall effect: Z = 2.08 (P = 0.038)
-2 -1 0 1 2
Favours active Favours sham
(1) antero-posterior coil orientation
(2) medial-lateral coil orientatioin
(3) S1
(4) SMA
(5) M1
(6) PMA
(7) 5Hz
(8) 10 Hz
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Analysis 1.4. Comparison 1 rTMS, Outcome 4 Pain short-term follow up, subgroup analysis: multiple-dose
vs single-dose studies.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 4 Pain short-term follow up, subgroup analysis: multiple-dose vs single-dose studies
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 (1) -0.016296 (0.259137) -0.02 [ -0.52, 0.49 ]
Andr -Obadia 2006 (2) -0.066506 (0.259406) -0.07 [ -0.57, 0.44 ]
Andr -Obadia 2008 (3) -0.41092 (0.190803) -0.41 [ -0.78, -0.04 ]
Andr -Obadia 2008 (4) -0.287518 (0.186973) -0.29 [ -0.65, 0.08 ]
Fregni 2005 0 (0) 0.0 [ 0.0, 0.0 ]
Hirayama 2006 (5) -0.38726 (0.317881) -0.39 [ -1.01, 0.24 ]
Hirayama 2006 (6) 0.18872 (0.309312) 0.19 [ -0.42, 0.79 ]
Hirayama 2006 (7) 0.23554 (0.310818) 0.24 [ -0.37, 0.84 ]
Hirayama 2006 (8) 0.19336 (0.309447) 0.19 [ -0.41, 0.80 ]
Lefaucheur 2001a -0.9332 (0.219521) -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b (9) 0.156 (0.2299) 0.16 [ -0.29, 0.61 ]
Lefaucheur 2001b (10) -0.274478 (0.232786) -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 -0.344828 (0.091099) -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 (11) -0.64827 (0.227388) -0.65 [ -1.09, -0.20 ]
Lefaucheur 2006 (12) 0.37847 (0.21398) 0.38 [ -0.04, 0.80 ]
Lefaucheur 2008 (13) 0.14778 (0.140702) 0.15 [ -0.13, 0.42 ]
Lefaucheur 2008 (14) -0.334132 (0.143793) -0.33 [ -0.62, -0.05 ]
Pleger 2004 -0.138771 (0.217836) -0.14 [ -0.57, 0.29 ]
Rollnik 2002 -0.150199 (0.199019) -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (15) -0.169857 (0.33183) -0.17 [ -0.82, 0.48 ]
Saitoh 2007 (16) -1.158204 (0.42585) -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (17) -1.110603 (0.418912) -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) -0.22 [ -0.37, -0.06 ]
-4 -2 0 2 4
Favours active Favours sham
(Continued . . . )
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(. . . Continued)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.07; Chi2 = 51.70, df = 20 (P = 0.00013); I2 =61%
Test for overall effect: Z = 2.80 (P = 0.0052)
2 Multiple-dose studies
Borckardt 2009 -2.717609 (0.742558) -2.72 [ -4.17, -1.26 ]
Carretero 2009 0.6 (0.403061) 0.60 [ -0.19, 1.39 ]
Defrin 2007 1.12 (0.642857) 1.12 [ -0.14, 2.38 ]
Kang 2009 0.43402 (0.216221) 0.43 [ 0.01, 0.86 ]
Passard 2007 -1.08 (0.392857) -1.08 [ -1.85, -0.31 ]
Subtotal (95% CI) -0.24 [ -1.25, 0.76 ]
Heterogeneity: Tau2 = 1.08; Chi2 = 29.86, df = 4 (P<0.00001); I2 =87%
Test for overall effect: Z = 0.47 (P = 0.64)
Total (95% CI) -0.20 [ -0.37, -0.03 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 85.27, df = 25 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.33 (P = 0.020)
Test for subgroup differences: Chi2 = 3.71, df = 1 (P = 0.05), I2 =73%
-4 -2 0 2 4
Favours active Favours sham
(1) 1Hz
(2) 20Hz
(3) 20Hz antero-posterior coil orientation
(4) 20 Hz medial-lateral coil orientation
(5) M1
(6) SMA
(7) S1
(8) PMA
(9) 0.5 Hz
(10) 10Hz
(11) 10Hz
(12) 1Hz
(13) 1Hz
(14) 10 Hz
(15) 1Hz
(16) 5Hz
(17) 10Hz
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Analysis 1.5. Comparison 1 rTMS, Outcome 5 Pain short-term follow up, subgroup analysis: motor cortex
studies only, low frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 5 Pain short-term follow up, subgroup analysis: motor cortex studies only, low frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 (1) -0.066506 (0.259406) 6.0 % -0.07 [ -0.57, 0.44 ]
Andr -Obadia 2008 (2) -0.287518 (0.186973) 7.8 % -0.29 [ -0.65, 0.08 ]
Andr -Obadia 2008 (3) -0.41092 (0.190803) 7.7 % -0.41 [ -0.78, -0.04 ]
Hirayama 2006 (4) -0.38726 (0.317881) 4.9 % -0.39 [ -1.01, 0.24 ]
Lefaucheur 2001a (5) -0.9332 (0.219521) 7.0 % -0.93 [ -1.36, -0.50 ]
Lefaucheur 2001b (6) -0.274478 (0.232786) 6.7 % -0.27 [ -0.73, 0.18 ]
Lefaucheur 2004 (7) -0.344828 (0.091099) 10.3 % -0.34 [ -0.52, -0.17 ]
Lefaucheur 2006 (8) -0.64827 (0.227388) 6.8 % -0.65 [ -1.09, -0.20 ]
Lefaucheur 2008 (9) -0.334132 (0.143793) 9.0 % -0.33 [ -0.62, -0.05 ]
Pleger 2004 (10) -0.138771 (0.217836) 7.0 % -0.14 [ -0.57, 0.29 ]
Rollnik 2002 (11) -0.150199 (0.199019) 7.5 % -0.15 [ -0.54, 0.24 ]
Saitoh 2007 (12) -1.158204 (0.42585) 3.4 % -1.16 [ -1.99, -0.32 ]
Saitoh 2007 (13) -1.110603 (0.418912) 3.4 % -1.11 [ -1.93, -0.29 ]
Subtotal (95% CI) 87.4 % -0.40 [ -0.54, -0.26 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 18.87, df = 12 (P = 0.09); I2 =36%
Test for overall effect: Z = 5.52 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 (14) 1.12 (0.642857) 1.8 % 1.12 [ -0.14, 2.38 ]
Kang 2009 (15) 0.43402 (0.216221) 7.1 % 0.43 [ 0.01, 0.86 ]
Passard 2007 (16) -1.08 (0.392857) 3.8 % -1.08 [ -1.85, -0.31 ]
Subtotal (95% CI) 12.6 % 0.10 [ -1.06, 1.26 ]
Heterogeneity: Tau2 = 0.87; Chi2 = 13.80, df = 2 (P = 0.001); I2 =86%
Test for overall effect: Z = 0.17 (P = 0.86)
Total (95% CI) 100.0 % -0.36 [ -0.54, -0.18 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 40.93, df = 15 (P = 0.00033); I2 =63%
Test for overall effect: Z = 3.85 (P = 0.00012)
-2 -1 0 1 2
Favours active Favours sham
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(1) 20Hz
(2) 20 Hz medial-lateral coil orientation
(3) 20Hz antero-posterior coil orientation
(4) 10Hz
(5) 10 Hz
(6) 10 Hz
(7) 10 Hz
(8) 10Hz
(9) 10Hz
(10) 10 Hz
(11) 20 Hz
(12) 5 Hz
(13) 10 Hz
(14) 5 Hz
(15) 10 Hz
(16) 10 Hz
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Analysis 1.6. Comparison 1 rTMS, Outcome 6 Sensitivity analysis - imputed correlation increased. Pain
short-term follow up, subgroup analysis: motor cortex studies only, low frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 6 Sensitivity analysis - imputed correlation increased. Pain short-term follow up, subgroup analysis: motor cortex studies only, low frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 (1) -0.066506 (0.207248) 6.6 % -0.07 [ -0.47, 0.34 ]
Andr -Obadia 2008 (2) -0.287518 (0.385697) 3.7 % -0.29 [ -1.04, 0.47 ]
Andr -Obadia 2008 (3) -0.41092 (0.152439) 7.8 % -0.41 [ -0.71, -0.11 ]
Hirayama 2006 (4) -0.38726 (0.253967) 5.7 % -0.39 [ -0.89, 0.11 ]
Lefaucheur 2001a (5) -0.9332 (0.175383) 7.3 % -0.93 [ -1.28, -0.59 ]
Lefaucheur 2001b (6) -0.274478 (0.185981) 7.1 % -0.27 [ -0.64, 0.09 ]
Lefaucheur 2004 (7) -0.344828 (0.072782) 9.3 % -0.34 [ -0.49, -0.20 ]
Lefaucheur 2006 (8) -0.64827 (0.181669) 7.2 % -0.65 [ -1.00, -0.29 ]
Lefaucheur 2008 (9) -0.334132 (0.102753) 8.8 % -0.33 [ -0.54, -0.13 ]
Pleger 2004 (10) -0.138771 (0.174037) 7.4 % -0.14 [ -0.48, 0.20 ]
Rollnik 2002 (11) -0.150199 (0.159003) 7.7 % -0.15 [ -0.46, 0.16 ]
Saitoh 2007 (12) -1.110603 (0.340227) 4.3 % -1.11 [ -1.78, -0.44 ]
Saitoh 2007 (13) -1.158204 (0.334683) 4.3 % -1.16 [ -1.81, -0.50 ]
Subtotal (95% CI) 87.3 % -0.42 [ -0.57, -0.28 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 29.29, df = 12 (P = 0.004); I2 =59%
Test for overall effect: Z = 5.59 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 (14) 1.12 (0.642857) 1.7 % 1.12 [ -0.14, 2.38 ]
Kang 2009 (15) 0.43402 (0.172747) 7.4 % 0.43 [ 0.10, 0.77 ]
Passard 2007 (16) -1.08 (0.392857) 3.6 % -1.08 [ -1.85, -0.31 ]
Subtotal (95% CI) 12.7 % 0.10 [ -1.04, 1.24 ]
Heterogeneity: Tau2 = 0.84; Chi2 = 14.42, df = 2 (P = 0.00074); I2 =86%
Test for overall effect: Z = 0.18 (P = 0.86)
Total (95% CI) 100.0 % -0.37 [ -0.55, -0.19 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 59.11, df = 15 (P<0.00001); I2 =75%
Test for overall effect: Z = 4.00 (P = 0.000063)
-2 -1 0 1 2
Favours active Favours sham
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(1) 20Hz
(2) 20 Hz medial-lateral coil orientation
(3) 20Hz antero-posterior coil orientation
(4) 10Hz
(5) 10 Hz
(6) 10 Hz
(7) 10 Hz
(8) 10Hz
(9) 10Hz
(10) 10 Hz
(11) 20 Hz
(12) 10 Hz
(13) 5 Hz
(14) 5 Hz
(15) 10 Hz
(16) 10 Hz
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Analysis 1.7. Comparison 1 rTMS, Outcome 7 Sensitivity analysis - imputed correlation decreased. Pain
short-term follow up, subgroup analysis: motor cortex studies only, low frequency studies excluded.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 7 Sensitivity analysis - imputed correlation decreased. Pain short-term follow up, subgroup analysis: motor cortex studies only, low frequency studies excluded
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Single-dose studies
Andr -Obadia 2006 (1) -0.066506 (0.316577) 5.8 % -0.07 [ -0.69, 0.55 ]
Andr -Obadia 2008 (2) -0.287518 (0.385697) 4.5 % -0.29 [ -1.04, 0.47 ]
Andr -Obadia 2008 (3) -0.41092 (0.232855) 8.0 % -0.41 [ -0.87, 0.05 ]
Hirayama 2006 (4) -0.38726 (0.387941) 4.5 % -0.39 [ -1.15, 0.37 ]
Lefaucheur 2001a (5) -0.9332 (0.267902) 7.0 % -0.93 [ -1.46, -0.41 ]
Lefaucheur 2001b (6) -0.274478 (0.284091) 6.6 % -0.27 [ -0.83, 0.28 ]
Lefaucheur 2004 (7) -0.344828 (0.111177) 12.2 % -0.34 [ -0.56, -0.13 ]
Lefaucheur 2006 (8) -0.64827 (0.277503) 6.7 % -0.65 [ -1.19, -0.10 ]
Lefaucheur 2008 (9) -0.334132 (0.156958) 10.6 % -0.33 [ -0.64, -0.03 ]
Pleger 2004 (10) -0.138771 (0.265846) 7.1 % -0.14 [ -0.66, 0.38 ]
Rollnik 2002 (11) -0.150199 (0.242881) 7.7 % -0.15 [ -0.63, 0.33 ]
Saitoh 2007 (12) -1.158204 (0.519705) 2.9 % -1.16 [ -2.18, -0.14 ]
Saitoh 2007 (13) -1.110603 (0.511237) 3.0 % -1.11 [ -2.11, -0.11 ]
Subtotal (95% CI) 86.5 % -0.39 [ -0.52, -0.25 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 12.58, df = 12 (P = 0.40); I2 =5%
Test for overall effect: Z = 5.68 (P < 0.00001)
2 Multiple-dose studies
Defrin 2007 (14) 1.12 (0.642857) 2.0 % 1.12 [ -0.14, 2.38 ]
Kang 2009 (15) 0.43402 (0.263875) 7.1 % 0.43 [ -0.08, 0.95 ]
Passard 2007 (16) -1.08 (0.392857) 4.4 % -1.08 [ -1.85, -0.31 ]
Subtotal (95% CI) 13.5 % 0.10 [ -1.08, 1.29 ]
Heterogeneity: Tau2 = 0.90; Chi2 = 13.14, df = 2 (P = 0.001); I2 =85%
Test for overall effect: Z = 0.17 (P = 0.87)
Total (95% CI) 100.0 % -0.35 [ -0.55, -0.16 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 30.31, df = 15 (P = 0.01); I2 =51%
Test for overall effect: Z = 3.58 (P = 0.00035)
-2 -1 0 1 2
Favours active Favours sham
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(1) 20Hz
(2) 20 Hz medial-lateral coil orientation
(3) 20Hz antero-posterior coil orientation
(4) 10Hz
(5) 10 Hz
(6) 10 Hz
(7) 10 Hz
(8) 10Hz
(9) 10Hz
(10) 10 Hz
(11) 20 Hz
(12) 5 Hz
(13) 10 Hz
(14) 5 Hz
(15) 10 Hz
(16) 10 Hz
Analysis 1.8. Comparison 1 rTMS, Outcome 8 Pain medium-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 8 Pain medium-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Low-frequency ≤ 1 Hz
Carretero 2009 0.36 (0.3954) 0.36 [ -0.41, 1.13 ]
2 High-frequency ≥ 5 Hz
Kang 2009 (1) 0.126074 (0.207526) 0.13 [ -0.28, 0.53 ]
Lefaucheur 2001a (2) -0.77794 (0.209117) -0.78 [ -1.19, -0.37 ]
Passard 2007 -0.4 (0.367347) -0.40 [ -1.12, 0.32 ]
-2 -1 0 1 2
Favours active Favours sham
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(1) 3 week follow up
(2) 12 days post
Analysis 1.9. Comparison 1 rTMS, Outcome 9 Pain long-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 9 Pain long-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Kang 2009 (1) -0.100705 (0.207229) 78.0 % -0.10 [ -0.51, 0.31 ]
Passard 2007 (2) -0.11 (0.390306) 22.0 % -0.11 [ -0.87, 0.65 ]
Total (95% CI) 100.0 % -0.10 [ -0.46, 0.26 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.56 (P = 0.57)
-1 -0.5 0 0.5 1
Favours active Favours sham
(1) 7 week follow up
(2) 60 day follow up
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Analysis 1.10. Comparison 1 rTMS, Outcome 10 Disability/pain interference short term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 10 Disability/pain interference short term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Kang 2009 (1) 0.29605 (0.211186) 0.30 [ -0.12, 0.71 ]
Passard 2007 (2) -0.55 (0.372449) -0.55 [ -1.28, 0.18 ]
-2 -1 0 1 2
Favours active Favours sham
(1) BPI total (excl. walking subscale) end of 5 day stim period
(2) BPI general activity subscale. 1 day post stim period
Analysis 1.11. Comparison 1 rTMS, Outcome 11 Disability/pain interference medium term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 11 Disability/pain interference medium term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Kang 2009 (1) 0.233504 (0.209504) 0.23 [ -0.18, 0.64 ]
Passard 2007 (2) -0.6 (0.375) -0.60 [ -1.33, 0.13 ]
-2 -1 0 1 2
Favours active Favours sham
(1) BPI total (excl. walking subscale) 1 week post stim period
(2) BPI general activity subscale. 16 days post stim period
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Analysis 1.12. Comparison 1 rTMS, Outcome 12 Disability/pain interference long-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 12 Disability/pain interference long-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Kang 2009 (1) -0.01742 (0.206721) -0.02 [ -0.42, 0.39 ]
Passard 2007 (2) -0.51 (0.372449) -0.51 [ -1.24, 0.22 ]
-1 -0.5 0 0.5 1
Favours active Favours sham
(1) BPI total (excl. walking subscale) 7 weeks post stim period
(2) BPI general activity subscale. 46 days post stim period
Analysis 1.13. Comparison 1 rTMS, Outcome 13 Quality of life short-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 13 Quality of life short-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Passard 2007 (1) -1.35 (0.410714) -1.35 [ -2.15, -0.55 ]
-2 -1 0 1 2
Favours experimental Favours control
(1) 1 day post stimulation period. Fibromyalgia impact questionnaire (total score)
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Analysis 1.14. Comparison 1 rTMS, Outcome 14 Quality of life medium-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 14 Quality of life medium-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Passard 2007 (1) -1.36 (0.410714) -1.36 [ -2.16, -0.56 ]
-2 -1 0 1 2
Favours experimental Favours control
(1) 16 days post stimulation. Fibromyalgia impact questionnaire (total score)
Analysis 1.15. Comparison 1 rTMS, Outcome 15 Quality of life long-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 1 rTMS
Outcome: 15 Quality of life long-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Passard 2007 (1) -0.61 (0.375) -0.61 [ -1.34, 0.12 ]
-1 -0.5 0 0.5 1
Favours experimental Favours control
(1) 46 days post stimulation. Fibromyalgia impact questionnaire (total score)
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Analysis 2.1. Comparison 2 CES, Outcome 1 Pain short-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 2 CES
Outcome: 1 Pain short-term follow up
Study or subgroup Active Stimulation Sham Stimulation
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Gabis 2003 10 2.83 (2.07) 10 2.65 (2.49) 15.4 % 0.08 [ -0.80, 0.95 ]
Gabis 2009 (1) 17 3.82 (2.86) 16 5.25 (2.29) 24.4 % -0.54 [ -1.23, 0.16 ]
Gabis 2009 (2) 19 3.26 (2.79) 23 4.65 (2.62) 31.0 % -0.51 [ -1.12, 0.11 ]
Tan 2006 18 5.73 (2.56) 20 6 (2.41) 29.2 % -0.11 [ -0.74, 0.53 ]
Total (95% CI) 64 69 100.0 % -0.31 [ -0.65, 0.04 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.92, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.75 (P = 0.080)
-1 -0.5 0 0.5 1
Favours active Favourssham
(1) back pain
(2) neck pain
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Analysis 3.1. Comparison 3 tDCS, Outcome 1 Pain post single treatment.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 1 Pain post single treatment
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.314924) -0.42 [ -1.04, 0.20 ]
Fenton 2009 -0.365489 (0.333475) -0.37 [ -1.02, 0.29 ]
Fregni 2006a 0 (0) 0.0 [ 0.0, 0.0 ]
Fregni 2006b 0 (0) 0.0 [ 0.0, 0.0 ]
Mori 2010 (1) -0.02 (0.4617) -0.02 [ -0.92, 0.88 ]
-1 -0.5 0 0.5 1
Favours active Favours sham
(1) post stim treatment 1
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Analysis 3.2. Comparison 3 tDCS, Outcome 2 Pain short-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 2 Pain short-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.314924) 20.0 % -0.42 [ -1.04, 0.20 ]
Fenton 2009 0.06593 (0.323217) 19.8 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 14.2 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) 1.11 (0.477041) 16.2 % 1.11 [ 0.18, 2.04 ]
Fregni 2006b (2) -0.73 (0.556122) 14.4 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 15.5 % -1.19 [ -2.18, -0.20 ]
Total (95% CI) 100.0 % -0.37 [ -1.01, 0.28 ]
Heterogeneity: Tau2 = 0.45; Chi2 = 17.04, df = 5 (P = 0.004); I2 =71%
Test for overall effect: Z = 1.11 (P = 0.27)
-2 -1 0 1 2
Favours active Favours sham
(1) DLPFC
(2) M1
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Analysis 3.3. Comparison 3 tDCS, Outcome 3 Pain short-term sensitivity analysis: correlation increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 3 Pain short-term sensitivity analysis: correlation increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.268318) 20.9 % -0.42 [ -0.94, 0.11 ]
Fenton 2009 0.06593 (0.275383) 20.8 % 0.07 [ -0.47, 0.61 ]
Fregni 2006a -1.32 (0.568878) 13.6 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) 1.11 (0.477041) 15.7 % 1.11 [ 0.18, 2.04 ]
Fregni 2006b (2) -0.73 (0.556122) 13.9 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 15.0 % -1.19 [ -2.18, -0.20 ]
Total (95% CI) 100.0 % -0.36 [ -0.97, 0.26 ]
Heterogeneity: Tau2 = 0.40; Chi2 = 17.54, df = 5 (P = 0.004); I2 =71%
Test for overall effect: Z = 1.15 (P = 0.25)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
(1) DLPFC
(2) M1
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Analysis 3.4. Comparison 3 tDCS, Outcome 4 Pain short-term sensitivity analysis: correlation decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 4 Pain short-term sensitivity analysis: correlation decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.355472) 19.2 % -0.42 [ -1.11, 0.28 ]
Fenton 2009 0.06593 (0.364833) 19.0 % 0.07 [ -0.65, 0.78 ]
Fregni 2006a -1.32 (0.568878) 14.5 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) -0.73 (0.556122) 14.8 % -0.73 [ -1.82, 0.36 ]
Fregni 2006b (2) 1.11 (0.477041) 16.5 % 1.11 [ 0.18, 2.04 ]
Mori 2010 -1.19 (0.507653) 15.8 % -1.19 [ -2.18, -0.20 ]
Total (95% CI) 100.0 % -0.37 [ -1.05, 0.30 ]
Heterogeneity: Tau2 = 0.48; Chi2 = 16.74, df = 5 (P = 0.01); I2 =70%
Test for overall effect: Z = 1.09 (P = 0.28)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
(1) M1
(2) DLPFC
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Analysis 3.5. Comparison 3 tDCS, Outcome 5 Pain short-term follow up, subgroup analysis: motor cortex
studies only.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 5 Pain short-term follow up, subgroup analysis: motor cortex studies only
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.314924) 27.4 % -0.42 [ -1.04, 0.20 ]
Fenton 2009 0.06593 (0.323217) 26.9 % 0.07 [ -0.57, 0.70 ]
Fregni 2006a -1.32 (0.568878) 14.3 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) -0.73 (0.556122) 14.8 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 16.6 % -1.19 [ -2.18, -0.20 ]
Total (95% CI) 100.0 % -0.59 [ -1.10, -0.08 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 7.23, df = 4 (P = 0.12); I2 =45%
Test for overall effect: Z = 2.28 (P = 0.022)
-2 -1 0 1 2
Favours active Favours sham
(1) M1
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Analysis 3.6. Comparison 3 tDCS, Outcome 6 Pain short-term follow up, motor cortex subgroup,
sensitivity analysis: correlation increased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 6 Pain short-term follow up, motor cortex subgroup, sensitivity analysis: correlation increased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.268318) 28.5 % -0.42 [ -0.94, 0.11 ]
Fenton 2009 0.06593 (0.275383) 28.0 % 0.07 [ -0.47, 0.61 ]
Fregni 2006a -1.32 (0.568878) 13.6 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) -0.71 (0.556122) 14.0 % -0.71 [ -1.80, 0.38 ]
Mori 2010 -1.19 (0.507653) 15.8 % -1.19 [ -2.18, -0.20 ]
Total (95% CI) 100.0 % -0.57 [ -1.07, -0.07 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 8.19, df = 4 (P = 0.08); I2 =51%
Test for overall effect: Z = 2.22 (P = 0.027)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
(1) M1
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Analysis 3.7. Comparison 3 tDCS, Outcome 7 Pain short-term follow up, motor cortex subgroup,
sensitivity analysis: correlation decreased.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 7 Pain short-term follow up, motor cortex subgroup, sensitivity analysis: correlation decreased
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Boggio 2009 -0.417904 (0.355472) 26.5 % -0.42 [ -1.11, 0.28 ]
Fenton 2009 0.06593 (0.364833) 25.8 % 0.07 [ -0.65, 0.78 ]
Fregni 2006a -1.32 (0.568878) 14.9 % -1.32 [ -2.43, -0.21 ]
Fregni 2006b (1) -0.73 (0.556122) 15.4 % -0.73 [ -1.82, 0.36 ]
Mori 2010 -1.19 (0.507653) 17.5 % -1.19 [ -2.18, -0.20 ]
Total (95% CI) 100.0 % -0.61 [ -1.12, -0.10 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 6.51, df = 4 (P = 0.16); I2 =39%
Test for overall effect: Z = 2.35 (P = 0.019)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
(1) M1
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Analysis 3.8. Comparison 3 tDCS, Outcome 8 Pain medium-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 8 Pain medium-term follow up
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
Fenton 2009 (1) 0.23766 (0.327394) 0.24 [ -0.40, 0.88 ]
Mori 2010 (2) -0.96 (0.492347) -0.96 [ -1.92, 0.00 ]
-2 -1 0 1 2
Favours active Favours sham
(1) 10-14 days post stimulation.
(2) 3/52 post stimulation period.
Analysis 3.9. Comparison 3 tDCS, Outcome 9 Quality of life short-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 9 Quality of life short-term follow up
Study or subgroup Experimental Control
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mori 2010 10 74.1 (19.5) 9 51.9 (15.2) 1.20 [ 0.21, 2.20 ]
-2 -1 0 1 2
Favours sham Favours active
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Analysis 3.10. Comparison 3 tDCS, Outcome 10 Quality of life medium-term follow up.
Review: Non-invasive brain stimulation techniques for chronic pain
Comparison: 3 tDCS
Outcome: 10 Quality of life medium-term follow up
Study or subgroup Experimental Control
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mori 2010 10 75 (23.3) 9 60 (17.7) 0.69 [ -0.25, 1.62 ]
-2 -1 0 1 2
Favours sham Favours active
A D D I T I O N A L T A B L E S
Table 1. rTMS studies - characteristics of stimulation
Study Location
of stimu-
lation
Coil ori-
entation
Frequency
(Hz)
Intensity
(% RMT)
Number
of trains
Duration
of trains
Inter-
train
intervals
(sec)
Number
of pulses
Treat-
ment ses-
sions per
group
André-
Obadia
2006
M1 con-
tralateral
to painful
side
Posteroan-
terior
20, 1 90 20 Hz: 20
1Hz: 1
20 Hz: 4
sec
1Hz: 26
mins
20 Hz: 84 1600 1
André-
Obadia
2008
M1 con-
tralateral
to painful
side
Posteroan-
terior
Medial-
lateral
20 90 20 4 sec 84 1600 1
Borckardt
2009
Left PFC Not speci-
fied
10 100 40 10 sec 20 4000 3 over a 5-
day period
Carretero
2009
Right
DLPFC
Not speci-
fied
1 110 20 60 sec 45 1200 Up to 20
on consec-
u-
tive work-
ing days
Defrin
2007
M1
midline
Not speci-
fied
5 115 500 10 sec 30 ? 500* 10, x 1
daily
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Table 1. rTMS studies - characteristics of stimulation (Continued)
Fregni
2005
Left and
right SII
Not speci-
fied
1 90 Not speci-
fied
Not speci-
fied
Not speci-
fied
1600 1
Hirayama
2006
M1,
S1, PMA,
SMA
Not speci-
fied
5 90 10 10 sec 50 500 1
Irlbacher
2006
M1 con-
tralateral
to painful
side
Not speci-
fied
5, 1 95 Not speci-
fied
Not speci-
fied
Not speci-
fied
500 1
Kang 2009 Right M1 45º pos-
tero-lateral
10 80 20 5 sec 55 1000 5, x 1 daily
Khedr
2005
M1 con-
tralateral
to painful
side
Not speci-
fied
20 80 10 10 sec 50 2000 5, x 1 daily
Lefaucheur
2001a
M1 con-
tralateral
to painful
side
Not speci-
fied
10 80 20 5 sec 55 1000 1
Lefaucheur
2001b
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 0.5 80 10 Hz: 20
0.5 Hz: 1
10 Hz: 5
sec
0.5 Hz: 20
mins
10 Hz: 55 10 Hz:
1000
0.5 Hz:
600
1
Lefaucheur
2004
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 80 20 5 sec 55 1000 1
Lefaucheur
2006
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 , 1 90 10 Hz: 20
1 Hz: 1
10 Hz: 6
sec
1 Hz: 20
mins
10 Hz: 54 10 Hz:
1200
1Hz: 1200
1
Lefaucheur
2008
M1 con-
tralateral
to painful
side
Posteroan-
terior
10, 1 90 10 Hz: 20
1 Hz: 1
10 Hz: 6
sec
1 Hz: 20
mins
10Hz: 54 10Hz:
1200
1Hz: 1200
1
Passard
2007
M1 con-
tralateral
to painful
side
Posteroan-
terior
10 80 25 8 sec 52 2000 10,
x 1 daily
(working
days)
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Table 1. rTMS studies - characteristics of stimulation (Continued)
Pleger
2004
M1 hand
area
Not speci-
fied
10 110 10 1.2 sec 10 120 1
Rollnik
2002
M1
midline
Not speci-
fied
20 80 20 2 sec Not speci-
fied
800 1
Saitoh
2007
M1 over
motor rep-
resentation
of painful
area
Not speci-
fied
10, 5 , 1 90 10 Hz; 5
5 Hz: 10
1 Hz: 1
10 Hz: 10
sec
5 Hz: 10
sec
1 Hz: 500
sec
10 Hz: 50
5 Hz: 50
500 1
M1 = primary motor cortex, DLPFC = dorsolateral prefrontal cortex, PFC = prefrontal cortex,S1 = primary somatosensory cortex, SII
= secondary somatosensory cortex, PMA = pre-motor area, SMA = supplementary motor area.
Table 2. CES studies - characteristics of stimulation
Study Electrode
placement
Frequency
(Hz)
Pulse width
(msec)
Waveform
shape
Intensity Duration
(mins)
Treat-
ment sessions
per group
Capel 2003 Ear clip elec-
trodes
10 2 Not specified 12 µA 53 x 2 daily for 4
days
Cork 2004 Ear clip elec-
trodes
0.5 not specified Modified
square wave
biphasic
100 µA 60 ? daily for 3
weeks
Gabis 2003 Mas-
toid processes
and forehead
77 3.3 Biphasic
asymmetric
≤ 4 mA 30 x 1 daily for 8
days
Gabis 2009 Mas-
toid processes
and forehead
77 3.3 Biphasic
asymmetric
≤ 4 mA 30 x 1 daily for 8
days
Katsnelson
2004
Mas-
toid processes
and forehead
Not specified Not specified 2 conditions:
symmetric,
asymmetric
11 to 15 mA 40 x 1 daily for 5
days
Lichtbroun
2001
Ear clip elec-
trodes
0.5 Not specified Biphasic
square wave
100 µA 60 x 1 daily for 30
days
Tan 2000 Ear clip elec-
trodes
0.5 Not specified Not specified 10 to 600 µA 12 (timing not
specified)
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Table 2. CES studies - characteristics of stimulation (Continued)
Tan 2006 Ear clip elec-
trodes
Not specified Not specified Not specified 100 to500µA 60 x 1 daily for 21
days
Table 3. tDCS studies - characteristics of stimulation
Study Location of
stimulation
Electrode pad
size
Intensity (mA) Anodal or catho-
dal?
Stimulus dura-
tion (mins)
Treatment ses-
sions per group
Boggio 2009 M1 contralateral
to painful side
35 cm2 2 mA Anodal 30 1
Fenton 2009 M1 dominant
hemisphere
35 cm2 1 mA Anodal 20 2
Fregni 2006a M1 contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Fregni 2006b M1 & DLPFC
contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
Mori 2010 M1 contralateral
to painful side
35 cm2 2 mA Anodal 20 5, x 1 daily
Valle 2009 M1 & DLPFC
contralateral
to painful side or
dominant hand
35 cm2 2 mA Anodal 20 5, x 1 daily
M1 = primary motor cortex, DLPFC = dorsolateral prefrontal cortex
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy (via Ovid)
1. exp Pain/
2. ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or temp?
romandib* joint or central or post*stroke or complex or regional or spinal cord) adj4 pain*).ab,ti.
3. (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti.
4. 1 or 3 or 2
5. exp Electric Stimulation Therapy/
6. ((brain* or cortex or cortical or transcranial* or cranial or magneti* or direct current or DC or electric*) adj4 stimulat*).ab,ti.
7. ((crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti.
8. ((non-invasive or non*invasive) adj4 stimulat*).ab,ti.
9. (theta burst stimulat* or iTBS or cTBS).ab,ti.
10. (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti.
11. (electrosleep or electronarco*).ab,ti.
12. 8 or 6 or 11 or 7 or 10 or 9 or 5
13. 4 and 12
Cochrane highly sensitive search strategy
Adapted Cochrane Highly Sensitive Search Strategy for MEDLINE (Higgins 2008) designed to identify RCTs and other trials which
may be suitable for inclusion in the review:
1. randomised controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. (placebo or sham).ab,ti.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
Appendix 2. Full list of searches and results
1. PaPaS specialised register, saved search: 177 results
“electric* stimulat* therap*” or “brain* stimulat*” or “cort* stimulat*” or “transcranial* stimulat*” or “cranial stimulat*” or “magneti*
stimulat*” or “direct current stimulat*” or “electric* stimulat*” or electrostim* or electrotherapy* or electro-therap* or “theta burst
stimulat*” or “transcran* magnet* stimulat*” or iTBS or cTBS or rTMS or “transcran* direct current stimulat*” or tDCS or electrosleep
or electronarco*
2. CENTRAL in The Cochrane Library
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#1 MeSH descriptor Pain explode all trees 25049
#2 (chronic* or back or musculoskel* or intractabl* or
neuropath* or phantom limb or fantom limb or neck or
myofasc* or “temporomandib* joint” or “temperomandib*
joint” or “tempromandib* joint” or central or (post NEXT
stroke) or complex or regional or “spinal cord”) near/4
pain*:ti,ab,kw
7785
#3 (sciatica or back-ache or back*ache or lumbago or
fibromyalg* or (trigemin* near/2 neuralg*) or (herp* near/2
neuralg*) or (diabet* near/2 neuropath*) or (reflex near/4
dystroph*) or (sudeck* near/2 atroph*) or causalg* or whip-
lash or whip*lash or polymyalg* or (failed back near/4
surg*) or (failed back near/4 syndrome*)):ti,ab,kw
3040
#4 (#1 OR #2 OR #3) 30353
#5 MeSH descriptor Transcranial Magnetic Stimulation
explode all trees
328
#6 MeSH descriptor Electronarcosis explode all trees 34
#7 (brain* or cortex or cortical or transcranial* or cranial or
magneti*) near/4 stimulat*:ti,ab,kw
1388
#8 (transcrani* or crani* or brain*) near/4 (electrostim* or
electro-stim* or electrotherap* or electro-therap*):ti,ab,kw
45
#9 (non-invasive or non*invasive) near/4 stimulat*:ti,ab,kw 55
#10 “theta burst stimulat*” or iTBS or cTBS:ti,ab,kw 9
#11 “transcranial magnetic stimulation” or rTMS or
“transcranial direct current stimulat*” or tDCS or “cranial
electrostimulation” or “cranial electrotherap*”:ti,ab,kw
747
#12 (electrosleep* or electronarco*):ti,ab,kw 45
#13 (#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR
#12)
1505
#14 (#4 AND #13) 106
3a. MEDLINE
Database: Ovid MEDLINE(R) <1950 to November Week 3 2009>
1 exp Pain/ (252061)
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2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (61945)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (25802)
4 1 or 3 or 2 (288507)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (4240)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (21248)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (116)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (526)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (359)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (5306)
11 (electrosleep or electronarco*).ab,ti. (357)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (23212)
13 4 and 12 (1069)
14 randomised controlled trial.pt. (291031)
15 controlled clinical trial.pt. (82962)
16 randomized.ab. (196258)
17 (placebo or sham).ab,ti. (164609)
18 drug therapy.fs. (1385685)
19 randomly.ab. (141449)
20 trial.ab. (203139)
21 groups.ab. (961704)
22 or/14-21 (2562312)
23 exp animals/ not humans.sh. (3518581)
24 22 not 23 (2157467)
25 24 and 13 (219)
3b. Database: Ovid MEDLINE(R) In-process & Other non-indexed citations
<November 25, 2009>
1 exp Pain/ (6)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (4772)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (1251)
4 1 or 3 or 2 (5661)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (0)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (1057)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (5)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (42)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (38)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (375)
11 (electrosleep or electronarco*).ab,ti. (0)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (1113)
13 4 and 12 (39)
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4. Database: EMBASE
<1980 to 2009 Week 47>
1 exp Pain/ (394924)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or
“temporomandib* joint*” or “temperomandib* joint*” or “tempromandib* joint*” or central or post*stroke or complex or regional or
spinal cord) adj4 pain*).ab,ti. (57196)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (21356)
4 1 or 3 or 2 (410258)
5 Transcranial Magnetic Stimulation/ or Electronarcosis/ (5841)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (18227)
7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (74)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (498)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (330)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (5259)
11 (electrosleep or electronarco*).ab,ti. (20)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (19954)
13 4 and 12 (1331)
14 random*.ti,ab. (415216)
15 factorial*.ti,ab. (8708)
16 (crossover* or cross over* or cross-over*).ti,ab. (40788)
17 placebo*.ti,ab. (114266)
18 (doubl* adj blind*).ti,ab. (87525)
19 (singl* adj blind*).ti,ab. (7775)
20 assign*.ti,ab. (113729)
21 allocat*.ti,ab. (36179)
22 volunteer*.ti,ab. (102464)
23 CROSSOVER PROCEDURE.sh. (21985)
24 DOUBLE-BLIND PROCEDURE.sh. (74829)
25 RANDOMIZED CONTROLLED TRIAL.sh. (176320)
26 SINGLE BLIND PROCEDURE.sh. (8721)
27 or/14-26 (691134)
28 ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/ (3551150)
29 HUMAN/ (6702208)
30 28 and 29 (569432)
31 28 not 30 (2981718)
32 27 not 31 (601828)
33 32 and 13 (234)
5. Database: PsycINFO
<1806 to November Week 4 2009>
1 exp Pain/ (26560)
2 ((chronic* or back or musculoskel* or intractabl* or neuropath* or phantom limb or fantom limb or neck or myofasc* or temp?
romandib* joint or central or post*stroke or complex or regional or spinal cord) adj4 pain*).ab,ti. (14094)
3 (sciatica or back-ache or back*ache or lumbago or fibromyalg* or (trigemin* adj2 neuralg*) or (herp* adj2 neuralg*) or (diabet*
adj2 neuropath*) or (reflex adj4 dystroph*) or (sudeck* adj2 atroph*) or causalg* or whip-lash or whip*lash or polymyalg* or (failed
back adj4 surg*) or (failed back adj4 syndrome*)).ab,ti. (2649)
4 1 or 3 or 2 (30822)
5 Transcranial Magnetic Stimulation/ or Electrosleep treatment/ (1830)
6 ((brain* or cortex or cortical or transcranial* or cranial or magneti*) adj4 stimulat*).ab,ti. (7832)
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7 ((transcrani* or crani* or brain*) adj4 (electrostim* or electro-stim* or electrotherap* or electro-therap*)).ab,ti. (47)
8 ((non-invasive or non*invasive) adj4 stimulat*).ab,ti. (144)
9 (theta burst stimulat* or iTBS or cTBS).ab,ti. (259)
10 (transcranial magnetic stimulation or rTMS or transcranial direct current stimulation or tDCS or cranial electrostimulation or
cranial electrotherapy).ab,ti. (2652)
11 (electrosleep or electronarco*).ab,ti. (140)
12 8 or 6 or 11 or 7 or 10 or 9 or 5 (8307)
13 4 and 12 (277)
14 (random* or placebo* or sham or trial or groups).ti,ab. (391590)
15 13 and 14 (64)
6. CINAHL
<Search run 11 January 2010>
1 exp PAIN/ 64959
2 ((chronic* OR back OR musculoskel* OR intractabl* OR
neuropath* OR phantom limb OR fantom limb OR neck
OR myofasc* OR ”temporomandib* joint*“ OR ”tempero-
mandib* joint*“ OR ”tempromandib* joint*“ OR central OR
post*stroke OR complex OR regional OR spinal cord) AND
pain*).ti,ab
25127
3 (sciatica OR back-ache OR back*ache OR lumbago OR fi-
bromyalg* OR ”trigemin* neuralg*“ OR ”herp* neuralg*“ OR
”diabet* neuropath*“ OR ”reflex dystroph*“ OR ”sudeck*
atroph*“ OR causalg* OR whip-lash OR whip*lash OR
polymyalg* OR ”failed back surg*“ OR ”failed back syn-
drome*“).ti,ab
4111
4 1 OR 2 OR 3 75018
5 ELECTRONARCOSIS/ 1
6 ELECTRIC STIMULATION/ 3829
7 ((brain* OR cortex OR cortical OR transcranial* OR cranial
OR ”magneti*) AND stimulat*).ti,ab
545
8 ((transcrani* OR crani* OR brain*) AND (electrostim* OR
electro-stim* OR electrotherap* OR electro-therap*)).ti,ab
26
9 ((“non-invasive brain” OR “non*invasive brain”) AND stimu-
lat*).ti,ab
12
10 (“theta burst stimulat*” OR iTBS OR cTBS).ti,ab 16
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(Continued)
11 (“transcranial magnetic stimulation” OR rTMS OR “transcra-
nial direct current stimulation” OR tDCS OR “cranial elec-
trostimulation” OR “cranial electrotherapy”).ti,ab
437
12 (electrosleep OR electronarco*).ti,ab 1
13 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 4387
14 4 AND 13 836
15 exp CLINICAL TRIALS/ 79642
16 (clinical AND trial*).af 148411
17 ((singl* OR doubl* OR trebl* OR tripl*) AND (blind* OR
mask*)).ti,ab
11736
18 (Randomi?ed AND control* AND trial*).af 65515
19 RANDOM ASSIGNMENT/ 22506
20 (Random* AND allocat*).ti,ab 3666
21 placebo*.af 34556
22 PLACEBOS/ 5386
23 QUANTITATIVE STUDIES/ 5131
24 15 OR 16 OR17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 176918
25 14 AND 24 226
7. SCOPUS
We did not to search this database as it includes all of MEDLINE, all of EMBASE and some of CINAHL, which have been searched
separately.
8. Search strategy for LILACS
http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/
1. Pain$ or dolor$ or intractabl$ or neuropath$ or phantom or fantom or myofasc$ or temp$romandibular or sciatic$ or back-ache or
backache or ache or lumbago or fibromyalg$ or neuralg$ or dystroph$ or atroph$ or causalgi$ or whip-lash or whiplash or polymyalg$
[Words]
2. ((Estimulaci$ or stimulat$) and (cerebra$ or brain$ or cortex or cortical or crania$ or transcranial$ or magneti$)) or electrostim$ or
electrotherapy$ or electro-therap$ or “theta burst stimul$” or iTBS or Ctbs or “transcrani$ magnet$ stimulat$” or rTMS or “transcrani$
direct current stimulat$” or tDCS or “cranial electrostimulat$” or “cranial electrotherapy$ or electrosleep or electronarco$ [Words]
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3. ((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation
OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR
(Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw
investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw
blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw
randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT
(Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR
Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) ANDNOT (Ct animal ANDNOT (Ct human and Ct animal)))
[Words]
4. 1 and 2 and 3 (68)
Appendix 3. Summary table of search results
Version Date of
Search
Records
retrieved
RCT/CCT
filter applied
Records
retrieved
Duplicates Unique records
1. PaPaS reg-
ister
July 09 17/11/09 177 no 177 2 175
2.
CENTRAL,
TheCochrane
Library
Issue 4 2009 30/11/09 106 CENTRAL 98 30 68
3a. Ovid
MEDLINE
1950
to November
Week 3
30/11/09 1069 Adapted
CHSSS
219 96 123
3b.
Ovid MED-
LINE In-Pro-
cess & Other
Non-Indexed
Citations
25 November 30/11/09 39 no 39 6 33
4. EMBASE
(Ovid)
1980 to 2009
Week 47
30/11/09 1331 yes 234 89 145
5. PsycINFO
(Ovid)
1806
to November
Week 4 2009
30/11/09 277 yes 64 45 19
6. CINAHL 1981 to
present
11/01/10 836 yes 226 37 189
7. SCOPUS Not searched
8. LILACS 15/12/09 yes 68 0 68
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(Continued)
REVIEWS
and TAs
9.
COCHRANE
REVIEWS
(CDSR)
Issue 4 2009 30/11/09 106 3 3
10. DARE Issue 4 2009 30/11/09 106 3 3
11. Tech as-
sessments
Issue 4 2009 30/11/09 106 2 2
12. Articles
identified by
authors post
search (not
from search
process)
3 3
13. Ad-
ditional arti-
cles identified
from
searching the
reference lists
(original pa-
pers and re-
views)
15 15
TOTALS Not including
extras
1133 305 843
Appendix 4. Trials register search results
Database Date of search Search strategy No. hits Agreed potential stud-
ies
National Research Reg-
ister (NRR) Archive
(NIHR)
23/10/09 (chronic* or back
or musculoskel* or in-
tractabl* or neuropath*
or phantom limb or fan-
tom limb or neck or
myofasc* or temp?ro-
mandib joint or central
or post*stroke or com-
366 2
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(Continued)
plex or regional or spinal
cord or sciatica or back-
ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or dia-
bet* neuropath* or re-
flex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash
or polymyalg* or failed
back surg* or failed back
syndrome) AND (brain*
or cortex or cortical or
transcranial* or cranial
or
magneti* or direct cur-
rent or DC or electric or
crani* or electrostim* or
electrotherap* or electro-
therap* or non-invasive
or non*invasive or theta
burst stimulat* or iTBS
or Ctbs or transcranial
magnetic stimulation or
rTMS or transcranial di-
rect current stimulation
or tDCS or cranial elec-
trostimulation or cranial
electrotherapy
or electrosleep or elec-
tronarco*) IN “TITLE”
Field
Clinicaltrials.gov 23/10/09
Search 1
Field - Interventional
studies
CONDITION:
chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck
OR myofasc* OR temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
62
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(Continued)
INTER-
VENTION: brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
Clinicaltrials.gov 23/10/09
Search 2
Field - Interventional
studies
CONDITION:
chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck
OR myofasc* OR temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica OR back-ache OR
back*ache OR lumbago
INTERVENTION:
transcranial magnetic
stimulation OR rTMS
OR transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*
OUTCOME: pain
8 (all also picked up in
search 1)
Clinicaltrials.gov 23/10/09
Search 3
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
0
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(Continued)
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed
back syndrome
INTER-
VENTION: brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap* OR electro-
therap* OR non-inva-
sive OR non*invasive
OR theta burst stimulat*
OR iTBS OR Ctbs
OUTCOME: pain
Clinicaltrials.gov 23/10/09
Search 4
Field - Interventional
studies
CONDITION:
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph* OR sudeck* at-
roph* OR causalg* OR
whip-lash OR whip*lash
or polymyalg* OR failed
back surg* OR failed
back syndrome
INTERVENTION:
transcranial magnetic
stimulation OR rTMS
OR transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*
OUTCOME: pain
0
TOTAL UNIQUE RE-
SULTS FOR CLINI-
CAL TRIALS.GOV
62 7
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(Continued)
HSRProj (Health Ser-
vices Research Projects
in Progress)
23 October 2009 (chronic* or back
or musculoskel* or in-
tractabl* or neuropath*
or phantom limb or fan-
tom limb or neck or
myofasc* or temp?ro-
mandib joint or central
or post*stroke or com-
plex or regional or spinal
cord or sciatica or back-
ache or back*ache or
lumbago or fibromyalg*
or trigem* neuralg* or
herp* neuralg* or dia-
bet* neuropath* or re-
flex dystroph* or sudeck*
atroph* or causalg* or
whip-lash or whip*lash
or polymyalg* or failed
back surg* or failed back
syndrome) AND (brain*
or cortex or cortical or
transcranial* or cranial
or
magneti* or direct cur-
rent or DC or electric or
crani* or electrostim* or
electrotherap* or electro-
therap* or non-invasive
or non*invasive or theta
burst stimulat* or iTBS
or Ctbs or transcranial
magnetic stimulation or
rTMS or transcranial di-
rect current stimulation
or tDCS or cranial elec-
trostimulation or cranial
electrotherapy
or electrosleep or elec-
tronarco*)
77 0
Current Controlled Tri-
als
23/10/09
Search 1
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(cranial electrother-
apy OR electrosleep OR
0
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(Continued)
electronarco*)
Current Controlled Tri-
als
23/10/09
Search 2
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(Ctbs OR transcranial
magnetic stimulation
OR rTMS OR transcra-
nial direct current stimu-
lationOR tDCSORcra-
nial electrostimulation )
0
Current Controlled Tri-
als
23/10/09
Search 3
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(crani* OR electrostim*
OR
electrotherap* OR elec-
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
4
Current Controlled Tri-
als
23/10/09
Search 4
(sudeck* atroph*
OR causalg* OR whip-
lash OR whip*lash OR
polymyalg* OR failed
back surg* OR failed
back syndrome) AND
(brain* OR cortex OR
corticalOR transcranial*
OR cranialORmagneti*
OR direct current OR
DC)
13
Current Controlled Tri-
als
23/10/09
Search 5
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(cranial electrostimula-
0
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(Continued)
tion
OR cranial electrother-
apy OR electrosleep OR
electronarco*)
Current Controlled Tri-
als
23/10/09
Search 6
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(Ctbs OR transcranial
magnetic stimulation
OR rTMS OR transcra-
nial direct current stim-
ulation OR tDCS )
9
Current Controlled Tri-
als
03/11/09
Search 7
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(crani* OR electrostim*
OR electrotherap* OR
electro-therap*)
36
Current Controlled Tri-
als
23/10/09
Search 8
(back-
ache OR back*ache OR
lumbago OR
fibromyalg* OR trigem*
neuralg* OR herp* neu-
ralg* OR diabet* neu-
ropath* OR reflex dys-
troph*) AND (non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
53
Current Controlled Tri-
als
3 November 2009
Search 9
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(cranial OR magneti*
52
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(Continued)
OR direct current OR
DC)
Current Controlled Tri-
als
03/11/09
Search 10
(back-ache
OR back*ache OR lum-
bago OR fibromyalg*
OR trigem* neuralg*
OR herp* neuralg* OR
diabet* neuropath* OR
reflex dystroph*) AND
(brain* OR cortex OR
cortical OR transcra-
nial*)
63
Current Controlled Tri-
als
03/11/09
Search 11
(temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica) AND(cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*)
0
Current Controlled Tri-
als
03/11/09
Search 12
(temp?
romandib joint OR cen-
tral OR post*stroke OR
complex OR regional
OR spinal cord OR sci-
atica) AND (transcranial
direct current stimula-
tion OR tDCS)
11
Current Controlled Tri-
als
03/11/09
Search 13
(central OR post*stroke
OR com-
plex OR regional OR
spinal cord OR sciatica)
AND (iTBS OR cTBS
OR transcranial mag-
netic stimulation OR
rTMS)
48
Current Controlled Tri-
als
03/11/09
Search 14
(central OR post*stroke
OR complex OR re-
gional OR spinal cord
OR sciatica) AND (elec-
trotherap* OR electro-
therap* OR non-inva-
199
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(Continued)
sive OR non*invasive
OR theta burst stimu-
lat*)
Current Controlled Tri-
als
03/11/09
Search 15
(central OR
post*stroke OR complex
OR regional OR spinal
cord OR sciatica) AND
(brain* OR cortex OR
corticalOR transcranial*
OR cranialORmagneti*
OR direct current OR
DC OR crani* OR elec-
trostim*)
1905
Current Controlled Tri-
als
03/11/09
Search 16
(temp?romandib joint)
AND (brain* OR cor-
texOR cortical OR tran-
scranial* OR cranial OR
magneti* OR direct cur-
rent ORDCOR electric
OR crani* OR electros-
tim* OR electrotherap*
OR electro-therap*)
0
Current Controlled Tri-
als
03/11/09
Search 17
(temp?romandib joint)
AND (iTBS OR cTBS
OR transcranial mag-
netic stimulation OR
rTMS)
0
Current Controlled Tri-
als
03/11/09
Search 18
(temp?romandib joint)
AND (non-invasive OR
non*invasive OR theta
burst stimulat*)
0
Current Controlled Tri-
als
03/11/09
Search 19
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (transcranial di-
rect current stimulation
OR tDCS OR cranial
electrostimulation
OR cranial electrother-
apy OR electrosleep OR
electronarco*)
16
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(Continued)
Current Controlled Tri-
als
03/11/09
Search 20
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (Ctbs OR tran-
scranial magnetic stimu-
lation OR Rtms)
55
Current Controlled Tri-
als
03/11/09
Search 21
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (crani* OR elec-
trostim* OR
electrotherap* OR elec-
tro-therap* OR non-in-
vasive OR non*invasive
OR theta burst stimulat*
OR iTBS)
557
Current Controlled Tri-
als
03/11/09
Search 22
(chronic* OR back OR
musculoskel* OR in-
tractabl*ORneuropath*
OR phantom limb OR
fantom limb OR neck)
AND (brain* OR cor-
texOR cortical OR tran-
scranial* OR cranial OR
magneti* OR direct cur-
rent OR DC)
2385
Current Controlled Tri-
als
19/11/09
Search 23
(temp*romandibular
joint) AND (brain* OR
cortex OR cortical OR
transcranial* OR cranial
OR magneti* OR di-
rect current ORDCOR
electric OR crani* OR
electrostim* OR elec-
trotherap*)
8
Current Controlled Tri-
als
19/11/09
Search 24
(temp*romandibular
joint) AND (elec-
tro-therap* OR non-in-
vasive OR non*invasive
1
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(Continued)
OR theta burst stimu-
lat* OR iTBS OR Ctbs
OR transcranial mag-
netic stimulation)
Current Controlled Tri-
als
19/11/09
Search 25
(temp*romandibular
joint) AND (rTMS OR
transcranial direct
current stimulation OR
tDCS OR cranial elec-
trostimulation OR cra-
nial electrotherapy OR
electrosleep OR elec-
tronarco*)
0
TOTAL
RESULTS FOR CUR-
RENT CON-
TROLLED TRIALS
5415 14
TOTAL
RESULTS FROM ALL
DATABASES
23
DUPLICATES BE-
TWEEN DATABASES
7
FINAL TOTAL FROM
TRIALS REGISTERS
SEARCHES
16
WH A T ’ S N E W
Last assessed as up-to-date: 22 April 2010.
Date Event Description
11 May 2011 Amended Contact details updated.
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H I S T O R Y
Protocol first published: Issue 1, 2010
Review first published: Issue 9, 2010
Date Event Description
13 September 2010 Amended The risk of bias tables have been amended so that the criteria “allocation concealment” is not
assessed for studies with cross-over designs and the criteria “free from carry-over effects?” is not
assessed for studies with parallel designs. These changes are now reflected in Figure 1 where those
criteria now appear as empty boxes for the appropriate studies. This is in line with the original
review protocol and the changes are necessary due to a copy-editing error rather than any change
to the review methods.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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C O N T R I B U T I O N S O F A U T H O R S
NOC: Conceived and designed the review protocol, co-implemented the search strategy alongside the Cochrane PaPaS Group Trials
Search Co-ordinator, applied eligibility criteria, assessed studies, extracted and analysed data, and lead the write up of the review.
BM: Closely informed the protocol design and acted as the second review author, applied eligibility criteria, assessed studies, extracted
data and assisted with the write up of the review.
LM: Provided statistical advice and support throughout the review and contributed to the design of the protocol.
LDS: Was involved in the conception and design of the review and acted as a third review author for conflicts in applying eligibility
criteria and assessing included studies.
SS: Informed the design of the protocol and has supported the implementation and reporting of the review throughout.
All authors read and commented upon the systematic review and commented on and approved the final manuscript.
D E C L A R A T I O N S O F I N T E R E S T
None known.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The database Scopus was not searched as the other searches had covered the full scope of this database.
As described in detail in Unit of analysis issues, on advice from a Cochrane statistician parallel and cross-over studies were meta-
analysed using the generic inverse variance method rather than combining them without this statistical adjustment as was specified in
the protocol. Subsequently the planned sensitivity analysis investigating the influence of study design was not deemed necessary.
The following decision was taken on encountering multiple outcomes within the same time period: for short-term outcomes where
more than one data point was available, we used the first post-stimulation measure, where multiple treatments were given we took the
first outcome at the end of the treatment period. For medium-term outcomes where more than one data point was available we used
the measure that was closest to the mid-point of this time period. It was decided to pool data from studies with a low or unclear risk
of bias as it was felt that the analysis specified in the protocol(including only those studies with an overall low risk of bias) was too
stringent and would not allow any statistical assessment of the data.
We have not used the GRADE approach (Guyatt 2008) to synthesising the evidence as we felt that individual discussion of the available
data would be more informative.
We did not use overall risk of bias in sensitivity analyses as we found that it lacked sensitivity. Instead we considered individual criteria
on the risk of bias assessment for sensitivity analyses. However, we excluded studies with a ’high’ risk of bias for any criterion from the
meta-analysis.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pain Management; Brain [∗physiology]; Chronic Disease; Electric Stimulation Therapy [adverse effects; ∗methods]; Magnetic Field
Therapy [adverse effects; ∗methods]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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